Patheon 10-K 10 Jan 14 2013 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Oct. 31, 2013	Jan. 08, 2014	Apr. 30, 2013
Document and Entity Information [Abstract]	'	'	'
Entity Registrant Name	'PATHEON INC	'	'
Entity Central Index Key	'0001400431	'	'
Current Fiscal Year End Date	'--10-31	'	'
Entity Filer Category	'Accelerated Filer	'	'
Document Type	'10-K	'	'
Document Period End Date	31-Oct-13	'	'
Document Fiscal Year Focus	'2013	'	'
Document Fiscal Period Focus	'FY	'	'
Amendment Flag	'false	'	'
Entity Common Stock, Shares Outstanding	'	140,938,525	'
Entity Well-known Seasoned Issuer	'No	'	'
Entity Voluntary Filers	'No	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Public Float	'	'	$208,149,058

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Oct. 31, 2013		Oct. 31, 2012
In Millions, unless otherwise specified
Current	'		'
Cash and cash equivalents	$61.60	[1]	$39.40	[1]
Accounts receivable, net	191.3	[2]	161.7	[2]
Inventories	137.8		82.3
Income taxes receivable	3.6		0.4
Prepaid expenses and other	15.3		11.9
Deferred tax assets—short term	6.1		4.3
Total current assets	415.7		300
Capital assets	496.7		416.4
Intangible assets	69.2		0
Deferred financing costs	20.2		4.9
Deferred tax assets	0.1		0
Goodwill	48.5		3.5
Investments	8.4		6.3
Other long-term assets	19		11.8
Total assets	1,077.80		742.9
Current	'		'
Short-term borrowings	3		2.4
Accounts payable and accrued liabilities	221.9		186.2
Income taxes payable	0.1		5.7
Deferred revenues—short term	15		13.9
Deferred tax liability - short term	0.1		0
Current portion of long-term debt	6.8		0
Total current liabilities	246.9		208.2
Long-term debt	599.2		310.7
Deferred revenues	20.1		28.9
Deferred tax liabilities	43.4		23
Other long-term liabilities	41.8		47.8
Total liabilities	951.4		618.6
Shareholders' equity	'		'
Restricted voting shares	610.6		572.5
Contributed surplus	16.7		16.5
Accumulated deficit	-514.5		-478.6
Accumulated other comprehensive income	13.6		13.9
Total shareholders' equity	126.4		124.3
Total liabilities and shareholders' equity	$1,077.80		$742.90
[1]	Includes cash and cash equivalents in bank accounts bearing interest rates up to 1%.
[2]	Includes accounts receivable, net of an allowance for doubtful accounts of $1.8 million and $0.8 million at October 31, 2013 and 2012, respectively.

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	12 Months Ended
In Millions, except Share data in Thousands, unless otherwise specified	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011
Income Statement [Abstract]	'	'	'
Revenues	$1,023.10	$749.10	$700
Cost of goods sold	774	589.8	568.2
Gross profit	249.1	159.3	131.8
Selling, general and administrative expenses	163.6	128.6	120.2
Research and development	10.9	0	0
Repositioning expenses	15.8	6.1	7
Acquisition and integration costs	13.1	3.2	0
Impairment charge	13.1	57.9	0
(Gain) loss on sale of capital assets	-1.3	0.4	0.2
Operating income (loss)	33.9	-36.9	4.4
Interest expense, net	47.8	26.5	25.6
Foreign exchange loss (gain)	0.8	0.5	-1.6
Refinancing expenses	29.2	0	0
Other income, net	-1.6	-0.9	-4.9
Loss from continuing operations before income taxes	-42.3	-63	-14.7
Current	8.7	9.2	1.6
Deferred	-15.3	34.2	-0.5
(Benefit from) provision for income taxes	-6.6	43.4	1.1
Loss from continuing operations	-35.7	-106.4	-15.8
Loss from discontinued operations	-0.2	-0.3	-0.6
Net loss for the period	-35.9	-106.7	-16.4
Net loss attributable to restricted voting shareholders	($35.90)	($106.70)	($16.40)
Basic and diluted loss per share	'	'	'
From continuing operations (in dollars per share)	($0.26)	($0.82)	($0.12)
From discontinued operations (in dollars per share)	($0.00)	($0.00)	($0.01)
Basic and diluted (loss) income per share (in dollars per share)	($0.26)	($0.82)	($0.13)
Weighted-average number of shares outstanding during period—basic and diluted (in thousands)	140,072	129,639	129,639

Consolidated_Statements_of_Oth

Consolidated Statements of Other Comprehensive Loss Statement (USD $)	12 Months Ended
In Millions, unless otherwise specified	Oct. 31, 2013		Oct. 31, 2012		Oct. 31, 2011
Statement of Comprehensive Income [Abstract]	'		'		'
Net loss attributable to restricted voting shareholders	($35.90)		($106.70)		($16.40)
Change in foreign currency translation on investments in subsidiaries, net of hedging activities	3.4	[1]	-11.9	[1]	5.3	[1]
Change in value of derivatives designated as foreign currency and interest rate cash flow hedges	-5	[2]	1.3	[2]	1.7	[2]
(Losses) gains on foreign currency and interest rate cash flow hedges reclassified to consolidated statement of operations	-0.6	[3]	0.5	[3]	-3	[3]
(Losses) gains on foreign currency and interest rate cash flow hedges reclassified to consolidated statement of operations3	1.9		-0.2		-2.5
Comprehensive loss attributable to restricted voting shareholders	($36.20)		($117)		($14.90)
[1]	Net of an income tax benefit of $0.0 million (2013), a benefit of $0.5 million (2012), and a benefit of $0.4 million (2011). The cumulative translation adjustment as of October 31, 2013 was $41.4 million versus $38.0 million as of October 31, 2012.
[2]	Net of an income tax benefit of $0.0 million (2013), a benefit of $0.1 million (2012), and an expense of $0.5 million (2011).
[3]	Net of an income tax benefit of $1.1 million (2011).

Consolidated_Statements_of_Oth1

Consolidated Statements of Other Comprehensive Loss - Parenthetical Information(Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011
Statement of Comprehensive Income [Abstract]	'	'	'
Net income tax (benefit) expense, tax	$0	$0.50	$0.40
Cumulative translation adjustment, tax	41.4	38	'
Net income tax (benefit) expense, tax	0	0.1	0.5
Net income tax benefit, tax	'	'	($1.10)

Consolidated_Statements_of_Cha

Consolidated Statements of Changes in Shareholders' Equity (USD $)	Total		Restricted Voting Shares [Member]	Contributed Surplus [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Income [Member]
In Millions, unless otherwise specified
Balance at Oct. 31, 2010	$249.10		$571.90	$10	($355.50)	$22.70
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'		'	'	'	'
Stock-based compensation	3.5		0	3.5	0	0
Comprehensive income (loss):	'		'	'	'	'
Net loss attributable to restricted voting shareholders	-16.4		0	0	-16.4	0
Change in foreign currency translation on investments in subsidiaries, net of hedging activities	5.3	[1]	0	0	0	5.3
Change in value of derivatives designated as foreign currency cash flow hedges	1.7	[2]	0	0	0	1.7
(Losses) gains on foreign currency and interest rate cash flow hedges reclassified to consolidated statement of operations3	-3	[3]	0	0	0	-3
Net change in minimum pension liability	-2.5		'	'	'	-2.5
Subtotal	-14.9		0	0	-16.4	1.5
Balance at Oct. 31, 2011	237.7		571.9	13.5	-371.9	24.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'		'	'	'	'
Stock options exercised	0.4		0.5	-0.1	'	'
Stock-based compensation	3.1		0	3.1	0	0
Foreign currency translation adjustments	0.1		0.1	'	'	'
Comprehensive income (loss):	'		'	'	'	'
Net loss attributable to restricted voting shareholders	-106.7		0	0	-106.7	0
Change in foreign currency translation on investments in subsidiaries, net of hedging activities	-11.9	[1]	0	0	0	-11.9
Change in value of derivatives designated as foreign currency cash flow hedges	1.3	[2]	0	0	0	1.3
(Losses) gains on foreign currency and interest rate cash flow hedges reclassified to consolidated statement of operations3	0.5	[3]	0	0	0	0.5
Net change in minimum pension liability	-0.2		'	'	'	-0.2
Subtotal	-117		0	0	-106.7	-10.3
Balance at Oct. 31, 2012	124.3		572.5	16.5	-478.6	13.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'		'	'	'	'
Proceeds from equity offering, net	29.2		29.2	0	'	'
Stock options exercised	5.9		8.9	-3	'	'
Stock-based compensation	3.2		0	3.2	0	0
Comprehensive income (loss):	'		'	'	'	'
Net loss attributable to restricted voting shareholders	-35.9		0	0	-35.9	0
Change in foreign currency translation on investments in subsidiaries, net of hedging activities	3.4	[1]	0	0	0	3.4
Change in value of derivatives designated as foreign currency cash flow hedges	-5	[2]	0	0	0	-5
(Losses) gains on foreign currency and interest rate cash flow hedges reclassified to consolidated statement of operations3	-0.6	[3]	0	0	0	-0.6
Net change in minimum pension liability	1.9		'	'	'	1.9
Subtotal	-36.2		0	0	-35.9	-0.3
Balance at Oct. 31, 2013	$126.40		$610.60	$16.70	($514.50)	$13.60
[1]	Net of an income tax benefit of $0.0 million (2013), a benefit of $0.5 million (2012), and a benefit of $0.4 million (2011). The cumulative translation adjustment as of October 31, 2013 was $41.4 million versus $38.0 million as of October 31, 2012.
[2]	Net of an income tax benefit of $0.0 million (2013), a benefit of $0.1 million (2012), and an expense of $0.5 million (2011).
[3]	Net of an income tax benefit of $1.1 million (2011).

Consolidated_Statement_of_Cash

Consolidated Statement of Cash Flows (USD $)	12 Months Ended
In Millions, unless otherwise specified	Oct. 31, 2013		Oct. 31, 2012		Oct. 31, 2011
Statement of Cash Flows [Abstract]	'		'		'
Loss from continuing operations	($35.70)		($106.40)		($15.80)
Operating activities	'		'		'
Depreciation and amortization	48.4		40.8		53.2
Impairment charge	13.1		57.9		0
Other non-cash interest	9.7		1.2		1.1
Change in other long-term assets and liabilities	-14.4		-2.2		-4
Deferred income taxes	-15.3		34.2		-0.6
Amortization of deferred revenues	-18.3		-13.1		-45
(Gain) loss on sale of capital assets	-1.3		0.4		0.2
Stock-based compensation expense	3.2		3.1		3.5
Excess tax benefit from share-based payment arrangements	-1		0		0
Other	-1.3		-0.9		-0.1
Total of net income and non-cash charges	-12.9		15		-7.5
Net change in non-cash working capital balances related to continuing operations	8.8		-6.8		1
Increase in deferred revenues	17.3		25.2		30.4
Cash provided by operating activities of continuing operations	13.2		33.4		23.9
Cash used in operating activities of discontinued operations	-0.2		-0.4		-1
Cash provided by operating activities	13		33		22.9
Investing activities	'		'		'
Additions to capital assets	-49.8		-53.4		-47.8
Proceeds on sale of capital assets	6.6		0.4		0.4
Proceeds on sale of business, net	0		1		0
Acquisitions, net of cash acquired	-256.1		0		0
Cash used in investing activities of continuing operations	-299.3		-52		-47.4
Cash provided by investing activities of discontinued operations	0		0.1		0
Cash used in investing activities	-299.3		-51.9		-47.4
Financing activities	'		'		'
(Decrease) increase in short-term borrowings	0		-3.8		4.2
Proceeds from long-term borrowings	647		40.9		13.5
Increase in deferred financing costs	-22.7		0		0
Repayment of debt, net of penalty payment	-353.5		-11.1		-15
Share issuance costs	-0.8		0		0
Proceeds on issuance of restricted voting shares	35.9		0.3		0
Excess tax benefit from share-based payment arrangements	1		0		0
Cash provided by financing activities of continuing operations	306.9		26.3		2.7
Cash provided by financing activities	306.9		26.3		2.7
Effect of exchange rate changes on cash and cash equivalents	1.6		-1.4		1.7
Net increase (decrease) in cash and cash equivalents during the period	22.2		6		-20.1
Cash and cash equivalents, beginning of period	39.4	[1]	33.4		53.5
Cash and cash equivalents, end of period	61.6	[1]	39.4	[1]	33.4
Supplemental cash flow information	'		'		'
Interest paid	42.1		25.4		25
Income taxes paid (received), net	$13.30		$2.20		($1.30)
[1]	Includes cash and cash equivalents in bank accounts bearing interest rates up to 1%.

Nature_of_Business

Nature of Business	12 Months Ended
	Oct. 31, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Nature of Business	'
	NATURE OF BUSINESS
	Nature of business
	Patheon Inc. ("Patheon" or the "Company") is a Canadian public company, which trades under the symbol PTI on The Toronto Stock Exchange ("TSX"). The Company is an independent provider of drug development and manufacturing services to global pharmaceutical, biotechnology and specialty pharmaceutical companies.
	Patheon's commercial manufacturing outsourcing services ("CMO") relate primarily to various sterile dosage forms, as well as solid oral, conventional and specialized dosage forms. The Company's sterile dosage forms include aseptically (sterile) filled and terminally sterilized liquids and vials, bottles and pre-filled syringes and sterile lyophilized (freeze-dried) products in vials. Conventional dosage forms include both coated and uncoated compressed tablets and hard shell gelatin and softgel capsules. The Company manufactures to customer specifications a wide variety of products in many packaging formats. The Company can be responsible for each aspect of the manufacturing and packaging process, from sourcing raw materials and packaging components to delivering the finished product in consumer-ready form to the customer's distribution facilities. As a result of our acquisition of all of the issued and outstanding shares of capital stock of Sobel USA Inc., a Delaware corporation, and Banner Pharmacaps Europe B.V., a private limited company organized under the laws of The Netherlands (collectively "Banner") for an aggregate purchase price of $269.0 million (the "Banner Acquisition"), the Company's services now also include development, licensing and commercialization of proprietary prescription, over the counter and nutritional products.
	Patheon's pharmaceutical development services ("PDS") include dosage form development, analytical methods development, pilot batch manufacture of new products for the regulatory drug approval process and the provision of scale-up services designed to demonstrate that a drug can be manufactured in commercial volumes.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	12 Months Ended
	Oct. 31, 2013
Accounting Policies [Abstract]	'
Summary of Significant Accounting Policies	'
	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Principles of consolidation and basis of presentation
	The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions have been eliminated.
	The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States ("U.S. GAAP") requires management to make estimates and assumptions that affect: the reported amounts of assets and liabilities; the disclosure of contingent assets and liabilities at the date of the consolidated financial statements; and the reported amounts of revenue and expenses in the reporting period. Management believes that the estimates and assumptions used in preparing its consolidated financial statements are reasonable and prudent; however, actual results could differ from those estimates.
	Certain prior year amounts in the audited consolidated financial statements have been reclassified to conform to the current year's presentation.
	Segment Information
	U.S. GAAP requires segmentation based on an entity’s internal organization and reporting of revenue and operating income based upon internal accounting methods commonly referred to as the “management approach.” Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker (“CODM”), or decision making group, in deciding how to allocate resources and in assessing performance. The Company’s CODM is its Chief Executive Officer. The Company has determined that, through the end of the year ended October 31, 2013 ("fiscal 2013"), it had two operating and reportable segments.
	Foreign exchange translation
	The Company's assets and liabilities that are not denominated in U.S. dollars are translated into U.S. dollars as follows: non-monetary assets are translated using the exchange rate in effect at year end, non-monetary assets and liabilities are translated at the exchange rates in effect at the time of acquisition or issue, and revenues and expenses are translated at the average rate during each month. Translation gains and losses related to the carrying value of the Company's foreign operations are included in accumulated other comprehensive income in shareholders' equity. Foreign exchange gains and losses on transactions occurring in a currency different than the entity's functional currency are reflected in income (loss).
	Revenue recognition
	The Company recognizes revenue for its commercial manufacturing and pharmaceutical development services when services are completed in accordance with specific agreements with its customers and when all costs connected with providing these services have been incurred, the price is fixed or determinable and collectability is reasonably assured. Customer deposits on pharmaceutical development services in progress are included in accounts payable and accrued liabilities.
	In the case of pharmaceutical development services, revenue is recognized on the achievement of specific milestones in accordance with the respective development service contracts. In the case of commercial manufacturing services, revenue is recognized when services are complete and the product has met rigorous quality assurance testing.
	The Company now manufactures and sells proprietary products as a result of the Banner Acquisition. With respect to the sales of these products, the Company recognizes revenue when title has transferred to the customer and the customer has assumed the risks and rewards of ownership. The Company also has agreements with various distributors that allow the Company to share in product profits. The Company recognizes these profits once the distributor ships the product and title passes to the distributor's customer. The Company does not offer return policies to its customers except for defective products.
	Deferred revenues
	The costs of certain capital assets are reimbursed to the Company by the pharmaceutical companies that are to benefit from the improvements in connection with the manufacturing and packaging agreements in force. These reimbursements are recorded as deferred revenues and are recognized as income over the remaining minimum term of the agreements. In certain instances the Company receives prepayment for future services and these amounts are amortized over the future required service periods.
	Goodwill
	Goodwill represents the excess of the purchase price of the Company's interest in subsidiary companies over the fair value of the underlying net identifiable assets arising on acquisitions, with a significant amount being recorded in fiscal 2013 as a result of the Banner Acquisition. The Company tests goodwill for impairment at least annually in the fiscal fourth quarter, or when indications of potential impairment exist. The Company monitors for the existence of potential impairment indicators throughout the fiscal year. Testing is performed with respect to each of the Company's reporting units that have been allocated goodwill, which the Company has determined are the sites within its CMO segment.
	If the Company's qualitative assessment reveals that goodwill impairment is more likely than not, the Company performs the two-step impairment test. Alternatively, the Company may bypass the qualitative test and initiate goodwill impairment testing with the first step of the two-step goodwill impairment test.
	During the first step of the goodwill impairment test, the Company compares the fair value of the reporting unit to its carrying value, including goodwill. If the fair value of a reporting unit exceeds its carrying value, then the Company concludes that no goodwill impairment has occurred. If the carrying value of the reporting unit exceeds its fair value, the Company performs the second step of the goodwill impairment test to measure possible goodwill impairment loss. During the second step, the Company hypothetically values the reporting unit's tangible and intangible assets and liabilities as if the reporting unit had been acquired in a business combination. The Company then compares the implied fair value of the reporting unit's goodwill to the carrying value of its goodwill. If the carrying value of the reporting unit's goodwill exceeds the implied fair value of the goodwill, the Company recognizes an impairment loss in an amount equal to the excess, not to exceed the carrying value of the reporting unit's goodwill. Once an impairment loss is recognized, the adjusted carrying value of the goodwill becomes the new accounting basis of the goodwill for the reporting unit.
	Intangible Assets
	As a result of the Banner Acquisition, the Company has recorded various intangible assets, including technology, in process research and development, customer relationships and trade names. The Company tests for impairment of definite lived intangible assets whenever events or changes in circumstances indicate that the carrying amount will not be recoverable.
	If such indicators are present, the Company assesses the recoverability of the intangible assets by determining whether the carrying value of such assets can be recovered through undiscounted future cash flows. If the sum of the undiscounted cash flows is less than the carrying amount, the excess of the carrying amount over the estimated fair value, based on the discounted cash flows, is recorded as a charge to earnings.
	For indefinite-lived intangible assets other than goodwill, the Company compares the fair value of the intangible asset with the asset's carrying amount. If the fair value is less than the carrying amount, the Company recognizes an impairment. This impairment test for indefinite-lived intangible assets other than goodwill is conducted annually, concurrently with the goodwill impairment test.
	Research and development expenses
	The Company now has research and development costs that are expensed as incurred. These expenses relate to proprietary research and development efforts and consist of salaries and benefits, supplies and other costs.
	Distribution expenses
	Costs, such as freight and handling, associated with the distribution of Banner's products are expensed within SG&A expenses when incurred. Distribution costs were $2.6 million in fiscal 2013 and $0 in the year ended October 31, 2012 ("fiscal 2012").
	Financial assets and liabilities
	All financial instruments, including derivatives, are included in the consolidated balance sheets and are measured at fair value except for loans and receivables and other financial liabilities, which are measured at amortized cost. Held-for-trading financial instruments are recorded at cost as they are initiated and are subsequently measured at fair value and all revaluation gains and losses are included in net income (loss) in the period in which they arise. All financial instrument transactions are recorded on the settlement date. Please refer to Note 13—Financial Instruments, Fair Value and Risk Management.
	The Company expenses as incurred all transaction costs, including fees paid to advisors and other related costs. Financing costs, including underwriting and arrangement fees paid to lenders are deferred and carried as an asset on the balance sheet and amortized into interest expense.
	Derivatives and hedge accounting
	The Company enters into foreign exchange forward contracts and collars to reduce its exposure to foreign currency denominated cash flows and changes in the fair value of foreign denominated assets and liabilities. Please refer to Note 13—Financial Instruments, Fair Value and Risk Management.
	All derivative instruments are recorded on the consolidated balance sheets at fair value unless exempted from derivative treatment as a normal purchase and sale. All changes in their fair value are recorded in income (loss) unless cash flow hedge accounting is used, in which case the changes in the fair value associated with the effective portions of the hedge are recorded in other comprehensive income.
	Cash and cash equivalents
	Cash and cash equivalents include cash in interest-bearing accounts and term deposits with remaining maturities of less than three months at the date the term deposit was acquired.
	Inventories
	Inventories consisting of raw materials, packaging components, spare parts, work-in-process, and finished goods are valued at the lower of cost and net realizable value. Cost approximates average cost, and includes cost of purchased materials, costs of conversion, namely labor and overhead, and other costs, such as freight in, necessary to bringing the inventories to their present location and condition.
	Capital assets
	Capital assets are carried at cost less accumulated depreciation. The cost of assets disposed of and the related accumulated depreciation are removed from the accounts and any resulting gain or loss is reflected in earnings.
	Depreciation is provided on the straight-line basis based on estimated useful lives as follows:
	Buildings	30 – 50 years
	Building equipment	15 years
	Machinery and equipment	5 – 15 years
	Office equipment	3 – 10 years
	Computer software	2 – 10 years
	Furniture and fixtures	7 – 10 years
	Repairs and maintenance costs are charged to operations as incurred.
	Impairment of long-lived depreciable assets
	The Company reviews whether there are any indicators of impairment of its capital assets and identifiable intangible assets ("long-lived depreciable assets"). If such indicators are present, the Company assesses the recoverability of the assets or group of assets by determining whether the carrying value of such assets can be recovered through undiscounted future cash flows. If the sum of undiscounted future cash flows is less than the carrying amount, the excess of the carrying amount over the estimated fair value, based on discounted future cash flows, is recorded as a charge to earnings.
	Employee benefit plans
	The Company provides a number of benefit plans to its employees including:
	(a) defined benefit pension plans; (b) post-employment benefit plans; (c) defined contribution plans; and (d) unfunded termination indemnities.
	The cost of defined benefit pension plans and other post-employment benefits, which include health care and dental benefits, related to employees' current service is charged to earnings annually. The cost is computed on an actuarial basis using the projected benefit method pro-rated based on service and management's best estimates of various actuarial factors, including salary escalation, other cost escalation and retirement ages of employees.
	The valuation of defined benefit pension plan assets is at current market value, based on an actuarial valuation, for purposes of calculating the expected return on plan assets. Past service costs resulting from plan amendments are deferred and amortized on a straight-line basis over the remaining service life of employees active at the time of amendment.
	Actuarial gains and losses arise from the difference between the actual long-term rate of return on plan assets for a period and the expected long-term rate of return on plan assets for that period, or from changes in actuarial assumptions used to determine the accrued benefit obligation. The excess of the net accumulated actuarial gain or loss over 10% of the greater of the benefit obligations and the fair value of plan assets is amortized over the average remaining service period of active employees. The average remaining service period of the active employees covered by the pension plans and the other retirement benefit plans at the measurement date of October 31, 2013 is 19 years (2012—18 years). When the restructuring of a benefit plan gives rise to both a curtailment and a settlement of obligations, the curtailment is accounted for prior to the settlement.
	The cost of defined contribution plans is charged to earnings as funds are contributed by the Company.
	Unfunded termination indemnities for the employees of the Company's subsidiary in Italy and Mexico are accrued based on Italian and Mexico severance pay statutes respectively. The liability recorded on the consolidated balance sheets is the amount to which the employees would be entitled if the employees' employment with the Company ceased.
	Income taxes
	The Company follows the liability method of income tax allocation. Under this method, deferred tax assets and liabilities are determined based on differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.
	The Company evaluates its ability to realize deferred tax assets on a quarterly basis. The factors used to assess the likelihood of realization of these assets include the Company's calculation of cumulative pre-tax book income or loss, turn-around of temporary timing differences, available tax planning strategies that could be implemented to realize the deferred tax assets, and forecasted pre-tax book income and taxable income by specific tax jurisdiction. Actual results may vary from these forecasts and result in a change in the ability of the Company to realize benefits of these tax assets in the future. If the Company is unable to meet its projected forecasts or implement certain tax planning strategies in jurisdictions for which there is currently no valuation allowance, the recording of a valuation allowance may be required.
	Stock options
	The fair value of stock options granted, modified or settled is recognized on a straight-line basis over the applicable stock option vesting period as stock-based compensation expense in the consolidated statements of operations and contributed surplus in the consolidated balance sheets. On the exercise of stock options, consideration received and the accumulated contributed surplus amount is credited to share capital. The company estimates forfeitures based on a weighted-average of historical forfeitures.
	For the purposes of calculating the stock-based compensation expense, the fair value of stock options is estimated at the date of the grant using the Black-Scholes option pricing model and the cost is amortized over the vesting period. This model requires the input of a number of assumptions including dividend yields, expected stock price volatility, expected time until exercise and risk-free interest rates. Although the assumptions used reflect management's best estimates, they involve assumptions based on market conditions generally outside of the control of the Company.
Loss per share
The calculation of loss per share—from continuing and discontinued operations equals reported net loss attributable to restricted voting shareholders—from continuing and discontinued operations divided by the weighted-average number of restricted voting shares outstanding during the year. Diluted income per share would reflect the assumed conversion of all dilutive securities using the treasury stock method.
Under the treasury stock method:
•	the exercise of options is assumed to be at the beginning of the period (or at the time of issuance, if later);
•	options for which the closing fair market value exceeds the option price are the only ones that are assumed to be dilutive;
•	the proceeds from the exercise of options, plus future period compensation expense on options granted on or after November 1, 2003, are assumed to be used to purchase restricted voting shares at the average price during the period; and
•	the number of restricted voting shares assumed to be dilutive, plus the weighted-average number of restricted voting shares outstanding during the year, is used in the denominator of the diluted earnings per share computation;
Since the Company was in a loss position in fiscal 2013, fiscal 2012 and the year ended October 31, 2011 ("fiscal 2011"), there is no dilutive effect. The Company did not include in the calculation of loss per share 11,017,225, 12,479,678, and 12,628,458 outstanding options in fiscal 2013, 2012 and 2011, respectively, because they were anti-dilutive in nature.
Government financing
The Company makes periodic applications for financial assistance under available government assistance programs in the various jurisdictions in which it operates. Grants relating to capital expenditures are reflected as a reduction of the cost of the related assets. Grants and tax credits relating to current operating expenditures are generally recorded as a reduction of expenses at the time the eligible expenses are incurred. In the case of certain foreign subsidiaries, the Company receives investment incentive allowances, which are accounted for as a reduction of income tax expense.
Recently issued accounting pronouncements
In April 2012, the Jumpstart Our Business Startups Act (the "JOBS Act") was enacted. Section 107 of the JOBS Act provides that an "emerging growth company" can utilize the extended transition period that is typically available only for private companies for implementing new or revised accounting standards. In other words, as an "emerging growth company," the Company can delay the adoption of certain new or revised accounting standards until such time as those standards apply to private companies.  The Company has elected not to avail itself of this exemption and, therefore, will be implementing new or revised accounting standards at the same time as other public companies that are not "emerging growth companies." As a result of the Banner Acquisition, the Company ceased to be an emerging growth company as the Company exceeded $1.0 billion in revenue during fiscal 2013.
In July 2013, the FASB issued ASU 2013-11, “Income Taxes, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists” (“ASU 2013-11”). ASU 2013-11 states that an unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, except as follows. To the extent a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction to settle any additional income taxes that would result from the disallowance of a tax position or the tax law of the applicable jurisdiction does not require the entity to use, and the entity does not intend to use, the deferred tax asset for such purpose, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets. The amendments in ASU 2013-11 are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013, with early adoption permitted. The amendments should be applied prospectively to all unrecognized tax benefits that exist at the effective date. Retrospective application is permitted. The adoption of this guidance is not expected to have a material impact on the Company's financial statements.
In July 2013, the FASB issued ASU 2013-10, “Derivatives and Hedging, Inclusion of the Fed Funds Effective Swap Rate (or Overnight Index Swap Rate) as a Benchmark Interest Rate for Hedge Accounting Purposes” (“ASU No. 2013-10”). ASU 2013-10 permits the Fed Funds Effective Swap Rate (OIS) to be used as a U.S. benchmark interest rate for hedge accounting purposes, in addition to UST and LIBOR. The amendments also remove the restriction on using different benchmark rates for similar hedges. Prior to the amendments in this ASU, only U.S. Treasury and the LIBOR swap rates were considered benchmark interest rates. Including the Fed Funds Effective Swap Rate (OIS) as an acceptable U.S. benchmark interest rate in addition to U.S. Treasury and LIBOR rates provides a more comprehensive spectrum of interest rates to be utilized as the designated benchmark interest rate risk component under the hedge accounting guidance. The amendments in ASU 2013-10 are effective prospectively for qualifying new or redesignated hedging relationships entered into on or after July 17, 2013. The adoption of this guidance is not expected to have a material impact on the Company's financial statements.
In March 2013, the FASB issued ASU 2013-05, "Parent's Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity" ("ASU 2013-05"). ASU 2013-05 resolves the diversity in practice concerning the release of the cumulative translation adjustment into net income when a parent either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets within a foreign entity. The guidance is effective for fiscal years and interim reporting periods within those fiscal years beginning after December 15, 2013. The amendments described in the ASU are to be applied prospectively to derecognition events occurring after the effective date; prior periods are not to be adjusted. The adoption of this guidance is not expected to have a material impact on the Company's financial statements.
In February 2013, the FASB issued ASU 2013-04, "Obligations Resulting from Joint and Several Liability Arrangements for Which the Total Amount of the Obligation Is Fixed at the Reporting Date" ("ASU 2013-04"). ASU 2013-04 provides guidance for the recognition, measurement and disclosure resulting from joint and several liability arrangements. Examples of obligations that fall within the scope of the ASU include certain debt arrangements, other contractual obligations and settled litigation. The new guidance is effective on a retrospective basis for fiscal years and interim periods within those fiscal years beginning after December 15, 2013. The adoption of this guidance is not expected to have a material impact on the Company's financial statements.
In February 2013, the FASB issued ASU 2013-02, "Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income" ("ASU 2013-02"). ASU 2013-02 requires enhanced disclosures about items reclassified out of accumulated other comprehensive income ("AOCI"). For items reclassified to net income in their entirety, the ASU requires information about the effect of significant reclassification items to appear on separate line items of net income. For those items where direct reclassification to net income is not required, companies must provide cross-references to other disclosures that provide details about the effects of the reclassification out of AOCI. Expanded disclosures concerning current period changes in AOCI balances are also required for each component of other comprehensive income on the face of the financial statements or in the notes. ASU 2013-02 is effective prospectively for fiscal years beginning after December 15, 2012, and interim periods within those fiscal years. The adoption of this guidance is not expected to have a material impact on the Company's financial statements.
In December 2011, the FASB issued ASU 2011-11, "Disclosures about Offsetting Assets and Liabilities," which requires enhanced disclosures about financial instruments and derivative instruments that are either (i) offset in accordance with either Section 210-20-45 or 815-10-45 or (ii) subject to an enforceable master netting arrangement or similar agreement, irrespective of whether they are offset in accordance with either Section 210-20-45 or Section 815-10-45. The amendments are effective for annual reporting periods beginning on or after January 1, 2013 and interim periods within those annual periods. The amendments are required to be applied retrospectively for all prior periods presented. The adoption of this guidance is not expected to have a material impact on the Company's financial statements.

Banner_Acquisition

Banner Acquisition	12 Months Ended
	Oct. 31, 2013
Business Combinations [Abstract]	'
Banner Acquisition	'
	BANNER ACQUISITION
	Background
	On December 14, 2012, the Company completed the Banner Acquisition. Banner is a pharmaceutical business focused on delivering proprietary softgel formulations, with four manufacturing facilities and a number of proprietary technologies and products.
	Purchase price allocation
	The Banner Acquisition is accounted for using the acquisition method of accounting in accordance with ASC Subtopic 805-10, "Business Combinations," and the fair value concepts set forth in ASC Subtopic 820-10, "Fair Value Measurements and Disclosures". Under ASC 805-10, the total purchase price for Banner was allocated to the assets acquired and liabilities assumed based on their respective fair values as of the acquisition date. The allocation of the purchase price is based on estimates and assumptions that are subject to change within the measurement period. The excess of the purchase price over the fair values of the assets acquired and liabilities assumed was recorded as goodwill. Goodwill largely consists of geographic expansion of product sales, manufacturing and other synergies of the combined companies, and the value of the assembled workforce.
	The estimated purchase price allocation for the Banner Acquisition is as follows:
		$
	Cash and cash equivalents	12.7
	Accounts receivable	53.4
	Inventories	53.7
	Income taxes receivable	4.3
	Prepaid expenses and other	3.6
	Deferred tax assets-short-term	1.8
	Capital assets	91
	Intangible assets	75.1
	Goodwill	45.1
	Deferred tax assets - long-term	0.1
	Other long-term assets	0.3
	Accounts payable and accrued liabilities	(35.7	)
	Deferred tax liabilities - short-term	(0.4	)
	Other long-term liabilities	(1.4	)
	Deferred tax liabilities-long-term	(34.6	)
	Total purchase price	269
	The Company recorded all of the $45.1 million of goodwill to its CMO segment. In addition, the Company does not expect any of the goodwill to be tax deductible.
	Valuations of intangible assets acquired
	The weighted-average life of the acquired intangible assets is approximately 11.0 years. The following table sets forth the components of the acquired intangible assets by type:
		Estimated Fair Value		Estimated Useful Life (in years)
		$
	Trade names	0.8		6-May
	Technology	46.4		12-Oct
	Customer relationships	11.1		12-Jul
	In-process research and development(1)	16.8		Indefinite
	Total	75.1
	(1) In process research and development was classified as indefinite-lived intangible assets at the time of the acquisition and will either begin to be amortized upon product approvals or written-off if not approved.
	Purchase price allocation and pre-acquisition adjustments
	The Company continues to evaluate pre-acquisition contingencies and tax balances including deferred tax assets and liabilities relating to Banner that existed as of the acquisition date. If the Company makes changes to the amounts recorded or identifies additional pre-acquisition contingencies during the remainder of the measurement period, such amounts recorded will be included as an adjustment to the purchase price allocation during the measurement period.
	Financial results of the acquired business
	The revenues and loss from continuing operations of Banner for the period from December 15, 2012 through October 31, 2013 included in the consolidated statement of operations are as follows:
		2013
		$
	Revenues	217.3
	Loss from continuing operations	(55.9	)
	Pro forma financial information
	The following table presents pro forma results of operations and gives effect to the Banner Acquisition as if the transaction had been consummated on November 1, 2011. This unaudited pro forma financial information is provided for informational purposes only and is not necessarily indicative of what the actual results of operations would have been had the transactions taken place on November 1, 2011, nor is it indicative of the future consolidated results of operations or financial position of the combined companies.
		Twelve months ended October 31,
		2013		2012
		$		$
	Revenues	1,056.70		1,016.40
	Loss from continuing operations	(9.1	)	(117.8	)
	Loss per share from continuing operations, basic and diluted	(0.065	)	(0.909	)
	The unaudited pro forma financial information was prepared using the acquisition method of accounting and is based on the historical financial information of the Company and Banner, reflecting the Company's and Banner's combined results of operations for the twelve month periods ended October 31, 2013 and 2012. The historical financial information has been adjusted to give effect to the pro forma events that are (i) directly attributable to the Banner Acquisition, (ii) factually supportable and (iii) expected to have a continuing impact on the combined results of the Company and Banner. The unaudited pro forma consolidated results reflect primarily the following pro forma adjustments:
	•	additional interest expense and related refinancing costs related to the long-term debt used to fund the acquisition;
	•	additional amortization expense related to the fair-value of identifiable intangible assets acquired;
	•	additional cost of goods sold resulting from an increase in the fair value of acquired inventory and an increase in depreciation expense relating to the fair values of acquired property and equipment; and
	•	removal of acquisition-related costs.

Discontinued_Operations_Plant_

Discontinued Operations, Plant Consolidations, Sales and Asset Impairments	12 Months Ended
	Oct. 31, 2013
Discontinued Operations and Disposal Groups [Abstract]	'
Discontinued Operations, Plant Consolidations, Sales and Asset Impairments	'
	DISCONTINUED OPERATIONS, PLANT CONSOLIDATIONS, SALES AND ASSET IMPAIRMENTS
	Puerto Rico
	The Company previously announced its plan to consolidate its Puerto Rico operations into its manufacturing site located in Manati and sell its plant in Caguas and that additional time was required to transition manufacturing operations from Caguas to Manati due to longer than expected customer regulatory time lines and increased product demand. The Company now expects the plant to close in the first quarter of fiscal 2014 and the total project repositioning expenses to be $14.2 million, of which $1.3 million was recorded in fiscal 2013. Because the business in the Caguas facility is being transferred within the existing site network, its results of operations are included in continuing operations in the consolidated financial statements.
	As previously announced, on February 28, 2013, the Company entered into a sale-leaseback agreement for the Caguas facility for $7.0 million. The lease agreement is a month to month tenancy and the Company currently expects to vacate the facility as of January 31, 2014. As a result of the sale leaseback, the Company recorded a prepaid rent asset for $1.5 million during the second quarter, which it began amortizing immediately. A gain of $1.1 million was recognized upon the sale.
	The results of discontinued operations for the Company's Carolina facility (which the Company closed effective January 31, 2009) for fiscal 2013, 2012 and 2011 are as follows:
		Years ended October 31,
		2013		2012		2011
		$		$		$
	Revenues	—		—		—
	Cost of goods sold	—		—		—
	Gross loss	—		—		—
	Selling, general and administrative expenses	0.2		0.4		0.6
	Gain on sale of capital assets	—		(0.1	)	—
	Operating loss	(0.2	)	(0.3	)	(0.6	)
	Loss before income taxes	(0.2	)	(0.3	)	(0.6	)
	Net loss for the period	(0.2	)	(0.3	)	(0.6	)
	On February 17, 2012, the Company finalized the sale of the Carolina, Puerto Rico facility for a nominal amount.
	United Kingdom
	In the second quarter of fiscal 2012, the Company determined to make certain adjustments over the ensuing 24 to 36 months to the scale and scope of business conducted at its Swindon, U.K., facility. These adjustments include winding down or transferring non-cephalosporin commercial production to other facilities and, to the extent possible and commercially appropriate, directing PDS projects that require commercialization activities to other facilities. The Company is working with each of its affected commercial customers to develop plans to maintain supply chain continuity to the extent possible and commercially appropriate.
	In connection with the change in the scale and scope of business to be conducted at its Swindon facility, the Company conducted an impairment analysis on long-term assets at the facility and concluded that a non-cash impairment charge of $57.9 million was required in the second quarter of fiscal 2012 to bring the assets down to their fair value of $9.5 million. The impairment charges reduced assets in the CMO segment by $55.1 million and PDS assets by $2.8 million.
	The impairment analysis included fair value (Level 3) measurements resulting from future cash flows from operations, as well as market value approach of land and buildings, internal transfer of assets, and expected salvage value on equipment. Cash inflows were based on current customer expectations and future contract expiry dates.  Cash outflows were based on expenses needed to run the facility in each period including on-going maintenance and capital expenditures.  The Company determined that, in light of certain restrictive covenants that require the use of the Swindon facility as a business industrial site, the best use of the asset is to continue using it in the pharmaceutical business.  The corporate weighted-average cost of capital was used for discounting future cash flows.
	Canada
	Subsequent to the closing of the Banner Acquisition, the Company performed a review of Banner's facilities and decided to close the Olds, Alberta, Canada facility by October 31, 2013. As a result of this decision, the Company conducted an impairment analysis on the long-term assets at this facility. Based on this analysis, which is discussed more fully below, the Company concluded that a non-cash impairment charge of $11.8 million was required to reduce the carrying value of the long-term assets to their fair value and that a non-cash impairment charge of $0.1 million was required to reduce the carrying value of the goodwill allocated to the Olds, Alberta, Canada reporting unit to its fair value. The impairment charges reduced assets in the CMO segment by a total of $11.8 million, of which $10.1 million was recorded in the first quarter of fiscal 2013. In the fourth quarter of fiscal 2013, the Company signed an asset purchase agreement with an outside party for $3.8 million, subject to normal closing adjustments. The carrying value of the land, building, and equipment was therefore reduced to the sale price less residual equipment sold to other Patheon sites. This resulted in a $1.7 million impairment charge in the fourth quarter of fiscal 2013. The Olds, Alberta, Canada facility was sold on November 1, 2013.
	Following the completion of the impairment analysis for the long-term assets at the Olds, Alberta, Canada facility, the Company evaluated whether the goodwill allocated to the Olds, Alberta, Canada reporting unit was impaired. The Company bypassed the qualitative assessment of whether it was more likely than not that goodwill was impaired, and performed the two-step impairment test. Because the reporting unit's carrying value is being reduced to net working capital plus the salvage value of the property, plant and equipment, the Company determined that there was no remaining value for the goodwill and thus it was fully impaired. The net amount required to be booked for the impairment of goodwill in the first quarter of fiscal 2013 was
	$0.1 million.
	On August 31, 2012, the Company completed the sale of Burlington Clinical Services ("BCS"), its global secondary clinical packaging and clinical distribution services business, to Bellwyck Packaging Solutions, a private company with 20 years experience providing clinical trial and contract services for secondary packaging. The total consideration for the sale of this business was approximately $2.70 million, of which $1.35 million was paid in cash at closing (subject to the retention of certain amounts in escrow) and $1.35 million to be paid in 24 months from the closing date if certain revenue targets are met by the new owner. The Company recognized a $0.4 million loss on the sale of the business in the consolidated statement of operations as "Loss on sale of capital assets."

Supplemental_Balance_Sheet_Inf

Supplemental Balance Sheet Information	12 Months Ended
	Oct. 31, 2013
Supplemental balance sheet information [Abstract]	'
Supplemental Balance Sheet Information	'
	SUPPLEMENTAL BALANCE SHEET INFORMATION
	Inventories
		As of October 31,
		2013			2012
		$			$
	Raw materials, packaging components and spare parts	78.7			47.9
	Work-in-process	42.3			34.4
	Finished goods	16.8			—
	Balance, end of the year	137.8			82.3
	Change in finished goods inventory is a result of the Banner Acquisition.
	Below is a roll-forward of the Company's inventory provisions for fiscal 2013 and 2012:
		As of October 31,
		2013			2012
		$			$
	Balance, beginning of the year	(14.0	)		(12.6	)
	Additions	(14.2	)		(6.5	)
	Write-offs	4.4			5.1
	Balance, end of the year	(23.8	)		(14.0	)
	Accounts payable and accrued liabilities
	The following is the breakdown of accounts payable and accrued liabilities:
		As of October 31,
		2013			2012
		$			$
	Trade payables	133			101.2
	Interest payable	1.7			1
	Accrued salaries and related expenses	52.9			51.4
	Customer deposits	16.7			16.4
	Other accruals	17.6			16.2
	Balance, end of the year	221.9			186.2
	Intangible assets
	As part of the Banner Acquisition, the Company obtained intangible assets. The following table summarizes gross carrying amounts and accumulated amortization related to the Company's identifiable intangible assets as of October 31, 2013:
		Gross carrying value			Accumulated amortization		Impairment		Net carrying value
	Trade names	0.8			(0.1	)	—		0.7
	Technology	46.4			(3.6	)	—		42.8
	Customer relationships	11.1			(1	)	—		10.1
	In-process research and development	16.8			—		(1.3	)	15.5
	Foreign exchange	0.1			—		—		0.1
	Balance, end of period	75.2			(4.7	)	(1.3	)	69.2
	Banner's in-process research and development (“IP R&D”) is classified as definite-lived or indefinite-lived depending on whether the product has been approved. IP R&D for products that have been approved is classified as a definite-lived intangible asset and is amortized over the life of the product. IPR&D for products that have not been approved is classified as an indefinite-lived intangible asset and either begins to be amortized upon approval or is written-off if the product is not approved. During fiscal 2013, the Company curtailed two Banner IP R&D projects which resulted in a $1.2 million impairment charge. Additionally, as a result of the annual impairment testing of indefinite-lived intangible assets, the Company incurred an additional charge of $0.1 million in fiscal 2013.
	Goodwill
	The following table summarizes the changes between October 31, 2012 and October 31, 2013 in the carrying amount of goodwill in total and by reporting segment:
		Commercial			PDS		Corp. & Other		Total
	Balance at October 31, 2012	3.5			—		—		3.5
	Additions	45.1			—		—		45.1
	Impairments	(0.1	)		—		—		(0.1	)
	Balance at October 31, 2013	48.5			—		—		48.5
	Deferred revenues
	The following table summarizes the deferred revenue activity for each of fiscal 2013, 2012 and 2011:
	Balance at October 31, 2010	$	45.9
	Cash received from customers	30.4
	Cash repaid to customers	(3.1		)
	Amortization of deferred revenues	(45.0		)
	Foreign exchange	0.2
	Other (1)	8.1
	Balance at October 31, 2011	$	36.5
	Cash received from customers	25.2
	Cash repaid to customers	(5.7		)
	Amortization of deferred revenues	(13.1		)
	Foreign exchange	(0.1		)
	Balance at October 31, 2012	$	42.8
	Cash received from customers	17.3
	Cash repaid to customers	—
	Amortization of deferred revenues	(18.3		)
Foreign exchange	1
Other (1)	(7.7		)
Balance at October 31, 2013	$	35.1
(1) Other changes to deferred revenues primarily consist of movement between deferred revenue and other long-term liabilities and in fiscal 2011 the amendments and eventual cancellation of a manufacturing agreement.

Capital_Assets

Capital Assets	12 Months Ended
	Oct. 31, 2013
Property, Plant and Equipment [Abstract]	'
Capital Assets	'
	CAPITAL ASSETS
		As of October 31,
		2013			2012
		Cost	Accumulated	Net Book	Cost	Accumulated	Net Book
			Depreciation	Value		Depreciation	Value
		$	$	$	$	$	$
	Land	37.9	—	37.9	30.7	—	30.7
	Buildings	309.6	78.8	230.8	298	94.3	203.7
	Machinery and equipment	417.9	256.4	161.5	420.5	283.6	136.9
	Office equipment (including software)	53.8	37.1	16.7	45.4	36	9.4
	Furniture and fixtures	13.5	9.8	3.7	15.5	13.3	2.2
	Construction in progress	46.1	—	46.1	33.5	—	33.5
	Balance, end of the year	878.8	382.1	496.7	843.6	427.2	416.4
	The amount of open purchase commitments related to authorized capital projects at October 31, 2013 and 2012 was approximately $9.9 million and $16.9 million, respectively. The expenditures related to the fiscal 2013 open purchase commitments are expected to be incurred during fiscal 2014. There were no capital leases included in the Capital Assets above.

ShortTerm_Borrowings

Short-Term Borrowings	12 Months Ended
	Oct. 31, 2013
Debt Disclosure [Abstract]	'
Short-Term Borrowings	'
	SHORT-TERM BORROWINGS
		As of October 31,
		2013	2012
		$	$
	Short-term insurance premium financing	3	2.4

LongTerm_Debt

Long-Term Debt	12 Months Ended
	Oct. 31, 2013
Debt Disclosure [Abstract]	'
Long-Term Debt	'
	LONG-TERM DEBT
	Long-term debt in the accompanying consolidated balance sheets at October 31, 2013 and 2012 consists of the following:
		October 31, 2013		October 31, 2012
		$		$
	Floating LIBOR plus 6.00% with LIBOR floor of 1.25% (currently 7.25%) due December 14, 2018 (the "Secured Term Loan")	569.3		—
	Italian subsidized loan with annual interest rate of 0.5%, and maturity date of June 30, 2020	7.4		—
	Italian bank loan with Euribor 6-month + 7.1% rate, and maturity date of June 30, 2020	0.8		—
	8.625% senior secured notes due April 15, 2017 (the "Notes")	—		280
	$85 million secured revolving credit facility maturing December 14, 2017, bearing interest ranging from 5.0% to 7.75% (the "Secured Revolving Facility")	43.7		—
	$75 million senior secured revolving loan facility maturing April 23, 2014, bearing interest ranging from 4.03% to 5.75% based upon floating LIBOR, US, or CAD prime, or federal funds effective rates, plus applicable margins (the "ABL")	—		30.7
	Total long-term debt outstanding	621.2		310.7
	Less original issue discount, net of accumulated amortization of $2.1 million	(15.2	)	—
	Less current portion	(6.8	)	—
	Balance, end of the period	599.2		310.7
	On December 14, 2012, the Company completed the refinancing of its existing debt (the "Refinancing"), pursuant to which it entered into a credit agreement (the "Credit Agreement") for a secured term loan in the amount of $575.0 million (the "Secured Term Loan") and a secured revolving credit facility of up to $85.0 million (the "Secured Revolving Facility" and, together with the Secured Term Loan, the "Credit Facility"). Up to $30.0 million of the Secured Revolving Facility is available for letters of credit. The Secured Term Loan matures on December 14, 2018, and the Secured Revolving Facility matures on December 14, 2017. The Secured Term Loan bears interest at a rate per annum equal to, at the option of the Company, LIBOR plus 6.00%, with a LIBOR "floor" of 1.25%, or an alternate base rate plus 5.00%, with an alternate base rate "floor" of 2.25%. Borrowings under the Secured Revolving Facility bear interest for eurodollar loans at Libor plus 5.50% and base rate loans at the base rate plus 4.50%. The Company will also pay a commitment fee of 0.50% per annum on the unused portion of the Secured Revolving Facility with a step down to 0.375% when the First Lien Leverage Ratio (as defined in the Credit Agreement) is less than or equal to 3.00 to 1.00.
	First Lien Leverage Ratio is generally defined in the Credit Agreement as the ratio of (i) the sum of the aggregate principal amount of the Company's and its restricted subsidiaries' indebtedness for borrowed money, principal amount of capital lease obligations and debt obligations evidenced by promissory notes or similar instruments plus the unrestricted cash of the Company and its restricted subsidiaries, in each case as set forth in the Credit Agreement, to (ii) Consolidated EBITDA. Consolidated EBITDA is generally defined in the Credit Agreement as income (loss) from continuing operations before repositioning expenses, interest expense, foreign exchange losses reclassified from other comprehensive income (loss), refinancing expenses, acquisition-related costs, gains and losses on sale of capital assets, income taxes, impairment charges, depreciation and amortization, stock-based compensation expense, consulting costs related to the Company's operational initiatives, purchase accounting adjustments, other income and expenses, non-cash charges, expenses related to the Banner Acquisition, pro forma cost savings from operational excellence initiatives and plant consolidations, pro forma synergies from the Banner Acquisition, and proceeds from business interruption insurance, among other adjustments. Consolidated EBITDA is not equivalent to Adjusted EBITDA, which, as discussed in Note 15, is the Company's measure of segment performance.
	The Company is required to make the following mandatory prepayments in respect of the Secured Term Loan: (i) 50% of Excess Cash Flow (as defined in the Credit Agreement) when the Company maintains a First Lien Leverage Ratio of greater than 3.50 to 1.00, with step downs to (a) 25% when the Company maintains a First Lien Leverage Ratio of less than or equal to 3.50 to 1.00 but greater than 3.00 to 1.00 and (b) 0% when the Company maintains a First Lien Leverage Ratio of less than or equal to 3.00 to 1.00; (ii) 100% of the net cash proceeds of certain asset sales (including insurance and condemnation proceeds), subject to thresholds, reinvestment rights and certain other exceptions; and (iii) 100% of the net cash proceeds of issuances of debt obligations, subject to certain exceptions and thresholds. Excess Cash Flow is generally defined in the Credit Agreement as Consolidated EBITDA (as defined in the Credit Agreement) plus, without duplication, (i) decreases in working capital, (ii) extraordinary or nonrecurring income or gains and (iii) certain other adjustments, minus, without duplication, (a) interest, (b) taxes, (c) increases in working capital, (d) capital expenditures paid in cash and (e) certain other adjustments, in each case as set forth in the Credit Agreement. In the event the Secured Term Loan is prepaid, refinanced, substituted or replaced (including by way of amendment) in whole or in part prior to December 14, 2013 concurrently with the incurrence of indebtedness similar to the Secured Term Loan with a lower all-in yield than that of the Secured Term Loan, any amounts so prepaid, refinanced, substituted or replaced will be subject to a prepayment fee of 1.00%.
	Under the Credit Agreement, the Company is required to maintain a First Lien Leverage Ratio below a certain amount for each of the Testing Periods as set forth in the Credit Agreement. For purposes of the Credit Agreement, a Testing Period means a single period consisting of the most recent four consecutive fiscal quarters ending on the covenant determination date. The following table discloses the maximum permitted First Lien Leverage Ratios permitted under the Credit Agreement:
	Testing Period Ending		Maximum Ratio
	April 30, 2013 through July 31, 2014		5.50 to 1.00
	October 31, 2014 through July 31, 2015		5.00 to 1.00
	October 31, 2015 through April 30, 2016		4.75 to 1.00
	July 31, 2016 through October 31, 2016		4.50 to 1.00
	January 31, 2017 and thereafter		4.25 to 1.00
	The Credit Agreement also provides for (i) certain representations, warranties and affirmative covenants, (ii) certain negative covenants in addition to the requirement to maintain the First Lien Leverage Ratio levels described above, including limitations on incurring indebtedness, liens, fundamental changes, asset sales, investments, dividends and repayment of certain indebtedness, and transactions with affiliates, in each case with baskets, thresholds and exceptions, and (iii) certain events of default, including for non-payment of principal and interest, breach of affirmative or negative covenants, certain cross defaults, change in control, bankruptcy events, certain ERISA events, certain unsatisfied judgments and actual or asserted invalidity of guarantees or security documents.
	The Company's failure to maintain the required First Lien Leverage Ratio or its breach of the other covenants and requirements contained in the Credit Agreement could result in an event of default, which may allow the Company's lenders to accelerate the Company's debt and may result in the acceleration of any other debt to which a cross-acceleration or cross-default provision applies. As of October 31, 2013, the Company was in compliance with the covenants and other requirements in the Credit Agreement.
	Provided that the Company is in compliance with the First Lien Leverage Ratio test and no default under the Credit Agreement is continuing or would result therefrom, the covenant in the Credit Agreement that limits the Company's ability to pay dividends or make other distributions to its shareholders generally permits (with certain exceptions and qualifications) the Company to pay dividends or make such distributions in an aggregate amount, when taken together with the aggregate amount of any prepayment, repurchase, redemption or defeasance of subordinated indebtedness, not to exceed (i) $15.0 million plus (ii) (a) $7.5 million plus (b) the aggregate amount of Excess Cash Flows for all fiscal years beginning with fiscal 2013 (net of required prepayments) and proceeds from equity issuances. The Company historically has not paid dividends on its restricted voting shares.
	The Credit Facility is guaranteed by certain wholly owned subsidiaries of the Company and secured by a first priority pledge on substantially all of the assets of the Company and the subsidiary guarantors, in each case subject to certain exceptions.
	As part of the Refinancing, effective December 14, 2012, the Company terminated all commitments and repaid all amounts owed under its ABL. In addition, on November 26, 2012, the Company commenced a cash tender offer for its $280.0 million of the Notes. As of 12:00 midnight, New York City time, on December 13, 2012, $279.4 million principal amount of the Notes had been tendered and not validly withdrawn, representing approximately 99.8% of the aggregate outstanding principal amount of the Notes. On December 14, 2012, the Company paid an aggregate of approximately $307.2 million in order to purchase the Notes tendered prior to December 14, 2012. In addition, the Company deposited with the trustee in respect of the Notes sufficient funds to redeem the remaining outstanding Notes on January 23, 2013 and pay accrued and unpaid interest thereon. As a result, the Company was released from its obligations under the Notes and the indenture governing the Notes pursuant to the satisfaction and discharge provisions of such indenture.
	During the third quarter of fiscal 2013, the Company received assistance from the Italian government in the form of two loans. One loan is a subsidized loan for approximately €6.0 million, of which the Company received €5.4 million during the three months ended July 31, 2013 with the remaining €0.6 million to be received in the fiscal year ending October 31, 2014 ("fiscal 2014"). The subsidized loan has an annual interest rate of 0.5%, a maturity date of June 30, 2020 with fixed semi- annual payments. The other loan is a bank loan for approximately €0.7 million, of which the Company received €0.6 million during the three months ended July 31, 2013 with the remaining €0.1 million to be received in fiscal 2014. The bank loan has a Euribor 6-month + 7.1% annual interest rate, a maturity date of June 30, 2020 and six variable semi-annual payments beginning December 2017.
	In addition to the two loans above, the Company was also approved to receive a grant for approximately €0.7 million to reimburse the Company for research and development costs incurred and was booked against the cost of goods sold in fiscal year 2013.
	Estimated minimum annual repayments of long-term debt based on current exchange rates for the next five years are:
		$
	2014	6.8
	2015	6.8
	2016	6.8
	2017	6.8
	2018	50.8
	Thereafter	543.2
	Total payments	621.2
	There are no capital leases included within the above future repayments of long-term debt.

Other_LongTerm_Liabilities

Other Long-Term Liabilities	12 Months Ended
	Oct. 31, 2013
Other Liabilities Disclosure [Abstract]	'
Other Long-Term Liabilities	'
	OTHER LONG-TERM LIABILITIES
		As of October 31,
		2013	2012
		$	$
	Defined benefit pension plans	17.6	22.3
	Other post-employment benefits	7.8	8
	Unfunded termination indemnities	6.4	5.7
	Other long-term liabilities	10	11.8
		41.8	47.8
	The unfunded termination indemnities relate to the employees of the Company's Italian subsidiary in 2012 and Italian and Mexican subsidiaries in 2013. In accordance with Italian severance pay statutes, an employee benefit is accrued for service to date and is payable when the employee's employment with the Company ceases. The termination indemnity liability is calculated in accordance with local civil and labor laws based on each employee's length of service, employment category and remuneration. The Italian termination liability is adjusted annually by a cost-of-living index provided by the government. Although there is no vesting period, the Italian government has established private accounts for these benefits and has required the Company to contribute $3.1 million in fiscal 2013 and $3.0 million in fiscal 2012 to these accounts, with additional contributions in the future. The liability recorded in the consolidated balance sheets is the amount to which the employees would be entitled if their employment with the Company ceased. The related expenses for fiscal 2013, 2012 and 2011 amounted to $3.1 million, $3.0 million and $3.1 million, respectively.
	The defined benefit and other benefit plans estimates above also do not include the unfunded termination indemnities related to the employees of the Company's Mexican subsidiary, which the Company acquired as part of the Banner Acquisition. According to the Mexican labor law, a termination indemnity is payable when a company terminates an employment relationship without justified cause (as defined in the labor law) and is equal to three months of salary and benefits, plus 20 days of salary and benefits per each credited service year. The termination indemnity liability is unfunded; therefore the liability is recognized through a reserve calculated by the actuaries. The related expense for fiscal 2013 was $0.4 million, and the reserve is recorded on the consolidated balance sheet as of October 31, 2013.
	Other long-term liabilities at October 31, 2013, include $3.0 million of customer funded capital liabilities, $0.8 million of post-employment benefits, $2.5 million for a deferred compensation plan and $0.7 million of deferred rent liability. Other long-term liabilities at October 31, 2012, include $5.2 million of customer funded capital liabilities, $0.8 million of post-employment benefits, $2.2 million for a deferred compensation plan and $0.8 million of deferred rent liability.

Employee_Future_Benefits

Employee Future Benefits	12 Months Ended
	Oct. 31, 2013
Compensation and Retirement Disclosure [Abstract]	'
Employee Future Benefits	'
	EMPLOYEE FUTURE BENEFITS
	Background
	The Company has a number of defined benefit pension plans. In addition, it has other benefit plans that provide post-retirement healthcare and dental benefits. The Company measured the accrued benefit obligation and the fair value of plan assets for accounting purposes as of October 31, 2013 for the defined benefit pension and other benefit plans.
	Information about the Company's defined benefit pension and other benefit plans, in aggregate, is as follows:
		Defined		Other		Defined		Other
		Benefit		Benefit		Benefit		Benefit
		Pension		Plans		Pension		Plans
		Plans		2013		Plans		2012
		2013				2012
		$		$		$		$
	Change in benefit obligation
	Benefit obligation, beginning of the year	112.4		8		111		7
	Opening benefit obligation from Banner Acquisition	16		—		—		—
	Current service cost	2.1		0.1		2		0.1
	Prior year service costs	—		—		1.2		—
	Interest cost	5.4		0.4		5.1		0.4
	Member contributions during the year	0.4		—		0.3		—
	Effect of curtailments	-1.6		—		-7.9		—
	Benefits paid	-4.2		-0.2		-3.3		-0.2
	Actuarial loss (gain)	3.5		-0.2		4.3		0.7
	Currency translation	-1		-0.3		-0.3		—
	Benefit obligation, end of the year	133		7.8		112.4		8
	Change in plan assets
	Market value of plan assets, beginning of year	90.1		—		80.3		—
	Opening market value of plan assets from Banner Acquisition	15.6		—		—		—
	Actual return on plan assets	8.9		—		6.9		—
	Member contributions during the year	0.4		—		0.3		—
	Employer contributions	6.4		0.2		5.6		0.2
	Benefits paid	-4.2		-0.2		-3.3		-0.2
	Currency translation	-1.1		—		0.3		—
	Market value of plan assets, end of the year	116.1		—		90.1		—
	Unfunded status of plans at October 31,	-16.9		-7.8		-22.3		(8.0	)
	As of October 31, 2013 and 2012, other long-term liabilities included an accrued benefit liability of $25.4 million and $30.3 million, respectively, for the defined benefit pension plan and the other benefit plan. As of October 31, 2013 and 2012, other long-term assets included an accrued benefit asset of $0.7 million and $0.0 million, respectively. A total of $27.0 million and $29.4 million of combined net actuarial losses and unrecognized prior service costs are included in other comprehensive income for fiscal 2013 and 2012, respectively, and have not yet been recognized as a component of net periodic pension costs. Please refer to Note 9—Other Long-Term Liabilities.
	Pension plan assumptions
	The following weighted-average assumptions were used to determine the projected benefit obligation of the Company's defined benefit and other post retirement plans at the end of the respective fiscal year:
		Defined Benefit Plans						Other Benefit Plans
		2013			2012			2013		2012
	Discount rate	4.4	%		4.7	%		4.3	%	5.2	%
	Rate of future compensation increases	3.1	%		3.5	%		—	%	—	%
	The following weighted-average assumptions were used to determine the net periodic benefit cost of the Company's defined benefit and other post retirement plans during the respective fiscal year:
		Defined Benefit Plans								Other Benefit Plans
		2013			2012			2011		2013		2012		2011
	Discount rate	4.6	%		4.9	%		5.2	%	4.3	%	5.2	%	5.2	%
	Expected long-term return on plan assets	5.3	%		5.9	%		6.9	%	—	%	—	%	—	%
	Rate of future compensation increases	3.1	%		3.5	%		3.9	%	—	%	—	%	—	%
	The 4.4% weighted-average discount rate used to determine the projected benefit obligation of the Company's plans at the end of fiscal 2013 was derived by reference to appropriate benchmark yields on high quality corporate bonds, with terms which approximate the duration of the benefit payments and the relevant benchmark bond indices considering the individual plan's characteristics, to select a rate at which the Company believes the pension benefits could have been effectively settled.
	The Company selects an expected long-term rate of return on its pension plan assets and, in doing so, considers a number of factors including, without limitation, recent and historical performance of plan assets, asset allocation and other third-party studies and surveys. The Company considered the pension plan portfolios' asset allocations over a variety of time periods and compared them with third-party studies and reviewed the performance of the capital markets in recent years and other factors and advice from various third parties, such as the pension plans' advisors, investment managers and actuaries. While the Company considered both the recent performance and the historical performance of pension plan assets, the Company's assumptions are based primarily on its estimates of long-term prospective rates of return. Using the aforementioned methodologies, the Company selected the 5.3% long-term rate of return on plan assets assumption used for the pension plans during fiscal 2013. Differences between actual and expected asset returns are recognized in the net periodic benefit cost over the remaining service period of the active participating employees.
	The rate of future compensation increases is an assumption used by the actuarial consultants for pension accounting and is determined based on the Company's current expectation for such increases.
	An approximate 8% annual rate of increase in the per capita cost of covered health care and dental benefits was assumed for fiscal 2013, with the assumption that the rate will decrease gradually over the next five years to 6% and will remain at that level thereafter. The following table outlines the effects of a one-percentage-point increase and decrease in the assumed health care and dental benefit trend rates.
	(in millions of USD)	Benefit			Benefit
		Obligation			Expense
		$			$
	Impact of:
	1% increase	1.1			0.1
	1% decrease	(1.0	)		(0.1	)
	The cost components of the Company's defined benefit pension plan and other benefit plans in aggregate are as follows:
		Years ended October 31,
		2013						2012				2011
		Defined Benefit			Other Benefit			Defined Benefit		Other Benefit		Defined Benefit		Other Benefit
		Pension Plans			Plans			Pension Plans		Plans		Pension Plans		Plans
		$			$			$		$		$		$
	Service cost	2.1			0.1			2		0.1		4		0.1
	Interest cost	5.4			0.4			5.1		0.4		5.3		0.4
Expected return on plan assets	(5.7	)		—			(5.1	)	—		(5.0	)	—
Amortization of actuarial loss	1.2			—			1.1		—		0.5		—
Amortization of prior service costs	0.1			—			0.3		—		—		—
Curtailment effect	(0.7	)		—			—		—		—		—
Net periodic benefit costs	2.4			0.5			3.4		0.5		4.8		0.5
Amounts for fiscal 2013 include the defined benefit pension plans for Mexico and The Netherlands under which the Company became obligated in connection with the Banner Acquisition.
Based on current information available from actuarial estimates, the Company anticipates that contributions required under its defined benefit pension plans and other benefit plans for fiscal 2014 will be approximately $7.0 million, compared to contributions of $6.6 million and $5.8 million that were made in fiscal 2013 and 2012, respectively. Required contributions to defined benefit pension plans in future years will be dependent upon a number of variables, including the long-term rate of return on plan assets. The amounts that the Company will be required to contribute to such plans in the future may vary.
The Company also provides retirement benefits for the majority of its employees at its Canadian, U.S., U.K. and Puerto Rican sites under defined contribution pension plans. The total expense for the plans amounted to $4.8 million, $4.5 million and $2.8 million for fiscal 2013, 2012 and 2011, respectively.
The Company amended its U.K. Pension Plan to freeze the accrual of additional benefits related to future service and allow the employees to enter into a defined contribution plan effective February 1, 2012.  All current and future U.K. employees will be eligible to participate in the defined contribution plan. Any pension benefits accrued in the U.K. Pension Plan will be retained in that plan until retirement unless the plan participant chooses to transfer the benefits to another arrangement. The curtailment impact reduced the projected benefit obligation by $7.9 million. This resulting gain was applied against the accumulated unrecognized net actuarial losses in other comprehensive (loss) income.
Total cash payments for employee future benefits totaled $11.4 million, $10.3 million and $14.6 million for fiscal 2013, 2012 and 2011, consisting of cash contributed by the Company to its defined benefit pension plans of $6.4 million, $5.6 million and $10.8 million, cash payments directly to beneficiaries for its other benefit plans of $0.2 million, $0.2 million and $0.2 million and cash contributed to its defined contribution plans of $4.8 million, $4.5 million and $2.8 million, respectively.
Pension plan assets
The Pension Committee for the Company's defined benefit plans (the "Pension Committee") has adopted (and revises from time to time) an investment policy for the Canadian, U.K., Mexico, and The Netherlands defined benefit plans with the objective of meeting or exceeding, over time, the expected long-term rate of return on plan assets assumption, weighed against a reasonable risk level. In connection with this objective, the Pension Committee retains professional investment managers that invest plan assets in the following asset classes: equity and fixed income securities and cash and other investments, which may include hedge funds and private equity and global balanced strategies.
The Company's defined benefit plans currently have the following targets for these asset classes, which are intended to be flexible guidelines for allocating the plans' assets among various classes of assets, and are reviewed periodically and considered for readjustment when an asset class weighting is outside of its target (recognizing that these are flexible targets that may vary from time to time) with the objective of achieving the expected long-term rate of return on plan assets assumption, weighed against a reasonable risk level, as follows:
	Defined	Defined		Defined		Defined
	Benefit Plans	Benefit Plans		Benefit Plans		Benefit Plans
	Canada	U.K.		Mexico		The Netherlands
Asset Category:
Equity securities	30-85%	25	%	0-5%		10	%
Debt securities	30-70%	25	%	95-100%		79	%
Other	0-20%	50	%	—	%	11	%
The fair value hierarchy must have the following levels: (a) quoted prices (unadjusted) in active markets for identical assets or liabilities (Level 1); (b) inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly (i.e., as prices) or indirectly (i.e., derived from prices) (Level 2); and (c) inputs for the asset or liability that are not based on observable market data (unobservable inputs) (Level 3).
The fair values of the defined benefit plans' assets at October 31, 2013, by asset categories were as follows:
Defined Benefit Plans	Total			Level 1			Level 2		Level 3
	$			$			$		$
Asset Category:
Equity securities	40.6			—			40.6		—
Debt securities	37.2			2.1			35.1		—
Cash and other investments	38.3			0.6			37.7		—
Total pension plan assets at fair value	116.1			2.7			113.4		—
The fair values of the defined benefit plans' assets at October 31, 2012, by asset categories were as follows:
Defined Benefit Plans	Total			Level 1			Level 2		Level 3
	$			$			$		$
Asset Category:
Equity securities	33.5			—			33.5		—
Debt securities	24			—			24		—
Cash and other investments	32.6			—			32.6		—
Total pension plan assets at fair value	90.1			—			90.1		—
Within the equity securities asset class, the investment policy adopted by the Pension Committee provides for investments in a broad range of publicly-traded securities ranging from domestic and international stocks and small to large capitalization stocks. Within the debt securities asset class, the investment policy provides for investments in a broad range of publicly-traded debt securities, including domestic and international treasury issues, and corporate debt securities. In the cash and other investments asset class, investments may be in cash and cash equivalents and other investments, which may include hedge funds and private equity not covered in the classes listed above, provided that such investments are approved by the Pension Committee prior to their selection.
The Pension Committee's investment policy does not allow the use of derivatives for speculative purposes, but such policy does allow its investment managers to use derivatives for the purpose of reducing risk exposures or to replicate exposures of a particular asset class.
Estimated future benefit payments
The following benefit payments, which reflect expected future service, as appropriate, are expected to be paid out of the Company's defined benefit plans and other post-retirement benefit plans:
	Total			Total Other
	Defined			Benefit Plan
	Benefit Plan			Payments
	Payments
	$			$
2014	3			0.2
2015	3.3			0.3
2016	3.5			0.3
2017	3.5			0.3
2018	3.9			0.3
Thereafter	22.1			2.3
	39.3			3.7
The Company expects to incur approximately $0.9 million of amortization from actuarial losses as part of its pension costs in fiscal 2014.

Shareholders_Equity

Shareholders' Equity	12 Months Ended
	Oct. 31, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Shareholders' Equity	'
	SHAREHOLDERS' EQUITY
	Share capital
	Share capital consists of the following:
		As of October 31,
		2013		2012
		$		$
	Authorized
	Unlimited Class I preferred shares—Issuable from time to time in one or more series, each series comprising the number of shares and having the designation, rights, privileges, restrictions and conditions determined by the Company's Board of Directors.	—		—
	Unlimited restricted voting shares.	—		—
	Issued and outstanding
	Restricted voting shares of 140,930,525; (2012—129,297,892)	610.6		572.5
	Restricted voting shares
	The Company's articles were amended on April 26, 2007 to re-designate the common shares as restricted voting shares. This occurred in connection with the issuance of the Class I, Preferred Shares, Series D. The holders of the Class I, Preferred Shares, Series D have the right to elect three of nine members of the Board of Directors. The holders of Patheon's restricted voting shares have the right to elect the remaining members of the Board of Directors. Under the rules of the TSX, voting equity securities are not to be designated, or called, common shares unless they have a right to vote in all circumstances that is not less, on a per share basis, than the voting rights of each other class of voting securities. Accordingly, the Company amended its articles to re-designate the common shares as restricted voting shares. This re-designation involved only a change in the name of the securities; the number of shares outstanding and the terms and conditions of the outstanding shares were not affected by the change.
	As of October 31, 2013, JLL Patheon Holdings and its affiliates ("JLL") owned an aggregate of 78,524,986 Patheon restricted voting shares, representing approximately 56% of Patheon's total restricted voting shares outstanding.
	Incentive stock option plan
	The Company has an incentive stock option plan in which directors, officers and key employees of the Company and its consolidated subsidiaries, as well as other persons engaged to provide ongoing management or consulting services to Patheon, are eligible to participate. On March 10, 2011, the Company's shareholders approved an amendment to the stock option plan, which, among other things, provides that the maximum number of shares that may be issued under the plan is 15,500,151, which currently represents 11% of the issued and outstanding restricted voting shares. The plan previously provided that the maximum number of shares that may be issued under the plan was 7.5% of the sum, at any point in time, of the issued and outstanding restricted voting shares of the Company and the aggregate number of restricted voting shares issuable upon exercise of the conversion rights attached to the issued and outstanding Class I Preferred Shares, Series C of the Company. As of October 31, 2013, 2012 and 2011, the total number of restricted voting shares issuable under the plan was 15,500,151 shares, 15,500,151 shares and 15,500,151 shares, respectively, and there were stock options outstanding to purchase 11,017,225 shares, 12,479,678 shares and 12,628,458 shares, respectively, under the plan. Before the March 2011 amendments, the plan provided that the exercise prices of options were determined at the time of grant and could not be less than the weighted-average market price of the Company's restricted voting shares on the TSX during the two trading days immediately preceding the grant date. Following the March 2011 amendments, the exercise prices of the options may not be less than the closing price of the restricted voting shares on the TSX (or on such other stock exchange in Canada or the United States on which restricted voting shares may be then listed and posted) on the grant date. Options generally expire in no more than 10 years after the grant date and are subject to early expiry in the event of death, resignation, dismissal or retirement of an optionee. Options generally have vesting periods of either three years or five years, with either one-third or one-fifth vesting on each anniversary of the grant date, respectively; however, on June 18, 2012 the Company granted 1,291,750 options to its executive committee members (other than its CEO) that vest upon the earlier of (i) the achievement of an adjusted EBITDA target or (ii) five years after the date of grant.
	A summary of the plan and changes during each of fiscal 2013, 2012 and 2011 are as follows:
		2013					2012					2011
	(Dollar amounts in Canadian dollars)	Shares		Weighted-			Shares			Weighted-		Shares		Weighted-
		Number		Average			Number			Average		Number		Average
				Exercise Price						Exercise Price				Exercise Price
				$						$				$
	Outstanding, beginning of the year	12,479,678		2.54			12,628,458			2.88		8,327,357		3.26
	Granted	1,630,000		4.19			2,968,502			2.08		5,862,000		2.5
	Exercised	(2,229,150	)	2.66			(129,966	)		2.59		—		—
	Forfeited	(863,303	)	2.95			(2,987,316	)		3.37		(1,560,899	)	3.34
	Outstanding, end of the year	11,017,225		2.72			12,479,678			2.54		12,628,458		2.88
	Exercisable, end of the year	3,052,975		2.64			3,717,875			2.91		3,893,124		3.65
	The following table summarizes changes in the number and weighted-average grant date fair value of non-vested stock option awards during fiscal 2013:
	(Dollar amounts in Canadian dollars)								Non-Vested Stock Option Awards		Weighted-
											Average
											Grant Date Fair Value
											$
	Balance at beginning of the year								8,761,802		1.24
	Granted								1,630,000		2.17
	Vested								(1,922,550	)	1.29
	Forfeited								(505,002	)	1.18
	Balance at end of the year								7,964,250		1.43
	The following table summarizes information about options outstanding at October 31, 2013:
	(Dollar amounts in Canadian dollars)	Options Outstanding							Options Exercisable
	Range of Exercise Prices	Number		Weighted-		Weighted-			Number		Weighted-
		Outstanding		Average		Average			Exercisable		Average
				Remaining		Exercise					Exercise
				Contractual		Price					Price
				Life
						$					$
	$1.54 - 2.07	2,729,750		8.5		1.94			429,100		1.82
	$2.08 - 2.61	2,179,700		6		2.52			1,286,100		2.57
	$2.62 - 2.88	4,000,000		7.4		2.62			1,000,000		2.62
	$2.89 - 3.77	815,438		7.3		3.32			225,438		3.39
	$3.78 - 11.21	1,292,337		8.7		4.6			112,337		5.33
	Total	11,017,225							3,052,975
	The Company issued 2,229,150 and 129,966 restricted voting shares with an intrinsic value of approximately $3.1 million and $0.2 million under the stock option plan during fiscal 2013 and 2012. The Company did not issue any restricted voting shares under the stock option plan during fiscal 2011.
	For purposes of calculating the stock-based compensation expense in connection with the Company's incentive stock option plan, the fair value of stock options is estimated at the date of the grant using the Black-Scholes option pricing model and the cost is amortized over the vesting period.
	The weighted-average fair value per share of stock options granted during fiscal 2013, 2012 and 2011 was $2.17, $1.08 and $1.30, respectively. The fair value of stock options for purposes of determining stock-based compensation was estimated on the date of grant using the following assumptions:
		2013		2012			2011
	Risk free interest rate	1.4	%	1.3	%		2.5	%
	Expected volatility	60	%	58	%		59	%
	Expected weighted-average life of options	5.1 years		5.5 years			5 years
	Expected dividend yield	0	%	0	%		0	%
	The Company recorded stock-based compensation expense in fiscal 2013, 2012 and 2011 of $3.2 million, $3.1 million and $3.5 million, respectively.
	The total fair value of shares that vested during fiscal 2013, 2012 and 2011 was $2.5 million, $2.6 million and $2.0 million, respectively. As of October 31, 2013, the total unrecognized compensation cost related to the non-vested stock options was $4.7 million, which is expected to be recognized through fiscal 2018, with a weighted-average remaining vesting period of 2.17 years.

Other_Information

Other Information	12 Months Ended
	Oct. 31, 2013
Supplemental Cash Flow Elements [Abstract]	'
Other Information	'
	OTHER INFORMATION
	Foreign exchange
	During fiscal 2013, the Company recorded a foreign exchange loss on cash flow hedges and transactions related to operating exposures of $0.8 million. During fiscal 2012 and 2011, the Company recorded a foreign exchange loss and gain on cash flow hedges and transactions related to operating exposures of $0.5 million and $1.6 million, respectively.
	Net change in non-cash working capital balances related to continuing operations
	The net changes in non-cash working capital balances related to continuing operations are as follows:
		2013		2012
		$		$
	Accounts receivable	24.4		(17.8	)
	Inventories	(0.8	)	(2.7	)
	Income taxes receivable	(1.6	)	2.2
	Prepaid expenses and other	(1.3	)	0.7
	Accounts payable and accrued liabilities	(11.0	)	5.3
	Income taxes payable	(0.9	)	5.5
		8.8		(6.8	)
	Related party transactions
	Revenues for contract manufacturing from a company controlled by Joaquin B. Viso (the "Viso Affiliate"), a director and significant shareholder of the Company, were $0.0 million in fiscal 2013 and less than $0.3 million and $0.1 million for fiscal 2012 and 2011, respectively. These transactions were conducted in the normal course of business and are recorded at the exchanged amounts. Accounts receivable at October 31, 2013 and 2012 were nil, respectively, resulting from these transactions. In addition, Patheon manufactures a product for a third party for which the product's intellectual property is owned by the Viso Affiliate. The manufacturing agreement was originally contracted between the third party and the Viso Affiliate, but has been administered directly between Patheon and the third party on normal commercial terms since 2003.
	As of October 31, 2013 and 2012, the Company had an investment of $5.8 million and $4.0 million, respectively, representing an 18% interest in two Italian companies (collectively referred to as "BSP Pharmaceuticals") whose largest investor was an officer of the Company until December 31, 2009. These companies specialize in the manufacture of cytotoxic pharmaceutical products. As a result of the shareholders' agreement with the other investors in BSP Pharmaceuticals that provides the Company with significant influence over BSP Pharmaceuticals' operations, the Company accounts for its investment in BSP Pharmaceuticals using the equity method. Accordingly, for fiscal 2013, 2012 and 2011, the Company recorded investment income of $1.5 million, $1.0 million and less than $0.1 million, respectively.
	In connection with its investment in BSP Pharmaceuticals, the Company has a management services agreement with BSP Pharmaceuticals that provides on-going sales and marketing services, and provided engineering and operational services during the construction of the BSP facility which was completed in 2008. There were no management fees recorded under this agreement for fiscal 2013, 2012 and 2011. Accounts receivable as of October 31, 2013 and 2012 include a balance of $0.0 million, in connection with the management services agreement.
	In connection with certain of BSP Pharmaceuticals' bank financing, the Company had made commitments that it would not dispose of its interest in BSP Pharmaceuticals prior to January 1, 2011, and if needed, irrevocably inject equity (pro-rata) in order to ensure BSP complies with certain specific bank covenants.
	The board of directors of the Company authorized management to provide the support and resources of the Company to JLL in connection with the proposed transaction that is discussed in “Note 20-Subsequent Events.” JLL agreed to reimburse the Company from time to time, within 30 days following its receipt of demand therefor and reasonably detailed invoices related thereto, for certain reasonable expenses incurred by the Company in connection with, among other things, but not limited to, expenses incurred in connection with the due diligence review, tax structuring, and integration strategy and planning related to the proposed transaction. As of October 31, 2013, the Company had $3.6 million as a receivable due from JLL.
	Please refer to “Note 20-Subsequent Events” for information regarding the Arrangement Agreement (as defined in such note).

Financial_Instruments_Fair_Val

Financial Instruments, Fair Value and Risk Management	12 Months Ended
	Oct. 31, 2013
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Financial Instruments, Fair Value and Risk Management	'
	FINANCIAL INSTRUMENTS, FAIR VALUE AND RISK MANAGEMENT
	Categories of financial assets and liabilities
	The carrying values of the Company's financial instruments, including those held for sale on the consolidated balance sheets are classified into the following categories:
	As of October 31,	2013			2012
		$			$
	Held-for-trading1	61.6			39.4
	Loans and receivables2	191.3			161.7
	Other financial liabilities3	830.9			499.3
	Derivatives designated as effective hedges4—gain (loss)	(4.2	)		1.4
	Other derivatives5	0.2			0.3
	_____________________________
	-1	Includes cash and cash equivalents in bank accounts bearing interest rates up to 1%.
	-2	Includes accounts receivable, net of an allowance for doubtful accounts of $1.8 million and $0.8 million at October 31, 2013 and 2012, respectively.
	-3	Includes bank indebtedness, accounts payable, accrued liabilities and long-term debt.
	-4	Includes the Company's forward contracts and collars in 2013 and 2012.
	-5	Includes the contingent consideration receivable related to the Burlington sale.
	The Company has determined the estimated fair values of its financial instruments based on appropriate valuation methodologies; however, considerable judgment is required to develop these estimates. The fair values of the Company's financial instruments are not materially different from their carrying values.
	The Credit Agreement is not collateralized by accounts receivable or inventory. Please refer to Note 8—Long Term Debt.
	Fair value measurements
	The Company classifies and discloses its fair value measurements using a fair value hierarchy that reflects the significance of the inputs used in making the measurements. The fair value hierarchy has the following levels: (a) quoted prices (unadjusted) in active markets for identical assets or liabilities (Level 1); (b) inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly (i.e., as prices) or indirectly (i.e., derived from prices) (Level 2); and (c) inputs for the asset or liability that are not based on observable market data (unobservable inputs) (Level 3).
	The fair value is principally applied to financial assets and liabilities such as derivative instruments consisting of foreign exchange forward contracts and collars. The following table provides a summary of the financial assets and liabilities that are measured at fair value as of October 31, 2013 and 2012:
		Fair value measurement at									Fair value measurement at
		October 31, 2013 using:									October 31, 2012 using:
	Assets measured at fair value	Level 1			Level 2			Level 3		Total	Level 1	Level 2	Level 3	Total
		$			$			$		$	$	$	$	$
	Derivatives designated as hedging instruments:
	Foreign exchange forward contracts	—			—			—		—	—	2.1	—	2.1
	Total assets	—			—			—		—	—	2.1	—	2.1
	Contingent consideration receivable	—			—			0.2		0.2	—	—	0.3	0.3
	Total assets	—			—			0.2		0.2	—	—	0.3	0.3
		Fair value measurement at									Fair value measurement at
		October 31, 2013 using:									October 31, 2012 using:
	Liabilities measured at fair value	Level 1			Level 2			Level 3		Total	Level 1	Level 2	Level 3	Total
		$			$			$		$	$	$	$	$
	Derivatives designated as hedging instruments - Short Term:
	Foreign exchange forward contracts	—			2.6			—		2.6	—	—	—	—
	Foreign exchange collars	—			0.8			—		0.8	—	0.7	—	0.7
		—			3.4			—		3.4	—	0.7	—	0.7
	Derivatives designated as hedging instruments - Long Term:
	Foreign exchange forward contracts	—			0.8			—		0.8	—	—	—	—
		—			0.8			—		0.8	—	—	—	—
	The following table presents the fair value of the Company's derivative financial instruments as well as their classification on the consolidated balance sheets as of October 31, 2013 and 2012:
		Asset Derivatives as of					Asset Derivatives as of
		31-Oct-13					31-Oct-12
	Fair values of derivative instruments	Balance Sheet Location		Fair Value			Balance Sheet Location		Fair Value
				$					$
	Derivatives designated as hedging instruments:
	Foreign exchange forward contracts	Prepaid expenses and other		—			Prepaid expenses and other		1.8
	Foreign exchange forward contracts	Other long-term assets		—			Other long-term assets		0.3
	Contingent consideration receivable	Prepaid expenses and other		0.2			Prepaid expenses and other		—
	Total designated derivatives			0.2					2.1
	Contingent consideration receivable	Other long-term assets		—			Other long-term assets		0.3
	Total non-designated derivatives			—					0.3
		Liability Derivatives as of					Liability Derivatives as of
		31-Oct-13					31-Oct-12
		Balance Sheet Location		Fair Value			Balance Sheet Location		Fair Value
				$					$
	Derivatives designated as hedging instruments:
	Foreign exchange collars	Accounts payable and accrued liabilities		0.8			Accounts payable and accrued liabilities		0.3
	Foreign exchange collars	Other long-term liabilities		—			Other long-term liabilities		0.4
	Foreign exchange forwards	Accounts payable and accrued liabilities		2.6			Accounts payable and accrued liabilities		—
	Foreign exchange forwards	Other long-term liabilities		0.8			Other long-term liabilities		—
	Total designated derivatives			4.2					0.7
On August 31, 2012, the Company completed the sale of its global secondary clinical packaging and clinical distribution services business to Bellwyck Packaging Solutions. The total consideration for the sale of this business was approximately $2.70 million, of which $1.35 million was paid in cash at closing (subject to the retention of certain amounts in escrow) and $1.35 million to be paid in 24 months from the closing date if certain revenue targets are met by the new owner.
The $1.35 million that will be paid 24 months following closing is treated as a contingent consideration receivable for accounting purposes. The contingent consideration receivable was valued at $0.3 million on the closing date at fair value based upon the present value of the agreed-upon revenue targets. The fair value of the contingent consideration receivable is marked to market on a quarterly basis with an adjustment to the related receivable and the gain/loss on sale of assets.
There was no change in the fair value of the Company's Level 3 financial instrument as of October 31, 2013.
The following table presents a roll-forward of the Company's only Level 3 financial instrument as of October 31, 2013:
(in millions of USD)	Contingent Consideration			Total
	$			$
Opening balance	0.3			0.3
Purchases	—			—
Issues	—			—
Total gains (losses)
In net loss	—			—
In other comprehensive income (foreign exchange)	(0.1	)		(0.1	)
Settlements	—			—
Transfers out of Level 3	—			—
Closing balance (October 31, 2013)	0.2			0.2
Foreign exchange forward contracts, interest rate swaps and other hedging arrangements
The Company utilizes financial instruments to manage the risk associated with fluctuations in foreign exchange and interest rates. The Company formally documents all relationships between hedging instruments and hedged items, as well as its risk management objective and strategy for undertaking various hedge transactions.
As of October 31, 2013, the Company's Canadian operations had entered into foreign exchange forward contracts to sell an aggregate amount of $106.3 million. These contracts hedge the Canadian operations' expected exposure to U.S. dollar denominated cash flows and mature at the latest on July 2, 2015, at an average exchange rate of $1.0162 Canadian. The mark-to-market value of these financial instruments as of October 31, 2013 was an unrealized loss of $3.4 million, which has been recorded in accumulated other comprehensive income in shareholders' equity, net of associated income tax.
As of October 31, 2013, the Company's Canadian operations had entered into foreign exchange collars to sell an aggregate amount of US $24.2 million. These contracts hedge the Canadian operations' expected exposure to U.S. dollar denominated cash flows and mature at the latest on July 2, 2014, at an average exchange rate of $0.9938 Canadian. The mark-to-market value of these financial instruments as of October 31, 2013 was an unrealized loss of $0.8 million, which has been recorded in accumulated other comprehensive income in shareholders' equity, net of associated income tax.
As of October 31, 2012, the Company's Canadian operations had entered into foreign exchange forward contracts to sell
an aggregate amount of $69.4 million. These contracts hedge the Canadian operations' expected exposure to U.S. dollar
denominated cash flows and mature at the latest on April 2, 2014, at an average exchange rate of $1.0373 Canadian. The mark-to-market value of these financial instruments as of October 31, 2012 was an unrealized gain of $2.2 million, which has been recorded in accumulated other comprehensive income in shareholders' equity, net of associated income tax.
As of October 31, 2012, the Company's Canadian operations had entered into foreign exchange forward contracts to sell
an aggregate amount of €6.0 million. These contracts hedge the Canadian operations' expected exposure to Euro denominated
receivables and mature at the latest on October 8, 2013, at an average exchange rate of $1.3000 Canadian. The mark-to-market
value of these financial instruments as of October 31, 2012 was an unrealized loss of $0.1 million, which has been recorded in
accumulated other comprehensive income in shareholders' equity, net of associated income tax.
Risks arising from financial instruments and risk management
The Company's activities expose it to a variety of financial risks, including market risk (including foreign exchange and interest rate), credit risk and liquidity risk. The Company's overall risk management program focuses on the unpredictability of financial markets and seeks to minimize potential adverse effects on the Company's financial performance. The Company uses derivative financial instruments to hedge certain risk exposures. The Company does not purchase any derivative financial instruments for speculative purposes.
Risk management is the responsibility of the Company's corporate finance team. The corporate finance team works with the Company's operational personnel to identify, evaluate and, where appropriate, hedge financial risks. The Company's corporate finance team also monitors material risks and discusses them with the Audit Committee of the Board of Directors.
Foreign exchange risk
As of October 31, 2013, the Company operated in Canada, the United States, Italy, France, the United Kingdom, Netherlands, Mexico and Japan. Foreign exchange risk arises because the value of the local currency receivable or payable for transactions denominated in foreign currencies may vary due to changes in exchange rates ("transaction exposures") and because the non-U.S. dollar denominated financial statements of the Company may vary on consolidation into the reporting currency of U.S. dollars ("translation exposures").
The Company's most significant transaction exposures arise in its Canadian operations. Approximately 90% of the revenues of the Canadian operations and approximately 10% of its operating expenses are transacted in U.S. dollars. As a result, the Company may experience transaction exposures because of volatility in the exchange rate between the Canadian and U.S. dollar. Based on the Company's current U.S. denominated net inflows, for the year ended October 31, 2013, fluctuations of +/-10% would, everything else being equal, have an effect on loss from continuing operations before taxes of approximately +/- $18.5 million, prior to hedging activities.
The objective of the Company's foreign exchange risk management activities is to minimize transaction exposures and the resulting volatility of the Company's earnings. The Company manages this risk by entering into foreign exchange forward contracts. As of October 31, 2013, the Company has entered into forward foreign exchange contracts to cover approximately 80% of its expected Canadian-U.S. dollar cash flow exposures for fiscal 2014. The Company does not currently hedge any translation exposures.
Translation gains and losses related to certain foreign currency denominated intercompany loans are included as part of the net investment in certain foreign subsidiaries, and are included in accumulated other comprehensive income (loss) in shareholders' equity.
Credit risk
Credit risk arises from cash and cash equivalents held with banks and financial institutions, derivative financial instruments (foreign exchange forward contracts and interest rate swaps with positive fair values), and credit exposure to customers, including outstanding accounts receivable. The maximum exposure to credit risk is equal to the carrying value of the financial assets.
The objective of managing counterparty credit risk is to prevent losses in financial assets. The Company assesses the credit quality of the counterparties, taking into account their financial position, past experience and other factors. Management also monitors the utilization of credit limits regularly. In cases where the credit quality of a customer does not meet the Company's requirements, a cash deposit is received before any services are provided. As of October 31, 2013 and 2012, the Company held deposits of $16.7 million and $16.4 million, respectively.
The carrying amount of accounts receivable is reduced through the use of an allowance account and the amount of the loss is recognized in the consolidated statements of operations within operating expenses. When a receivable balance is considered uncollectible, it is written off against the allowance for accounts receivable. Subsequent recoveries of amounts previously written off are credited against operating expenses in the consolidated statements of operations.
Liquidity risk
Liquidity risk arises through the excess of financial obligations over available financial assets due at any point in time. The Company's objective in managing liquidity risk is to maintain sufficient readily available reserves in order to meet its liquidity requirements at all times. The Company mitigates liquidity risk by maintaining cash and cash equivalents on hand and through the availability of funding from credit facilities. As of October 31, 2013, the Company was holding cash and cash equivalents of $61.6 million and had undrawn lines of credit available to it of $66.1 million. The contractual maturities of the Company's financial liabilities are presented in Note 8—Long-Term Debt.

Income_Taxes

Income Taxes	12 Months Ended
	Oct. 31, 2013
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	INCOME TAXES
	The following is a reconciliation of the expected income tax (benefit) expense obtained by applying a single statutory tax rate of 25.00% (which is a mixture of federal and provincial rates) of Patheon Inc., to the loss from continuing operations before income taxes.
		As of October 31,
		2013			2012		2011
		$			$		$
	Expected income tax benefit using statutory tax rates	(10.6	)		(15.9	)	(3.9	)
	Change in valuation allowance	19			56.6		4
	Permanent differences and other:
	Foreign	(4.1	)		3.4		2.3
	Domestic	(5.5	)		(2.2	)	(5.6	)
	Foreign rate differentials	(5.4	)		1.5		2.5
	Other	—			—		1.8
	(Benefit from) provision for income taxes	(6.6	)		43.4		1.1
	Effective tax rate	15.6	%		(68.9	)%	(7.5	)%
	Permanent foreign differences reconciling expected income tax expense using statutory tax rates to the provision for income taxes were primarily meals and entertainment costs, employee costs, and salary and benefits that are not deductible in Italy, France, Canada and the United States.  Other permanent domestic differences were primarily due to recording research and development investment tax credits and the book versus tax treatment of foreign exchange gains in Canada resulting from the change in functional currency of the Company's corporate division in Canada to U.S. dollars (as previously disclosed).
	The tax effects of significant items comprising the Company's net deferred income tax liabilities are as follows:
		2013			2012
		$			$
	Net operating loss carry-forward	33.4			18
	Accounting provisions not currently deductible for tax purposes	21.8			17.7
	Unrealized foreign exchange losses (gains) on debt	5.6			(0.4	)
	Deferred financing costs	5.1			0.2
	Deferred revenue	11			12.2
	Unclaimed R&D expenditures	16.8			14
	Investment tax credits and other credits	27			20.1
	Other	0.4			—
	Tax depreciation in excess of book depreciation	(40.1	)		(28.5	)
	Valuation allowance	(91.8	)		(72.0	)
	Purchased intangible assets	(26.5	)		—
		(37.3	)		(18.7	)
	The short-term and long-term deferred income tax assets and liabilities after netting are as follows:
		2013			2012
		$			$
	Short-term deferred income tax assets	6.2			4.3
	Long-term deferred income tax liabilities	(43.5	)		(23.0	)
		(37.3	)		(18.7	)
	The Company has tax-effected net operating losses, consisting of federal, state and foreign, of $31.6 million; $15.7 million of the losses have an indefinite life and $15.9 million have expiry dates ranging from October 31, 2015 to October 31, 2033. The Company has tax credits of $39.6 million with expiry dates beginning October 31, 2017.
	The Company has not recorded deferred tax liabilities on the unremitted earnings of foreign subsidiaries as the Company currently intends to reinvest these earnings in its foreign operations indefinitely. Under Canadian tax laws, the Company's unremitted earnings from its foreign subsidiaries are exempt from income tax but may be subject to withholding tax at the source upon distribution. Determination of this withholding tax liability is not practicable.
	At the end of each quarter of fiscal 2013 the Company assessed its need for valuation allowances against its deferred tax assets in certain jurisdictions. The Company determined that it is more likely than not that a portion of its U.S. tax assets will not be realized and therefore required a valuation allowance against them. In addition, the Company released a portion of its previously established U.S. valuation allowance on other tax assets due to a change in judgment about the ability of the Company to realize those assets in the future. The net effect was an increase to the valuation allowance on the Company’s U.S. tax assets.
	As of October 31, 2013 and 2012, unrecognized tax benefits were $3.8 million and $0.8 million, respectively. The increase is primarily related to assets acquired in the Banner Acquisition. At October 31, 2013 and 2012, unrecognized tax benefits of $2.6 million and $0.0 million, respectively, related to permanent income tax differences, will have a favorable effect on the Company's effective tax rate if recognized; the remaining balance would result in a reclassification on the balance sheet.
	The Company classifies interest recognized under ASC 740 as a component of interest expense in the consolidated statements of operations. Penalties, if incurred, are recorded as other operating expenses in the consolidated statements of operations. The Company recorded no material amount of interest expense or penalties under ASC 740 for fiscal 2013 and 2012.
	For Canadian purposes, the Company is generally no longer subject to examinations for the fiscal years ended October 31, 2008 and prior. During 2012, the Canadian company was under examination by the Canada Revenue Agency for the fiscal years ended October 31, 2007 through October 31, 2008. The audit was concluded in fiscal 2013 resulting in a net deferred tax benefit to the company of $1.1 million.
	During fiscal 2012, the U.S. Internal Revenue Service conducted a desk review of the U.S. federal income tax return for the Company’s October 31, 2010 tax year as a result of a net operating loss carry-back. There were no adjustments proposed and the case was under review by the Joint Committee on Taxation. In fiscal 2013, the Joint Committee on Taxation accepted the findings of the Service.
	During fiscal 2013, the U.S. Internal Revenue Service initiated an audit of the Company’s consolidated October 31, 2011 tax year. The file was closed with no adjustments to taxable income. During fiscal 2013, the U.S. Internal Revenue Service initiated an examination of Banner's December 31, 2011 U.S. federal income tax returns. The Company has been indemnified by the sellers in the event of an unforeseen adjustment to taxable income.
	During fiscal 2011, the French tax authority concluded an examination of the Company’s income tax returns for the years ended October 31, 2007 and 2008. The Company appealed the assessment related to transfer pricing, but the French authorities maintained the assessment and the Company appealed. The examination was closed in November 2013 with no adjustments to taxable income.
	Statutes related to foreign and state jurisdictions are open from October 31, 2007 to October 31, 2013. Certain carry forward tax attributes generated in prior years remain subject to examination and adjustment.
	During the next 12 months, the Company expects no material change in the total amount of unrecognized tax benefits. A reconciliation of the beginning and ending amounts of the tax reserves is as follows:
	Balance at October 31, 2010	$	1.4
	Decrease related to positions taken in the current year	(0.8		)
	Increase based on tax positions taken in current year	0.2
	Balance at October 31, 2011	$	0.8
	Decrease related to positions taken in the current year	—
	Increase based on tax positions taken in current year	—
	Balance at October 31, 2012	$	0.8
	Decrease related to positions taken in the current year	(0.2		)
	Increase based on tax positions taken in current year	3.3
	Reductions related to lapse of applicable statute of limitations	(0.1		)
	Balance at October 31, 2013	$	3.8
	Below is a breakout of the Company's (loss) income from continuing operations before income taxes and applicable provision for (benefit from) income taxes:
		Years ended October 31,
		2013			2012		2011
	Loss from continuing operations before income taxes	$			$		$
	Domestic	(30.6	)		(14.3	)	(12.5	)
Foreign	(11.7	)		(48.7	)	(2.2	)
	(42.3	)		(63.0	)	(14.7	)
	Years ended October 31,
	2013			2012		2011
(Benefit from) provision for income taxes	$			$		$
Domestic - Current	—			—		—
Domestic - Deferred	—			34.4		—
Foreign - Current	8.7			9.2		1.6
Foreign - Deferred	(15.3	)		(0.2	)	(0.5	)
	(6.6	)		43.4		1.1

Segmented_Information

Segmented Information	12 Months Ended
	Oct. 31, 2013
Segment Reporting [Abstract]	'
Segmented Information	'
	SEGMENTED INFORMATION
	Through the end of fiscal 2013, the Company was organized and managed in two operating and reportable segments: CMO and PDS. These segments were organized around the service activities provided to the Company's customers.
		As of and for the year ended October 31, 2013
		Commercial		PDS		Corp. & Other		Total
		$		$		$		$
	Revenues	876.8		146.3		—		1,023.10
	Adjusted EBITDA	146		41		(40.8	)	146.2
	Total assets	905.7		71.8		100.3		1,077.80
	Depreciation	43.8		3.8		0.8		48.4
	Impairment	13.1		—		—		13.1
	Goodwill	48.5		—		—		48.5
	Capital expenditures	45.4		4.3		0.1		49.8
		As of and for the year ended October 31, 2012
		Commercial		PDS		Corp. & Other		Total
		$		$		$		$
	Revenues	610.7		138.4		—		749.1
	Adjusted EBITDA	92.4		30.7		(35.7	)	87.4
	Total assets	617.4		69.7		55.8		742.9
	Depreciation	35		4.9		0.9		40.8
	Impairment	55.1		2.8		—		57.9
	Goodwill	3.5		—		—		3.5
	Capital expenditures	47.3		4.7		1.4		53.4
		As of and for the year ended October 31, 2011
		Commercial		PDS		Corp. & Other		Total
		$		$		$		$
	Revenues	572.6		127.4		—		700
	Adjusted EBITDA	85.1		24.1		(30.3	)	78.9
	Total assets	673		84.5		67.1		824.6
	Depreciation	46.4		5.8		1		53.2
	Goodwill	3.5		—		—		3.5
	Capital expenditures	38.4		8.8		0.6		47.8
	Cash and cash equivalents as well as deferred tax assets are considered to be part of "Corp. & Other" in the breakout of total assets shown above. In fiscal 2013, the impairment of $13.1 million related to impairment of Olds, Alberta, Canada facility for $11.8 million and $1.3 million relating to impairment of Banner's IP R&D. In fiscal 2012 the Company, following an impairment analysis, recorded impairment charges of $57.9 million related to its Swindon facility.
	We evaluate the performance of our segments based on segment Adjusted EBITDA. Commencing with the first quarter of fiscal 2013, we revised our calculation of Adjusted EBITDA to exclude stock-based compensation expense, consulting costs related to our operational initiatives and purchase accounting adjustments. In addition, we recently incurred litigation expenses related to Procaps filing an antitrust complaint against us as a result of the Banner Acquisition. We determined that excluding these items from Adjusted EBITDA better reflected our segments' underlying performance. Based on the revisions to the definition of Adjusted EBITDA, we recasted the presentation of Adjusted EBITDA for fiscal 2011 and 2012 to be consistent with the current period presentation. Our Adjusted EBITDA (as revised) is now income (loss) from continuing operations before repositioning expenses, interest expense, foreign exchange losses reclassified from other comprehensive income (loss), refinancing expenses, acquisition and integration costs (including certain product returns and inventory write-offs recorded in gross profit), gains and losses on sale of capital assets, income taxes, impairment charges, depreciation and amortization, stock-based compensation expense, consulting costs related to our operational initiatives, purchase accounting adjustments, acquisition-related litigation expenses and other income and expenses. The Company's presentation of Adjusted EBITDA may not be comparable to similarly-titled measures used by other companies.
	Below is a reconciliation of Adjusted EBITDA to its closest U.S. GAAP measure.
		Years ended October 31,
		2013		2012		2011
		$		$		$
	Adjusted EBITDA:
	Total Adjusted EBITDA per above	146.2		87.4		78.9
	Depreciation and amortization	(48.4	)	(40.8	)	(53.2	)
	Repositioning expenses	(15.8	)	(6.1	)	(7.0	)
	Acquisition and integration costs	(20.2	)	(3.2	)	—
	Interest expense, net	(47.8	)	(26.5	)	(25.6	)
	Impairment charge	(13.1	)	(57.9	)	—
	Gain (loss) on sale of capital assets	1.3		(0.4	)	(0.2	)
	Refinancing expenses	(29.2	)	—		—
	Benefit from (provision for) income taxes	6.6		(43.4	)	(1.1	)
	Consulting	(2.3	)	(13.3	)	(9.0	)
	Acquisition-related litigation expenses	(6.4	)	—		—
	Stock-based compensation expense	(3.2	)	(3.1	)	(3.5	)
	Purchase accounting adjustments	(5.0	)	—		—
	Other	1.6		0.9		4.9
	Loss from continuing operations	(35.7	)	(106.4	)	(15.8	)
	As illustrated in the table below, revenues are attributed to countries based on the location of the customer's billing address, capital assets are attributed to the country in which they are located and goodwill is attributed to the country in which the entity to which the goodwill pertains is located:
		As of and for the year ended October 31, 2013
		Canada		U.S.*		Europe		Other **	Total
		$		$		$		$	$
	Revenues	22		607.3		333.4		60.4	1,023.10
	Capital assets	116.5		180.8		191.9		7.5	496.7
	Impairment	11.8		1.3		—		—	13.1
	Goodwill	3.3		35.1		7		3.1	48.5
	Intangible assets	1		48		12.2		8	69.2
		As of and for the year ended October 31, 2012
	Canada		U.S.*		Europe		Other	Total
	$		$		$		$	$
Revenues	13.7		434.2		259.4		41.8	749.1
Capital assets	115.7		144.8		154.4		1.5	416.4
Impairment	—		—		57.9		—	57.9
Goodwill	3.5		—		—		—	3.5
	As of and for the year ended October 31, 2011
	Canada		US*		Europe		Other	Total
	$		$		$		$	$
Revenues	12		348.9		302.4		36.7	700
Capital assets	115.6		133.6		223.3		1.7	474.2
Goodwill	3.5		—		—		—	3.5
_________________________________
*    Includes Puerto Rico
**    Includes Mexico in fiscal 2013
During fiscal 2013, the Company did not have any one customer that accounted for more than 10% of the total revenues. During fiscal 2012, the Company had one customer that accounted for approximately 11% of total revenues. In fiscal 2011, the Company did not have any one customer that accounted for more than 10% of total revenues.

Commitments_and_Contingencies

Commitments and Contingencies	12 Months Ended
	Oct. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies	'
	COMMITMENTS AND CONTINGENCIES
	Operating leases
	The Company has entered into long-term rental agreements expiring at various dates until 2020. The future rental payments for the next five years and thereafter are estimated as follows:
		$
	2014	4.7
	2015	2.7
	2016	1.4
	2017	0.9
	2018	0.9
	Thereafter	0.5
	Total payments	11.1
	The Company's total rental expenses related to its operating leases for fiscal 2013, 2012 and 2011 were $9.4 million, $7.5 million and $7.2 million, respectively.
	Contingencies
	On December 10, 2012, Procaps S.A. (“Procaps”) filed a complaint against the Company in the United States District Court for the Southern District of Florida (Case No. 12-cv-24356-DLG).  The complaint involves the Company's collaboration agreement with Procaps, pursuant to which both companies agreed to work together with respect to the marketing of a line of certain prescription pharmaceutical soft-gel development and manufacturing services. Procaps alleges that the Company's acquisition of Banner, a business that historically has generated less than 10% of its revenues from softgel services for prescription pharmaceuticals, transformed the collaboration agreement into an anticompetitive restraint of trade and an agreement between direct competitors to set prices, divide markets and/or allocate geographic territories.  Procaps seeks (i) a declaratory judgment that the collaboration agreement must cease and/or terminate; (ii) an injunction requiring that the Company divest all of Banner's soft-gel manufacturing capabilities; and (iii) monetary damages under federal and state antitrust and unfair competition laws, including treble damages for violations of the Sherman Act. The Company subsequently answered Procaps' complaint and filed its affirmative defenses to the complaint.  On May 15, 2013, Procaps served its supplemental initial disclosures pleading damages.  The parties are currently conducting discovery and trial is scheduled to commence in June 2014.
	The Company has not included any accrual in the consolidated financial statements as of October 31, 2013 related to the matter as a result of its assessment that the likelihood of a material loss in connection with the matter is not probable. Due to the early stage of the lawsuit, an estimate of the potential damages or range of damages cannot be made at this time.  However, an adverse outcome in this matter could have a material adverse effect on the Company's business, results of operations and financial condition.
	One putative class action and four individual plaintiff actions are pending in the United States against one of the Company's customers in connection with the recall of certain lots of allegedly defective products manufactured by the Company for the customer. The Company has also been named in the putative class action and in three of the individual plaintiff actions. The customer has given the Company notice of its intent to seek indemnification from the Company for all damages, costs and expenses, pursuant to the manufacturing services agreement between the customer and the Company. As these cases are at an early stage, the Company is unable to estimate the number of potential claimants or the amount of potential damages for which the Company may be directly or indirectly liable in the above actions.
	Other
	The Company may be subject to lawsuits, investigations and other claims, including environmental, labor, product, customer disputes and other matters in the normal course of operations and otherwise. The Company believes that adequate provisions have been recorded in the accounts where required. Although it is not possible to estimate the extent of potential costs, if any, the Company believes that the ultimate resolution of such contingencies will not have a material adverse impact on the results of operations, financial position or liquidity.
	The Company's tax filings are subject to audit by taxation authorities. Although the Company believes that it has adequately provided for income taxes based on the information available, the outcome of audits cannot be known with certainty and the potential impact on the financial statements is not determinable.

Repositioning_Expenses

Repositioning Expenses	12 Months Ended
	Oct. 31, 2013
Restructuring and Related Activities [Abstract]	'
Repositioning Expenses	'
	REPOSITIONING EXPENSES
	During fiscal 2013, the Company incurred $15.8 million in repositioning expenses, of which $9.9 million related to Banner cost saving initiatives; $2.1 million to the plan of termination commenced in fiscal 2012 (the "Plan of Termination"), $2.3 million to restructuring initiatives at the Bourgoin, France facility, and $1.3 million related to the shutdown of the Caguas facility.
	In fiscal 2012, the Company announced the Plan of Termination to reduce the Company's workforce by approximately 91 employees across the Company's global PDS and CMO segments. In connection with the Plan of Termination, the Company recorded approximately $4.4 million of estimated expenses associated with employee termination benefits during fiscal 2012. The Company anticipates that it may further adjust the size of the workforce at the Swindon or other facilities as it continues its transformation process. In addition, repositioning expenses of $1.7 million related to the shutdown of the Caguas facility were incurred during fiscal 2012.
	During fiscal 2011, the Company incurred $7.0 million in repositioning expenses, of which $4.0 million related to the shutdown of the Caguas facility. The remaining $3.0 million related to the Company's 2011 strategic initiatives in Zug and Swindon.
	The following is a summary of the Company's repositioning expenses and related liabilities as of and for the fiscal years ended October 31, 2013, 2012 and 2011:
	As of and for the year ended October 31, 2013	Commercial	PDS	Corporate	Total
		$	$	$	$
	Total repositioning liabilities at October 31, 2012				5.5
	Employee-related expenses	9.9	1.8	3.8	15.5
	Consulting, professional and project costs	0.3	—	—	0.3
	Total expenses	10.2	1.8	3.8	15.8
	Repositioning expenses paid				(13.6	)
	Total repositioning liabilities at October 31, 2013				7.7
	As of and for the year ended October 31, 2012	Commercial	PDS	Corporate	Total
		$	$	$	$
	Total repositioning liabilities at October 31, 2011				6.7
	Employee-related expenses	2.8	1.8	—	4.6
	Consulting, professional and project costs	1.4	0.1	—	1.5
	Total expenses	4.2	1.9	—	6.1
	Repositioning expenses paid				(7.3	)
	Total repositioning liabilities at October 31, 2012				5.5
	As of and for the year ended October 31, 2011	Commercial	PDS	Corporate	Total
		$	$	$	$
	Total repositioning liabilities at October 31, 2010				3.2
	Employee-related expenses	3.3	—	1	4.3
	Consulting, professional and project management costs	2.7	—	—	2.7
	Total expenses	6	—	1	7
	Repositioning expenses paid				(3.5	)
	Total repositioning liabilities at October 31, 2011				6.7

Refinancing_Expenses

Refinancing Expenses	12 Months Ended
	Oct. 31, 2013
Refinancing Expenses and Deferred Financing Costs [Abstract]	'
Refinancing Expenses	'
	REFINANCING EXPENSES
	During fiscal 2013, the Company incurred $29.2 million of refinancing expenses comprised of a $23.8 million early redemption penalty related to the repayment of the Notes, and $5.3 million related to the write-off of deferred financing costs on the Notes and the ABL and $0.1 million in other related charges. In addition, new creditor and third party fees of $22.7 million were capitalized in long term assets and an original issue discount of $17.3 million was capitalized and netted against the carrying value of the related debt. Both the new fees and the original issue discount are being amortized to interest expense over the term of the Credit Agreement. Please refer to Note 8—Long-Term Debt.

Quarterly_Results_of_Operation

Quarterly Results of Operations - Unaudited	12 Months Ended
	Oct. 31, 2013
Quarterly Financial Information Disclosure [Abstract]	'
Quarterly Results of Operations - Unuadited	'
	QUARTERLY RESULTS OF OPERATIONS - UNAUDITED
	The following is a summary of the Company's unaudited quarterly results of operations:
	Year Ended October 31, 2013
		1st Quarter(1)		2nd Quarter(2)		3rd Quarter(3)	4th Quarter(4)
		(Dollar information in millions of USD, except per share
		information)
		$		$		$	$
	Revenues	213.5		253.9		265.7	290
	Gross profit	42.4		57		71.1	78.6
	(Loss) income from continuing operations	(51.4	)	0.1		4.3	11.3
	Loss from discontinued operations	—		—		—	(0.2	)
	Net (loss) income attributable to restricted voting shareholders	(51.4	)	0.1		4.3	11.1
	Basic (loss) income per share:
	From continuing operations	(0.384	)	0.001		0.031	0.08
	From discontinued operations	—		—		—	(0.001	)
		(0.384	)	0.001		0.031	0.079
	Diluted (loss) income per share:
	From continuing operations	(0.384	)	0.001		0.03	0.078
	From discontinued operations	—		—		—	(0.001	)
		(0.384	)	0.001		0.03	0.077
	Year Ended October 31, 2012
		1st Quarter(5)		2nd Quarter(6)		3rd Quarter(7)	4th Quarter(8)
		(Dollar information in millions of USD, except per share
		information)
		$		$		$	$
	Revenues	153.9		181.5		203.7	210
	Gross profit	14.4		34		55.5	55.4
	(Loss) income from continuing operations	(19.3	)	(79.6	)	15.5	(23.0	)
	Loss from discontinued operations	(0.1	)	(0.1	)	—	(0.1	)
	Net (loss) income attributable to restricted voting shareholders	(19.4	)	(79.7	)	15.5	(23.1	)
	Basic and diluted income (loss) per share:
	From continuing operations	(0.149	)	(0.614	)	0.12	(0.177	)
	From discontinued operations	(0.001	)	(0.001	)	—	(0.001	)
		(0.150	)	(0.615	)	0.12	(0.178	)
	-1	Loss from continuing operations included $29.0 million in refinancing expenses, $10.1 million in impairment expenses of the Olds, Alberta, Canada facility, $4.4 million in acquisition costs related to the Banner Acquisition, and $4.0 million in repositioning expenses relating primarily to Banner.
	-2	Income from continuing operations included $2.5 million in repositioning costs relating primarily to Banner, $1.8 million in consulting fees relating to strategic initiatives, and $3.7 million in integration-related costs relating to the Banner Acquisition.
	-3	Income from continuing operations includes $4.6 million in repositioning costs relating primarily to Banner and our operation in Bourgoin, France, $4.0 million relating to acquisition-related litigation costs, $1.2 million in acquisition-related costs relating primarily to Banner, $1.2 million in impairment of IP R&D, and $0.4 million in consulting fees relating to strategic initiatives.
	-4	Income from continuing operations includes $4.8 million in repositioning costs relating primarily to Banner, Puerto Rico, and Swindon, $3.8 million in acquisition-related costs relating primarily to the pending merger that was announced on November 18, 2013, $2.4 million in acquisition-related litigation costs, $1.8 million in impairment primarily relating to the Olds, Alberta, Canada facility, and $1.1 million for inventory write-off's in gross profit associated with the Olds, Alberta, Canada closure.
	-5	Loss from continuing operations included $6.4 million of consulting fees related to strategic initiatives.
	-6	Loss from continuing operations included a $57.9 million impairment charge, $4.4 million of repositioning expenses related to the Plan of Termination and $6.0 million in consulting fees related to strategic initiatives.
	-7	Income from continuing operations included $1.0 million of consulting fees related to strategic initiatives.
	-8	Loss from continuing operations included $36.6 million from recording of a valuation allowance against the Company's Canadian deferred tax assets and $3.2 million of acquisition-related costs.

Subsequent_Events

Subsequent Events	12 Months Ended
	Oct. 31, 2013
Subsequent Events [Abstract]	'
Subsequent Events	'
	SUBSEQUENT EVENTS
	On November 18, 2013 the Company entered into an arrangement agreement (the "Arrangement Agreement") with JLL/Delta Patheon Holdings, L.P., a limited partnership ("Newco") under which the Company would be taken private pursuant to a court-approved plan of arrangement (the "Arrangement") under the Canada Business Corporations Act. Newco is sponsored by an entity controlled by JLL Partners, Inc. and Koninklijke DSM N.V. ("DSM"). JLL currently owns approximately 56% of the Company's restricted voting shares and all of the Company's outstanding Class I, Preferred Shares, Series D.
	The Arrangement Agreement contemplates that Newco will acquire, directly or indirectly, all of the restricted voting shares of Patheon, including those held by JLL, for cash consideration of US$9.32 per share (the "Cash Consideration"). In addition, all of the Class I, Preferred Shares, Series D will be purchased for nominal consideration and canceled. The Cash Consideration will be paid in U.S. dollars at closing, and is equivalent to approximately CAD$9.72 per share (based on the daily noon exchange rate of the Bank of Canada on November 18, 2013).
	As part of the transaction, the limited partners of the JLL-affiliated investment fund that indirectly owns approximately 56% of the Company's restricted voting shares will also receive the same Cash Consideration per restricted voting share as is provided to the Company’s minority shareholders. As part of the transaction, the general and limited partners of such investment fund will make indirect investments in Newco of approximately $60 million and $50 million, in aggregate, respectively.
	On the closing of the transaction, the Company's business and DSM's existing pharmaceutical products business will be combined. Following completion of the transaction, the Company will apply to de-list its restricted voting shares from the TSX and its restricted voting shares will no longer trade publicly.
	The transaction has been approved unanimously by the Company's Board of Directors (with interested directors abstaining) following the report and unanimous favorable recommendation of a special committee of independent directors.
	The implementation of the Arrangement will be subject to shareholder approval at the special meeting of holders of the Company’s restricted voting shares to be held to approve the transaction (the “Special Meeting”), which is expected to be held in calendar 2014. The transaction will constitute a "business combination" for the purposes of Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions (“MI 61-101”), and the implementation of the Arrangement will be subject to approval by a majority of the votes cast at the Special Meeting by holders of the Company’s restricted voting shares present in person or represented by proxy at the Special Meeting, other than those holders of restricted voting shares excluded pursuant to Section 8.1(2) of MI 61-101 (the “Majority-of-the-Minority Vote”), in addition to approval by 66⅔% of all votes cast at the Special Meeting by holders of the Company’s restricted voting shares present in person or represented by proxy at the Special Meeting. The transaction is also subject to approval by the Ontario Superior Court of Justice, in addition to regulatory approvals and certain closing conditions customary in transactions of this nature.
	Certain affiliates of JLL and all of the directors and executive officers of the Company who hold the Company’s restricted voting shares have entered into voting agreements pursuant to which, among other things, they have agreed to vote, or cause to be voted, the restricted voting shares beneficially owned by them in favor of the Arrangement. As a result, the parties to the voting agreements eligible to vote in the Majority-of-the-Minority Vote own approximately 20.45% of the outstanding restricted voting shares eligible to be counted in the Majority-of-the-Minority Vote. The parties to the voting agreements own approximately 66.08% of all outstanding restricted voting shares.
	The transaction will be financed through a combination of committed debt and equity financing, subject to the terms of those commitments. The Company has received committed debt financing of $1.65 billion. The Company has also received committed equity financing that includes an aggregate contribution of $489 million from JLL, certain co-investors and management, as well as DSM's contribution of its existing pharmaceutical products business. Patheon has also received from JLL and DSM a limited guarantee of certain obligations of Newco under the transaction.
	The Arrangement Agreement provides for, among other things, a non-solicitation covenant on the part of Patheon (subject to customary fiduciary out provisions). The Arrangement Agreement also provides Newco with a right to match potential third party proposals received by the Company. The Company is permitted to terminate the Arrangement Agreement in certain circumstances, including to allow the Company to accept a superior proposal subject to fulfilling certain conditions. Those conditions include the payment to Newco of a termination fee of $23.64 million under certain circumstances.
	In addition, the Company is entitled to a termination fee from Newco in certain circumstances. Such termination fee is either $49.26 million or $24.63 million, depending on the circumstances of termination.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Oct. 31, 2013
Accounting Policies [Abstract]	'
Principles of consolidation	'
	Principles of consolidation and basis of presentation
	The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions have been eliminated.
Basis of presentation	'
	The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States ("U.S. GAAP") requires management to make estimates and assumptions that affect: the reported amounts of assets and liabilities; the disclosure of contingent assets and liabilities at the date of the consolidated financial statements; and the reported amounts of revenue and expenses in the reporting period. Management believes that the estimates and assumptions used in preparing its consolidated financial statements are reasonable and prudent; however, actual results could differ from those estimates.
	Certain prior year amounts in the audited consolidated financial statements have been reclassified to conform to the current year's presentation.
Segment Information	'
	Segment Information
	U.S. GAAP requires segmentation based on an entity’s internal organization and reporting of revenue and operating income based upon internal accounting methods commonly referred to as the “management approach.” Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker (“CODM”), or decision making group, in deciding how to allocate resources and in assessing performance. The Company’s CODM is its Chief Executive Officer. The Company has determined that, through the end of the year ended October 31, 2013 ("fiscal 2013"), it had two operating and reportable segments.
Foreign exchange translation	'
	Foreign exchange translation
	The Company's assets and liabilities that are not denominated in U.S. dollars are translated into U.S. dollars as follows: non-monetary assets are translated using the exchange rate in effect at year end, non-monetary assets and liabilities are translated at the exchange rates in effect at the time of acquisition or issue, and revenues and expenses are translated at the average rate during each month. Translation gains and losses related to the carrying value of the Company's foreign operations are included in accumulated other comprehensive income in shareholders' equity. Foreign exchange gains and losses on transactions occurring in a currency different than the entity's functional currency are reflected in income (loss).
Revenue recognition	'
	Revenue recognition
	The Company recognizes revenue for its commercial manufacturing and pharmaceutical development services when services are completed in accordance with specific agreements with its customers and when all costs connected with providing these services have been incurred, the price is fixed or determinable and collectability is reasonably assured. Customer deposits on pharmaceutical development services in progress are included in accounts payable and accrued liabilities.
	In the case of pharmaceutical development services, revenue is recognized on the achievement of specific milestones in accordance with the respective development service contracts. In the case of commercial manufacturing services, revenue is recognized when services are complete and the product has met rigorous quality assurance testing.
	The Company now manufactures and sells proprietary products as a result of the Banner Acquisition. With respect to the sales of these products, the Company recognizes revenue when title has transferred to the customer and the customer has assumed the risks and rewards of ownership. The Company also has agreements with various distributors that allow the Company to share in product profits. The Company recognizes these profits once the distributor ships the product and title passes to the distributor's customer. The Company does not offer return policies to its customers except for defective products.
Deferred revenues	'
	Deferred revenues
	The costs of certain capital assets are reimbursed to the Company by the pharmaceutical companies that are to benefit from the improvements in connection with the manufacturing and packaging agreements in force. These reimbursements are recorded as deferred revenues and are recognized as income over the remaining minimum term of the agreements. In certain instances the Company receives prepayment for future services and these amounts are amortized over the future required service periods.
Goodwill	'
	Goodwill
	Goodwill represents the excess of the purchase price of the Company's interest in subsidiary companies over the fair value of the underlying net identifiable assets arising on acquisitions, with a significant amount being recorded in fiscal 2013 as a result of the Banner Acquisition. The Company tests goodwill for impairment at least annually in the fiscal fourth quarter, or when indications of potential impairment exist. The Company monitors for the existence of potential impairment indicators throughout the fiscal year. Testing is performed with respect to each of the Company's reporting units that have been allocated goodwill, which the Company has determined are the sites within its CMO segment.
	If the Company's qualitative assessment reveals that goodwill impairment is more likely than not, the Company performs the two-step impairment test. Alternatively, the Company may bypass the qualitative test and initiate goodwill impairment testing with the first step of the two-step goodwill impairment test.
	During the first step of the goodwill impairment test, the Company compares the fair value of the reporting unit to its carrying value, including goodwill. If the fair value of a reporting unit exceeds its carrying value, then the Company concludes that no goodwill impairment has occurred. If the carrying value of the reporting unit exceeds its fair value, the Company performs the second step of the goodwill impairment test to measure possible goodwill impairment loss. During the second step, the Company hypothetically values the reporting unit's tangible and intangible assets and liabilities as if the reporting unit had been acquired in a business combination. The Company then compares the implied fair value of the reporting unit's goodwill to the carrying value of its goodwill. If the carrying value of the reporting unit's goodwill exceeds the implied fair value of the goodwill, the Company recognizes an impairment loss in an amount equal to the excess, not to exceed the carrying value of the reporting unit's goodwill. Once an impairment loss is recognized, the adjusted carrying value of the goodwill becomes the new accounting basis of the goodwill for the reporting unit.
Intangible assets	'
	Intangible Assets
	As a result of the Banner Acquisition, the Company has recorded various intangible assets, including technology, in process research and development, customer relationships and trade names. The Company tests for impairment of definite lived intangible assets whenever events or changes in circumstances indicate that the carrying amount will not be recoverable.
	If such indicators are present, the Company assesses the recoverability of the intangible assets by determining whether the carrying value of such assets can be recovered through undiscounted future cash flows. If the sum of the undiscounted cash flows is less than the carrying amount, the excess of the carrying amount over the estimated fair value, based on the discounted cash flows, is recorded as a charge to earnings.
	For indefinite-lived intangible assets other than goodwill, the Company compares the fair value of the intangible asset with the asset's carrying amount. If the fair value is less than the carrying amount, the Company recognizes an impairment. This impairment test for indefinite-lived intangible assets other than goodwill is conducted annually, concurrently with the goodwill impairment test.
Research and development expenses	'
	Research and development expenses
	The Company now has research and development costs that are expensed as incurred. These expenses relate to proprietary research and development efforts and consist of salaries and benefits, supplies and other costs.
Distribution expenses	'
	Distribution expenses
	Costs, such as freight and handling, associated with the distribution of Banner's products are expensed within SG&A expenses when incurred.
Financial assets and liabilities	'
	Financial assets and liabilities
	All financial instruments, including derivatives, are included in the consolidated balance sheets and are measured at fair value except for loans and receivables and other financial liabilities, which are measured at amortized cost. Held-for-trading financial instruments are recorded at cost as they are initiated and are subsequently measured at fair value and all revaluation gains and losses are included in net income (loss) in the period in which they arise. All financial instrument transactions are recorded on the settlement date. Please refer to Note 13—Financial Instruments, Fair Value and Risk Management.
	The Company expenses as incurred all transaction costs, including fees paid to advisors and other related costs. Financing costs, including underwriting and arrangement fees paid to lenders are deferred and carried as an asset on the balance sheet and amortized into interest expense.
Derivatives and hedge accounting	'
	Derivatives and hedge accounting
	The Company enters into foreign exchange forward contracts and collars to reduce its exposure to foreign currency denominated cash flows and changes in the fair value of foreign denominated assets and liabilities. Please refer to Note 13—Financial Instruments, Fair Value and Risk Management.
	All derivative instruments are recorded on the consolidated balance sheets at fair value unless exempted from derivative treatment as a normal purchase and sale. All changes in their fair value are recorded in income (loss) unless cash flow hedge accounting is used, in which case the changes in the fair value associated with the effective portions of the hedge are recorded in other comprehensive income.
Cash and cash equivalents	'
	Cash and cash equivalents
	Cash and cash equivalents include cash in interest-bearing accounts and term deposits with remaining maturities of less than three months at the date the term deposit was acquired.
Inventories	'
	Inventories
	Inventories consisting of raw materials, packaging components, spare parts, work-in-process, and finished goods are valued at the lower of cost and net realizable value. Cost approximates average cost, and includes cost of purchased materials, costs of conversion, namely labor and overhead, and other costs, such as freight in, necessary to bringing the inventories to their present location and condition.
Capital assets	'
	Capital assets
	Capital assets are carried at cost less accumulated depreciation. The cost of assets disposed of and the related accumulated depreciation are removed from the accounts and any resulting gain or loss is reflected in earnings.
	Depreciation is provided on the straight-line basis based on estimated useful lives as follows:
	Buildings	30 – 50 years
	Building equipment	15 years
	Machinery and equipment	5 – 15 years
	Office equipment	3 – 10 years
	Computer software	2 – 10 years
	Furniture and fixtures	7 – 10 years
	Repairs and maintenance costs are charged to operations as incurred.
Impairment of long-lived depreciable assets	'
	Impairment of long-lived depreciable assets
	The Company reviews whether there are any indicators of impairment of its capital assets and identifiable intangible assets ("long-lived depreciable assets"). If such indicators are present, the Company assesses the recoverability of the assets or group of assets by determining whether the carrying value of such assets can be recovered through undiscounted future cash flows. If the sum of undiscounted future cash flows is less than the carrying amount, the excess of the carrying amount over the estimated fair value, based on discounted future cash flows, is recorded as a charge to earnings.
Employee benefit plans	'
	Employee benefit plans
	The Company provides a number of benefit plans to its employees including:
	(a) defined benefit pension plans; (b) post-employment benefit plans; (c) defined contribution plans; and (d) unfunded termination indemnities.
	The cost of defined benefit pension plans and other post-employment benefits, which include health care and dental benefits, related to employees' current service is charged to earnings annually. The cost is computed on an actuarial basis using the projected benefit method pro-rated based on service and management's best estimates of various actuarial factors, including salary escalation, other cost escalation and retirement ages of employees.
	The valuation of defined benefit pension plan assets is at current market value, based on an actuarial valuation, for purposes of calculating the expected return on plan assets. Past service costs resulting from plan amendments are deferred and amortized on a straight-line basis over the remaining service life of employees active at the time of amendment.
	Actuarial gains and losses arise from the difference between the actual long-term rate of return on plan assets for a period and the expected long-term rate of return on plan assets for that period, or from changes in actuarial assumptions used to determine the accrued benefit obligation. The excess of the net accumulated actuarial gain or loss over 10% of the greater of the benefit obligations and the fair value of plan assets is amortized over the average remaining service period of active employees. The average remaining service period of the active employees covered by the pension plans and the other retirement benefit plans at the measurement date of October 31, 2013 is 19 years (2012—18 years). When the restructuring of a benefit plan gives rise to both a curtailment and a settlement of obligations, the curtailment is accounted for prior to the settlement.
	The cost of defined contribution plans is charged to earnings as funds are contributed by the Company.
	Unfunded termination indemnities for the employees of the Company's subsidiary in Italy and Mexico are accrued based on Italian and Mexico severance pay statutes respectively. The liability recorded on the consolidated balance sheets is the amount to which the employees would be entitled if the employees' employment with the Company ceased.
Income taxes	'
	Income taxes
	The Company follows the liability method of income tax allocation. Under this method, deferred tax assets and liabilities are determined based on differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.
	The Company evaluates its ability to realize deferred tax assets on a quarterly basis. The factors used to assess the likelihood of realization of these assets include the Company's calculation of cumulative pre-tax book income or loss, turn-around of temporary timing differences, available tax planning strategies that could be implemented to realize the deferred tax assets, and forecasted pre-tax book income and taxable income by specific tax jurisdiction. Actual results may vary from these forecasts and result in a change in the ability of the Company to realize benefits of these tax assets in the future. If the Company is unable to meet its projected forecasts or implement certain tax planning strategies in jurisdictions for which there is currently no valuation allowance, the recording of a valuation allowance may be required.
Stock options	'
	Stock options
	The fair value of stock options granted, modified or settled is recognized on a straight-line basis over the applicable stock option vesting period as stock-based compensation expense in the consolidated statements of operations and contributed surplus in the consolidated balance sheets. On the exercise of stock options, consideration received and the accumulated contributed surplus amount is credited to share capital. The company estimates forfeitures based on a weighted-average of historical forfeitures.
	For the purposes of calculating the stock-based compensation expense, the fair value of stock options is estimated at the date of the grant using the Black-Scholes option pricing model and the cost is amortized over the vesting period. This model requires the input of a number of assumptions including dividend yields, expected stock price volatility, expected time until exercise and risk-free interest rates. Although the assumptions used reflect management's best estimates, they involve assumptions based on market conditions generally outside of the control of the Company.
Loss per share	'
	Loss per share
	The calculation of loss per share—from continuing and discontinued operations equals reported net loss attributable to restricted voting shareholders—from continuing and discontinued operations divided by the weighted-average number of restricted voting shares outstanding during the year. Diluted income per share would reflect the assumed conversion of all dilutive securities using the treasury stock method.
	Under the treasury stock method:
	•	the exercise of options is assumed to be at the beginning of the period (or at the time of issuance, if later);
	•	options for which the closing fair market value exceeds the option price are the only ones that are assumed to be dilutive;
	•	the proceeds from the exercise of options, plus future period compensation expense on options granted on or after November 1, 2003, are assumed to be used to purchase restricted voting shares at the average price during the period; and
	•	the number of restricted voting shares assumed to be dilutive, plus the weighted-average number of restricted voting shares outstanding during the year, is used in the denominator of the diluted earnings per share computation;
Government financing	'
	Government financing
	The Company makes periodic applications for financial assistance under available government assistance programs in the various jurisdictions in which it operates. Grants relating to capital expenditures are reflected as a reduction of the cost of the related assets. Grants and tax credits relating to current operating expenditures are generally recorded as a reduction of expenses at the time the eligible expenses are incurred. In the case of certain foreign subsidiaries, the Company receives investment incentive allowances, which are accounted for as a reduction of income tax expense.
Recently issued accounting pronouncements	'
	Recently issued accounting pronouncements
	In April 2012, the Jumpstart Our Business Startups Act (the "JOBS Act") was enacted. Section 107 of the JOBS Act provides that an "emerging growth company" can utilize the extended transition period that is typically available only for private companies for implementing new or revised accounting standards. In other words, as an "emerging growth company," the Company can delay the adoption of certain new or revised accounting standards until such time as those standards apply to private companies.  The Company has elected not to avail itself of this exemption and, therefore, will be implementing new or revised accounting standards at the same time as other public companies that are not "emerging growth companies." As a result of the Banner Acquisition, the Company ceased to be an emerging growth company as the Company exceeded $1.0 billion in revenue during fiscal 2013.
	In July 2013, the FASB issued ASU 2013-11, “Income Taxes, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists” (“ASU 2013-11”). ASU 2013-11 states that an unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, except as follows. To the extent a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction to settle any additional income taxes that would result from the disallowance of a tax position or the tax law of the applicable jurisdiction does not require the entity to use, and the entity does not intend to use, the deferred tax asset for such purpose, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets. The amendments in ASU 2013-11 are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013, with early adoption permitted. The amendments should be applied prospectively to all unrecognized tax benefits that exist at the effective date. Retrospective application is permitted. The adoption of this guidance is not expected to have a material impact on the Company's financial statements.
	In July 2013, the FASB issued ASU 2013-10, “Derivatives and Hedging, Inclusion of the Fed Funds Effective Swap Rate (or Overnight Index Swap Rate) as a Benchmark Interest Rate for Hedge Accounting Purposes” (“ASU No. 2013-10”). ASU 2013-10 permits the Fed Funds Effective Swap Rate (OIS) to be used as a U.S. benchmark interest rate for hedge accounting purposes, in addition to UST and LIBOR. The amendments also remove the restriction on using different benchmark rates for similar hedges. Prior to the amendments in this ASU, only U.S. Treasury and the LIBOR swap rates were considered benchmark interest rates. Including the Fed Funds Effective Swap Rate (OIS) as an acceptable U.S. benchmark interest rate in addition to U.S. Treasury and LIBOR rates provides a more comprehensive spectrum of interest rates to be utilized as the designated benchmark interest rate risk component under the hedge accounting guidance. The amendments in ASU 2013-10 are effective prospectively for qualifying new or redesignated hedging relationships entered into on or after July 17, 2013. The adoption of this guidance is not expected to have a material impact on the Company's financial statements.
	In March 2013, the FASB issued ASU 2013-05, "Parent's Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity" ("ASU 2013-05"). ASU 2013-05 resolves the diversity in practice concerning the release of the cumulative translation adjustment into net income when a parent either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets within a foreign entity. The guidance is effective for fiscal years and interim reporting periods within those fiscal years beginning after December 15, 2013. The amendments described in the ASU are to be applied prospectively to derecognition events occurring after the effective date; prior periods are not to be adjusted. The adoption of this guidance is not expected to have a material impact on the Company's financial statements.
	In February 2013, the FASB issued ASU 2013-04, "Obligations Resulting from Joint and Several Liability Arrangements for Which the Total Amount of the Obligation Is Fixed at the Reporting Date" ("ASU 2013-04"). ASU 2013-04 provides guidance for the recognition, measurement and disclosure resulting from joint and several liability arrangements. Examples of obligations that fall within the scope of the ASU include certain debt arrangements, other contractual obligations and settled litigation. The new guidance is effective on a retrospective basis for fiscal years and interim periods within those fiscal years beginning after December 15, 2013. The adoption of this guidance is not expected to have a material impact on the Company's financial statements.
	In February 2013, the FASB issued ASU 2013-02, "Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income" ("ASU 2013-02"). ASU 2013-02 requires enhanced disclosures about items reclassified out of accumulated other comprehensive income ("AOCI"). For items reclassified to net income in their entirety, the ASU requires information about the effect of significant reclassification items to appear on separate line items of net income. For those items where direct reclassification to net income is not required, companies must provide cross-references to other disclosures that provide details about the effects of the reclassification out of AOCI. Expanded disclosures concerning current period changes in AOCI balances are also required for each component of other comprehensive income on the face of the financial statements or in the notes. ASU 2013-02 is effective prospectively for fiscal years beginning after December 15, 2012, and interim periods within those fiscal years. The adoption of this guidance is not expected to have a material impact on the Company's financial statements.
	In December 2011, the FASB issued ASU 2011-11, "Disclosures about Offsetting Assets and Liabilities," which requires enhanced disclosures about financial instruments and derivative instruments that are either (i) offset in accordance with either Section 210-20-45 or 815-10-45 or (ii) subject to an enforceable master netting arrangement or similar agreement, irrespective of whether they are offset in accordance with either Section 210-20-45 or Section 815-10-45. The amendments are effective for annual reporting periods beginning on or after January 1, 2013 and interim periods within those annual periods. The amendments are required to be applied retrospectively for all prior periods presented. The adoption of this guidance is not expected to have a material impact on the Company's financial statements.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Oct. 31, 2013
Accounting Policies [Abstract]	'
Capital Asset Estimated Useful Lives	'
	Depreciation is provided on the straight-line basis based on estimated useful lives as follows:
	Buildings	30 – 50 years
	Building equipment	15 years
	Machinery and equipment	5 – 15 years
	Office equipment	3 – 10 years
	Computer software	2 – 10 years
	Furniture and fixtures	7 – 10 years
	CAPITAL ASSETS
		As of October 31,
		2013			2012
		Cost	Accumulated	Net Book	Cost	Accumulated	Net Book
			Depreciation	Value		Depreciation	Value
		$	$	$	$	$	$
	Land	37.9	—	37.9	30.7	—	30.7
	Buildings	309.6	78.8	230.8	298	94.3	203.7
	Machinery and equipment	417.9	256.4	161.5	420.5	283.6	136.9
	Office equipment (including software)	53.8	37.1	16.7	45.4	36	9.4
	Furniture and fixtures	13.5	9.8	3.7	15.5	13.3	2.2
	Construction in progress	46.1	—	46.1	33.5	—	33.5
	Balance, end of the year	878.8	382.1	496.7	843.6	427.2	416.4

Banner_Acquisition_Tables

Banner Acquisition (Tables)	12 Months Ended
	Oct. 31, 2013
Business Combinations [Abstract]	'
Estimated purchase price allocation for Banner Acquisition	'
	The estimated purchase price allocation for the Banner Acquisition is as follows:
		$
	Cash and cash equivalents	12.7
	Accounts receivable	53.4
	Inventories	53.7
	Income taxes receivable	4.3
	Prepaid expenses and other	3.6
	Deferred tax assets-short-term	1.8
	Capital assets	91
	Intangible assets	75.1
	Goodwill	45.1
	Deferred tax assets - long-term	0.1
	Other long-term assets	0.3
	Accounts payable and accrued liabilities	(35.7	)
	Deferred tax liabilities - short-term	(0.4	)
	Other long-term liabilities	(1.4	)
	Deferred tax liabilities-long-term	(34.6	)
	Total purchase price	269
Weighted-average life of acquired intangible assets	'
	The weighted-average life of the acquired intangible assets is approximately 11.0 years. The following table sets forth the components of the acquired intangible assets by type:
		Estimated Fair Value		Estimated Useful Life (in years)
		$
	Trade names	0.8		6-May
	Technology	46.4		12-Oct
	Customer relationships	11.1		12-Jul
	In-process research and development(1)	16.8		Indefinite
	Total	75.1
	(1) In process research and development was classified as indefinite-lived intangible assets at the time of the acquisition and will either begin to be amortized upon product approvals or written-off if not approved.
Unaudited pro-forma financial information for Banner	'
	This unaudited pro forma financial information is provided for informational purposes only and is not necessarily indicative of what the actual results of operations would have been had the transactions taken place on November 1, 2011, nor is it indicative of the future consolidated results of operations or financial position of the combined companies.
		Twelve months ended October 31,
		2013		2012
		$		$
	Revenues	1,056.70		1,016.40
	Loss from continuing operations	(9.1	)	(117.8	)
	Loss per share from continuing operations, basic and diluted	(0.065	)	(0.909	)
	The revenues and loss from continuing operations of Banner for the period from December 15, 2012 through October 31, 2013 included in the consolidated statement of operations are as follows:
		2013
		$
	Revenues	217.3
	Loss from continuing operations	(55.9	)

Discontinued_Operations_Plant_1

Discontinued Operations, Plant Consolidations, Sales and Asset Impairments (Tables)	12 Months Ended
	Oct. 31, 2013
Discontinued Operations and Disposal Groups [Abstract]	'
Schedule of Disposal Groups, Including Discontinued Operations, Income Statement, Balance Sheet and Additional Disclosures	'
	The results of discontinued operations for the Company's Carolina facility (which the Company closed effective January 31, 2009) for fiscal 2013, 2012 and 2011 are as follows:
		Years ended October 31,
		2013		2012		2011
		$		$		$
	Revenues	—		—		—
	Cost of goods sold	—		—		—
	Gross loss	—		—		—
	Selling, general and administrative expenses	0.2		0.4		0.6
	Gain on sale of capital assets	—		(0.1	)	—
	Operating loss	(0.2	)	(0.3	)	(0.6	)
	Loss before income taxes	(0.2	)	(0.3	)	(0.6	)
	Net loss for the period	(0.2	)	(0.3	)	(0.6	)

Supplemental_Balance_Sheet_Inf1

Supplemental Balance Sheet Information (Tables)	12 Months Ended
	Oct. 31, 2013
Supplemental balance sheet information [Abstract]	'
Schedule of Inventory, Current	'
	Inventories
		As of October 31,
		2013			2012
		$			$
	Raw materials, packaging components and spare parts	78.7			47.9
	Work-in-process	42.3			34.4
	Finished goods	16.8			—
	Balance, end of the year	137.8			82.3
Inventory Valuation Reserve	'
	Below is a roll-forward of the Company's inventory provisions for fiscal 2013 and 2012:
		As of October 31,
		2013			2012
		$			$
	Balance, beginning of the year	(14.0	)		(12.6	)
	Additions	(14.2	)		(6.5	)
	Write-offs	4.4			5.1
	Balance, end of the year	(23.8	)		(14.0	)
Schedule of Accounts Payable and Accrued Liabilities	'
	The following is the breakdown of accounts payable and accrued liabilities:
		As of October 31,
		2013			2012
		$			$
	Trade payables	133			101.2
	Interest payable	1.7			1
	Accrued salaries and related expenses	52.9			51.4
	Customer deposits	16.7			16.4
	Other accruals	17.6			16.2
	Balance, end of the year	221.9			186.2
Schedule of gross carrying amounts and accumulated amortization of Company's identifiable intangible assets	'
	As part of the Banner Acquisition, the Company obtained intangible assets. The following table summarizes gross carrying amounts and accumulated amortization related to the Company's identifiable intangible assets as of October 31, 2013:
		Gross carrying value			Accumulated amortization		Impairment		Net carrying value
	Trade names	0.8			(0.1	)	—		0.7
	Technology	46.4			(3.6	)	—		42.8
	Customer relationships	11.1			(1	)	—		10.1
	In-process research and development	16.8			—		(1.3	)	15.5
	Foreign exchange	0.1			—		—		0.1
	Balance, end of period	75.2			(4.7	)	(1.3	)	69.2
Schedule of changes in carrying amounts of Goodwill	'
	The following table summarizes the changes between October 31, 2012 and October 31, 2013 in the carrying amount of goodwill in total and by reporting segment:
		Commercial			PDS		Corp. & Other		Total
	Balance at October 31, 2012	3.5			—		—		3.5
	Additions	45.1			—		—		45.1
	Impairments	(0.1	)		—		—		(0.1	)
	Balance at October 31, 2013	48.5			—		—		48.5
Deferred Revenue, by Arrangement, Disclosure	'
	The following table summarizes the deferred revenue activity for each of fiscal 2013, 2012 and 2011:
	Balance at October 31, 2010	$	45.9
	Cash received from customers	30.4
	Cash repaid to customers	(3.1		)
	Amortization of deferred revenues	(45.0		)
	Foreign exchange	0.2
	Other (1)	8.1
	Balance at October 31, 2011	$	36.5
	Cash received from customers	25.2
	Cash repaid to customers	(5.7		)
	Amortization of deferred revenues	(13.1		)
	Foreign exchange	(0.1		)
	Balance at October 31, 2012	$	42.8
	Cash received from customers	17.3
	Cash repaid to customers	—
	Amortization of deferred revenues	(18.3		)
	Foreign exchange	1
	Other (1)	(7.7		)
	Balance at October 31, 2013	$	35.1
	(1) Other changes to deferred revenues primarily consist of movement between deferred revenue and other long-term liabilities and in fiscal 2011 the amendments and eventual cancellation of a manufacturing agreement.

Capital_Assets_Tables

Capital Assets (Tables)	12 Months Ended
	Oct. 31, 2013
Property, Plant and Equipment [Abstract]	'
Schedule of Capital Assets	'
	Depreciation is provided on the straight-line basis based on estimated useful lives as follows:
	Buildings	30 – 50 years
	Building equipment	15 years
	Machinery and equipment	5 – 15 years
	Office equipment	3 – 10 years
	Computer software	2 – 10 years
	Furniture and fixtures	7 – 10 years
	CAPITAL ASSETS
		As of October 31,
		2013			2012
		Cost	Accumulated	Net Book	Cost	Accumulated	Net Book
			Depreciation	Value		Depreciation	Value
		$	$	$	$	$	$
	Land	37.9	—	37.9	30.7	—	30.7
	Buildings	309.6	78.8	230.8	298	94.3	203.7
	Machinery and equipment	417.9	256.4	161.5	420.5	283.6	136.9
	Office equipment (including software)	53.8	37.1	16.7	45.4	36	9.4
	Furniture and fixtures	13.5	9.8	3.7	15.5	13.3	2.2
	Construction in progress	46.1	—	46.1	33.5	—	33.5
	Balance, end of the year	878.8	382.1	496.7	843.6	427.2	416.4

ShortTerm_Borrowings_Tables

Short-Term Borrowings (Tables)	12 Months Ended
	Oct. 31, 2013
Debt Disclosure [Abstract]	'
Schedule of Short-term Borrowings	'
	SHORT-TERM BORROWINGS
		As of October 31,
		2013	2012
		$	$
	Short-term insurance premium financing	3	2.4

LongTerm_Debt_Tables

Long-Term Debt (Tables)	12 Months Ended
	Oct. 31, 2013
Debt Disclosure [Abstract]	'
Schedule of Long-term Debt Instruments	'
	Long-term debt in the accompanying consolidated balance sheets at October 31, 2013 and 2012 consists of the following:
		October 31, 2013		October 31, 2012
		$		$
	Floating LIBOR plus 6.00% with LIBOR floor of 1.25% (currently 7.25%) due December 14, 2018 (the "Secured Term Loan")	569.3		—
	Italian subsidized loan with annual interest rate of 0.5%, and maturity date of June 30, 2020	7.4		—
	Italian bank loan with Euribor 6-month + 7.1% rate, and maturity date of June 30, 2020	0.8		—
	8.625% senior secured notes due April 15, 2017 (the "Notes")	—		280
	$85 million secured revolving credit facility maturing December 14, 2017, bearing interest ranging from 5.0% to 7.75% (the "Secured Revolving Facility")	43.7		—
	$75 million senior secured revolving loan facility maturing April 23, 2014, bearing interest ranging from 4.03% to 5.75% based upon floating LIBOR, US, or CAD prime, or federal funds effective rates, plus applicable margins (the "ABL")	—		30.7
	Total long-term debt outstanding	621.2		310.7
	Less original issue discount, net of accumulated amortization of $2.1 million	(15.2	)	—
	Less current portion	(6.8	)	—
	Balance, end of the period	599.2		310.7
	The following table discloses the maximum permitted First Lien Leverage Ratios permitted under the Credit Agreement:
	Testing Period Ending		Maximum Ratio
	April 30, 2013 through July 31, 2014		5.50 to 1.00
	October 31, 2014 through July 31, 2015		5.00 to 1.00
	October 31, 2015 through April 30, 2016		4.75 to 1.00
	July 31, 2016 through October 31, 2016		4.50 to 1.00
	January 31, 2017 and thereafter		4.25 to 1.00
Schedule of Maturities of Long-term Debt	'
	Estimated minimum annual repayments of long-term debt based on current exchange rates for the next five years are:
		$
	2014	6.8
	2015	6.8
	2016	6.8
	2017	6.8
	2018	50.8
	Thereafter	543.2
	Total payments	621.2

Other_LongTerm_Liabilities_Tab

Other Long-Term Liabilities (Tables)	12 Months Ended
	Oct. 31, 2013
Other Liabilities Disclosure [Abstract]	'
Schedule of Other Long-Term Liabilities	'
	OTHER LONG-TERM LIABILITIES
		As of October 31,
		2013	2012
		$	$
	Defined benefit pension plans	17.6	22.3
	Other post-employment benefits	7.8	8
	Unfunded termination indemnities	6.4	5.7
	Other long-term liabilities	10	11.8
		41.8	47.8

Employee_Future_Benefits_Table

Employee Future Benefits (Tables)	12 Months Ended
	Oct. 31, 2013
Compensation and Retirement Disclosure [Abstract]	'
Schedule of Benefit Obligations in Excess of Fair Value of Plan Assets	'
	Information about the Company's defined benefit pension and other benefit plans, in aggregate, is as follows:
		Defined		Other		Defined		Other
		Benefit		Benefit		Benefit		Benefit
		Pension		Plans		Pension		Plans
		Plans		2013		Plans		2012
		2013				2012
		$		$		$		$
	Change in benefit obligation
	Benefit obligation, beginning of the year	112.4		8		111		7
	Opening benefit obligation from Banner Acquisition	16		—		—		—
	Current service cost	2.1		0.1		2		0.1
	Prior year service costs	—		—		1.2		—
	Interest cost	5.4		0.4		5.1		0.4
	Member contributions during the year	0.4		—		0.3		—
	Effect of curtailments	-1.6		—		-7.9		—
	Benefits paid	-4.2		-0.2		-3.3		-0.2
	Actuarial loss (gain)	3.5		-0.2		4.3		0.7
	Currency translation	-1		-0.3		-0.3		—
	Benefit obligation, end of the year	133		7.8		112.4		8
	Change in plan assets
	Market value of plan assets, beginning of year	90.1		—		80.3		—
	Opening market value of plan assets from Banner Acquisition	15.6		—		—		—
	Actual return on plan assets	8.9		—		6.9		—
	Member contributions during the year	0.4		—		0.3		—
	Employer contributions	6.4		0.2		5.6		0.2
	Benefits paid	-4.2		-0.2		-3.3		-0.2
	Currency translation	-1.1		—		0.3		—
	Market value of plan assets, end of the year	116.1		—		90.1		—
	Unfunded status of plans at October 31,	-16.9		-7.8		-22.3		(8.0	)
Schedule of Weighted Average Assumptions Used for Projected Benefit Obligation and Net Periodic Cost of Plans	'
	The following weighted-average assumptions were used to determine the projected benefit obligation of the Company's defined benefit and other post retirement plans at the end of the respective fiscal year:
		Defined Benefit Plans						Other Benefit Plans
		2013			2012			2013		2012
	Discount rate	4.4	%		4.7	%		4.3	%	5.2	%
	Rate of future compensation increases	3.1	%		3.5	%		—	%	—	%
	The following weighted-average assumptions were used to determine the net periodic benefit cost of the Company's defined benefit and other post retirement plans during the respective fiscal year:
		Defined Benefit Plans								Other Benefit Plans
		2013			2012			2011		2013		2012		2011
	Discount rate	4.6	%		4.9	%		5.2	%	4.3	%	5.2	%	5.2	%
	Expected long-term return on plan assets	5.3	%		5.9	%		6.9	%	—	%	—	%	—	%
	Rate of future compensation increases	3.1	%		3.5	%		3.9	%	—	%	—	%	—	%
Schedule of Effect of One-Percentage-Point Change in Assumed Health Care Cost Trend Rates	'
	The following table outlines the effects of a one-percentage-point increase and decrease in the assumed health care and dental benefit trend rates.
	(in millions of USD)	Benefit			Benefit
		Obligation			Expense
		$			$
	Impact of:
	1% increase	1.1			0.1
	1% decrease	(1.0	)		(0.1	)
Schedule of Net Benefit Costs	'
	The cost components of the Company's defined benefit pension plan and other benefit plans in aggregate are as follows:
		Years ended October 31,
		2013						2012				2011
		Defined Benefit			Other Benefit			Defined Benefit		Other Benefit		Defined Benefit		Other Benefit
		Pension Plans			Plans			Pension Plans		Plans		Pension Plans		Plans
		$			$			$		$		$		$
	Service cost	2.1			0.1			2		0.1		4		0.1
	Interest cost	5.4			0.4			5.1		0.4		5.3		0.4
	Expected return on plan assets	(5.7	)		—			(5.1	)	—		(5.0	)	—
	Amortization of actuarial loss	1.2			—			1.1		—		0.5		—
	Amortization of prior service costs	0.1			—			0.3		—		—		—
	Curtailment effect	(0.7	)		—			—		—		—		—
	Net periodic benefit costs	2.4			0.5			3.4		0.5		4.8		0.5
Schedule of Allocation of Plan Assets	'
	The fair values of the defined benefit plans' assets at October 31, 2013, by asset categories were as follows:
	Defined Benefit Plans	Total			Level 1			Level 2		Level 3
		$			$			$		$
	Asset Category:
	Equity securities	40.6			—			40.6		—
	Debt securities	37.2			2.1			35.1		—
	Cash and other investments	38.3			0.6			37.7		—
	Total pension plan assets at fair value	116.1			2.7			113.4		—
	The fair values of the defined benefit plans' assets at October 31, 2012, by asset categories were as follows:
	Defined Benefit Plans	Total			Level 1			Level 2		Level 3
		$			$			$		$
	Asset Category:
	Equity securities	33.5			—			33.5		—
	Debt securities	24			—			24		—
	Cash and other investments	32.6			—			32.6		—
	Total pension plan assets at fair value	90.1			—			90.1		—
	The Company's defined benefit plans currently have the following targets for these asset classes, which are intended to be flexible guidelines for allocating the plans' assets among various classes of assets, and are reviewed periodically and considered for readjustment when an asset class weighting is outside of its target (recognizing that these are flexible targets that may vary from time to time) with the objective of achieving the expected long-term rate of return on plan assets assumption, weighed against a reasonable risk level, as follows:
		Defined	Defined		Defined		Defined
		Benefit Plans	Benefit Plans		Benefit Plans		Benefit Plans
		Canada	U.K.		Mexico		The Netherlands
	Asset Category:
	Equity securities	30-85%	25	%	0-5%		10	%
	Debt securities	30-70%	25	%	95-100%		79	%
	Other	0-20%	50	%	—	%	11	%
Schedule of Expected Benefit Payments	'
	The following benefit payments, which reflect expected future service, as appropriate, are expected to be paid out of the Company's defined benefit plans and other post-retirement benefit plans:
		Total			Total Other
		Defined			Benefit Plan
		Benefit Plan			Payments
		Payments
		$			$
	2014	3			0.2
	2015	3.3			0.3
	2016	3.5			0.3
	2017	3.5			0.3
	2018	3.9			0.3
	Thereafter	22.1			2.3
		39.3			3.7

Shareholders_Equity_Tables

Shareholders' Equity (Tables)	12 Months Ended
	Oct. 31, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Share Capital	'
	Share capital consists of the following:
		As of October 31,
		2013		2012
		$		$
	Authorized
	Unlimited Class I preferred shares—Issuable from time to time in one or more series, each series comprising the number of shares and having the designation, rights, privileges, restrictions and conditions determined by the Company's Board of Directors.	—		—
	Unlimited restricted voting shares.	—		—
	Issued and outstanding
	Restricted voting shares of 140,930,525; (2012—129,297,892)	610.6		572.5
Schedule of Share-based Compensation, Stock Options, Activity	'
	A summary of the plan and changes during each of fiscal 2013, 2012 and 2011 are as follows:
		2013					2012					2011
	(Dollar amounts in Canadian dollars)	Shares		Weighted-			Shares			Weighted-		Shares		Weighted-
		Number		Average			Number			Average		Number		Average
				Exercise Price						Exercise Price				Exercise Price
				$						$				$
	Outstanding, beginning of the year	12,479,678		2.54			12,628,458			2.88		8,327,357		3.26
	Granted	1,630,000		4.19			2,968,502			2.08		5,862,000		2.5
	Exercised	(2,229,150	)	2.66			(129,966	)		2.59		—		—
	Forfeited	(863,303	)	2.95			(2,987,316	)		3.37		(1,560,899	)	3.34
	Outstanding, end of the year	11,017,225		2.72			12,479,678			2.54		12,628,458		2.88
	Exercisable, end of the year	3,052,975		2.64			3,717,875			2.91		3,893,124		3.65
Schedule of Nonvested Share Activity	'
	The following table summarizes changes in the number and weighted-average grant date fair value of non-vested stock option awards during fiscal 2013:
	(Dollar amounts in Canadian dollars)								Non-Vested Stock Option Awards		Weighted-
											Average
											Grant Date Fair Value
											$
	Balance at beginning of the year								8,761,802		1.24
	Granted								1,630,000		2.17
	Vested								(1,922,550	)	1.29
	Forfeited								(505,002	)	1.18
	Balance at end of the year								7,964,250		1.43
Stock Options Outstanding and Exercisable	'
	The following table summarizes information about options outstanding at October 31, 2013:
	(Dollar amounts in Canadian dollars)	Options Outstanding							Options Exercisable
	Range of Exercise Prices	Number		Weighted-		Weighted-			Number		Weighted-
		Outstanding		Average		Average			Exercisable		Average
				Remaining		Exercise					Exercise
				Contractual		Price					Price
				Life
						$					$
	$1.54 - 2.07	2,729,750		8.5		1.94			429,100		1.82
	$2.08 - 2.61	2,179,700		6		2.52			1,286,100		2.57
	$2.62 - 2.88	4,000,000		7.4		2.62			1,000,000		2.62
	$2.89 - 3.77	815,438		7.3		3.32			225,438		3.39
	$3.78 - 11.21	1,292,337		8.7		4.6			112,337		5.33
	Total	11,017,225							3,052,975
Stock Options, Valuation Assumptions	'
	The fair value of stock options for purposes of determining stock-based compensation was estimated on the date of grant using the following assumptions:
		2013		2012			2011
	Risk free interest rate	1.4	%	1.3	%		2.5	%
	Expected volatility	60	%	58	%		59	%
	Expected weighted-average life of options	5.1 years		5.5 years			5 years
	Expected dividend yield	0	%	0	%		0	%

Other_Information_Other_Inform

Other Information Other Information (Tables)	12 Months Ended
	Oct. 31, 2013
Supplemental Cash Flow Elements [Abstract]	'
Schedule Of Changes In Working Capital Balances	'
	The net changes in non-cash working capital balances related to continuing operations are as follows:
		2013		2012
		$		$
	Accounts receivable	24.4		(17.8	)
	Inventories	(0.8	)	(2.7	)
	Income taxes receivable	(1.6	)	2.2
	Prepaid expenses and other	(1.3	)	0.7
	Accounts payable and accrued liabilities	(11.0	)	5.3
	Income taxes payable	(0.9	)	5.5
		8.8		(6.8	)

Financial_Instruments_Fair_Val1

Financial Instruments, Fair Value and Risk Management (Tables)	12 Months Ended
	Oct. 31, 2013
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Schedule Of Financial Instruments	'
	The carrying values of the Company's financial instruments, including those held for sale on the consolidated balance sheets are classified into the following categories:
	As of October 31,	2013			2012
		$			$
	Held-for-trading1	61.6			39.4
	Loans and receivables2	191.3			161.7
	Other financial liabilities3	830.9			499.3
	Derivatives designated as effective hedges4—gain (loss)	(4.2	)		1.4
	Other derivatives5	0.2			0.3
	_____________________________
	-1	Includes cash and cash equivalents in bank accounts bearing interest rates up to 1%.
	-2	Includes accounts receivable, net of an allowance for doubtful accounts of $1.8 million and $0.8 million at October 31, 2013 and 2012, respectively.
	-3	Includes bank indebtedness, accounts payable, accrued liabilities and long-term debt.
	-4	Includes the Company's forward contracts and collars in 2013 and 2012.
	-5	Includes the contingent consideration receivable related to the Burlington sale.
Fair Value Measurements, Recurring and Nonrecurring	'
	The following table provides a summary of the financial assets and liabilities that are measured at fair value as of October 31, 2013 and 2012:
		Fair value measurement at									Fair value measurement at
		October 31, 2013 using:									October 31, 2012 using:
	Assets measured at fair value	Level 1			Level 2			Level 3		Total	Level 1	Level 2	Level 3	Total
		$			$			$		$	$	$	$	$
	Derivatives designated as hedging instruments:
	Foreign exchange forward contracts	—			—			—		—	—	2.1	—	2.1
	Total assets	—			—			—		—	—	2.1	—	2.1
	Contingent consideration receivable	—			—			0.2		0.2	—	—	0.3	0.3
	Total assets	—			—			0.2		0.2	—	—	0.3	0.3
		Fair value measurement at									Fair value measurement at
		October 31, 2013 using:									October 31, 2012 using:
	Liabilities measured at fair value	Level 1			Level 2			Level 3		Total	Level 1	Level 2	Level 3	Total
		$			$			$		$	$	$	$	$
	Derivatives designated as hedging instruments - Short Term:
	Foreign exchange forward contracts	—			2.6			—		2.6	—	—	—	—
	Foreign exchange collars	—			0.8			—		0.8	—	0.7	—	0.7
		—			3.4			—		3.4	—	0.7	—	0.7
	Derivatives designated as hedging instruments - Long Term:
	Foreign exchange forward contracts	—			0.8			—		0.8	—	—	—	—
		—			0.8			—		0.8	—	—	—	—
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value	'
	The following table presents the fair value of the Company's derivative financial instruments as well as their classification on the consolidated balance sheets as of October 31, 2013 and 2012:
		Asset Derivatives as of					Asset Derivatives as of
		31-Oct-13					31-Oct-12
	Fair values of derivative instruments	Balance Sheet Location		Fair Value			Balance Sheet Location		Fair Value
				$					$
	Derivatives designated as hedging instruments:
	Foreign exchange forward contracts	Prepaid expenses and other		—			Prepaid expenses and other		1.8
	Foreign exchange forward contracts	Other long-term assets		—			Other long-term assets		0.3
	Contingent consideration receivable	Prepaid expenses and other		0.2			Prepaid expenses and other		—
	Total designated derivatives			0.2					2.1
	Contingent consideration receivable	Other long-term assets		—			Other long-term assets		0.3
	Total non-designated derivatives			—					0.3
		Liability Derivatives as of					Liability Derivatives as of
		31-Oct-13					31-Oct-12
		Balance Sheet Location		Fair Value			Balance Sheet Location		Fair Value
				$					$
	Derivatives designated as hedging instruments:
	Foreign exchange collars	Accounts payable and accrued liabilities		0.8			Accounts payable and accrued liabilities		0.3
	Foreign exchange collars	Other long-term liabilities		—			Other long-term liabilities		0.4
	Foreign exchange forwards	Accounts payable and accrued liabilities		2.6			Accounts payable and accrued liabilities		—
	Foreign exchange forwards	Other long-term liabilities		0.8			Other long-term liabilities		—
	Total designated derivatives			4.2					0.7
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation	'
	The following table presents a roll-forward of the Company's only Level 3 financial instrument as of October 31, 2013:
	(in millions of USD)	Contingent Consideration			Total
		$			$
	Opening balance	0.3			0.3
	Purchases	—			—
	Issues	—			—
	Total gains (losses)
	In net loss	—			—
	In other comprehensive income (foreign exchange)	(0.1	)		(0.1	)
	Settlements	—			—
	Transfers out of Level 3	—			—
	Closing balance (October 31, 2013)	0.2			0.2

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Oct. 31, 2013
Income Tax Disclosure [Abstract]	'
Reconciliation of Expected Income Tax (Benefit) Expense	'
	The following is a reconciliation of the expected income tax (benefit) expense obtained by applying a single statutory tax rate of 25.00% (which is a mixture of federal and provincial rates) of Patheon Inc., to the loss from continuing operations before income taxes.
		As of October 31,
		2013			2012		2011
		$			$		$
	Expected income tax benefit using statutory tax rates	(10.6	)		(15.9	)	(3.9	)
	Change in valuation allowance	19			56.6		4
	Permanent differences and other:
	Foreign	(4.1	)		3.4		2.3
	Domestic	(5.5	)		(2.2	)	(5.6	)
	Foreign rate differentials	(5.4	)		1.5		2.5
	Other	—			—		1.8
	(Benefit from) provision for income taxes	(6.6	)		43.4		1.1
	Effective tax rate	15.6	%		(68.9	)%	(7.5	)%
Schedule of Significant Items Comprising Net Deferred Income Tax Assets	'
	The tax effects of significant items comprising the Company's net deferred income tax liabilities are as follows:
		2013			2012
		$			$
	Net operating loss carry-forward	33.4			18
	Accounting provisions not currently deductible for tax purposes	21.8			17.7
	Unrealized foreign exchange losses (gains) on debt	5.6			(0.4	)
	Deferred financing costs	5.1			0.2
	Deferred revenue	11			12.2
	Unclaimed R&D expenditures	16.8			14
	Investment tax credits and other credits	27			20.1
	Other	0.4			—
	Tax depreciation in excess of book depreciation	(40.1	)		(28.5	)
	Valuation allowance	(91.8	)		(72.0	)
	Purchased intangible assets	(26.5	)		—
		(37.3	)		(18.7	)
Schedule of Deferred Tax Assets and Liabilities	'
	The short-term and long-term deferred income tax assets and liabilities after netting are as follows:
		2013			2012
		$			$
	Short-term deferred income tax assets	6.2			4.3
	Long-term deferred income tax liabilities	(43.5	)		(23.0	)
		(37.3	)		(18.7	)
Schedule of Unrecognized Tax Benefits Roll Forward	'
	A reconciliation of the beginning and ending amounts of the tax reserves is as follows:
	Balance at October 31, 2010	$	1.4
	Decrease related to positions taken in the current year	(0.8		)
	Increase based on tax positions taken in current year	0.2
	Balance at October 31, 2011	$	0.8
	Decrease related to positions taken in the current year	—
	Increase based on tax positions taken in current year	—
	Balance at October 31, 2012	$	0.8
	Decrease related to positions taken in the current year	(0.2		)
	Increase based on tax positions taken in current year	3.3
	Reductions related to lapse of applicable statute of limitations	(0.1		)
	Balance at October 31, 2013	$	3.8
Schedule of Loss from Continuing Operations before Income Tax, Domestic and Foreign	'
	Below is a breakout of the Company's (loss) income from continuing operations before income taxes and applicable provision for (benefit from) income taxes:
		Years ended October 31,
		2013			2012		2011
	Loss from continuing operations before income taxes	$			$		$
	Domestic	(30.6	)		(14.3	)	(12.5	)
	Foreign	(11.7	)		(48.7	)	(2.2	)
		(42.3	)		(63.0	)	(14.7	)
Schedule of Provision for (Benefit from) Income Taxes, Domestic and Foreign	'
		Years ended October 31,
		2013			2012		2011
	(Benefit from) provision for income taxes	$			$		$
	Domestic - Current	—			—		—
	Domestic - Deferred	—			34.4		—
	Foreign - Current	8.7			9.2		1.6
	Foreign - Deferred	(15.3	)		(0.2	)	(0.5	)
		(6.6	)		43.4		1.1

Segmented_Information_Tables

Segmented Information (Tables)	12 Months Ended
	Oct. 31, 2013
Segment Reporting [Abstract]	'
Reconciliation of Other Significant Reconciling Items from Segments to Consolidated	'
		As of and for the year ended October 31, 2013
		Commercial		PDS		Corp. & Other		Total
		$		$		$		$
	Revenues	876.8		146.3		—		1,023.10
	Adjusted EBITDA	146		41		(40.8	)	146.2
	Total assets	905.7		71.8		100.3		1,077.80
	Depreciation	43.8		3.8		0.8		48.4
	Impairment	13.1		—		—		13.1
	Goodwill	48.5		—		—		48.5
	Capital expenditures	45.4		4.3		0.1		49.8
		As of and for the year ended October 31, 2012
		Commercial		PDS		Corp. & Other		Total
		$		$		$		$
	Revenues	610.7		138.4		—		749.1
	Adjusted EBITDA	92.4		30.7		(35.7	)	87.4
	Total assets	617.4		69.7		55.8		742.9
	Depreciation	35		4.9		0.9		40.8
	Impairment	55.1		2.8		—		57.9
	Goodwill	3.5		—		—		3.5
	Capital expenditures	47.3		4.7		1.4		53.4
		As of and for the year ended October 31, 2011
		Commercial		PDS		Corp. & Other		Total
		$		$		$		$
	Revenues	572.6		127.4		—		700
	Adjusted EBITDA	85.1		24.1		(30.3	)	78.9
	Total assets	673		84.5		67.1		824.6
	Depreciation	46.4		5.8		1		53.2
	Goodwill	3.5		—		—		3.5
	Capital expenditures	38.4		8.8		0.6		47.8
Reconciliation of Operating Profit (Loss)	'
	Below is a reconciliation of Adjusted EBITDA to its closest U.S. GAAP measure.
		Years ended October 31,
		2013		2012		2011
		$		$		$
	Adjusted EBITDA:
	Total Adjusted EBITDA per above	146.2		87.4		78.9
	Depreciation and amortization	(48.4	)	(40.8	)	(53.2	)
	Repositioning expenses	(15.8	)	(6.1	)	(7.0	)
	Acquisition and integration costs	(20.2	)	(3.2	)	—
	Interest expense, net	(47.8	)	(26.5	)	(25.6	)
	Impairment charge	(13.1	)	(57.9	)	—
	Gain (loss) on sale of capital assets	1.3		(0.4	)	(0.2	)
	Refinancing expenses	(29.2	)	—		—
	Benefit from (provision for) income taxes	6.6		(43.4	)	(1.1	)
	Consulting	(2.3	)	(13.3	)	(9.0	)
	Acquisition-related litigation expenses	(6.4	)	—		—
	Stock-based compensation expense	(3.2	)	(3.1	)	(3.5	)
	Purchase accounting adjustments	(5.0	)	—		—
	Other	1.6		0.9		4.9
	Loss from continuing operations	(35.7	)	(106.4	)	(15.8	)
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas	'
	As illustrated in the table below, revenues are attributed to countries based on the location of the customer's billing address, capital assets are attributed to the country in which they are located and goodwill is attributed to the country in which the entity to which the goodwill pertains is located:
		As of and for the year ended October 31, 2013
		Canada		U.S.*		Europe		Other **	Total
		$		$		$		$	$
	Revenues	22		607.3		333.4		60.4	1,023.10
	Capital assets	116.5		180.8		191.9		7.5	496.7
	Impairment	11.8		1.3		—		—	13.1
	Goodwill	3.3		35.1		7		3.1	48.5
	Intangible assets	1		48		12.2		8	69.2
		As of and for the year ended October 31, 2012
		Canada		U.S.*		Europe		Other	Total
		$		$		$		$	$
	Revenues	13.7		434.2		259.4		41.8	749.1
	Capital assets	115.7		144.8		154.4		1.5	416.4
	Impairment	—		—		57.9		—	57.9
	Goodwill	3.5		—		—		—	3.5
		As of and for the year ended October 31, 2011
		Canada		US*		Europe		Other	Total
		$		$		$		$	$
	Revenues	12		348.9		302.4		36.7	700
	Capital assets	115.6		133.6		223.3		1.7	474.2
	Goodwill	3.5		—		—		—	3.5
	_________________________________
	*    Includes Puerto Rico
	**    Includes Mexico in fiscal 2013

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	12 Months Ended
	Oct. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Contractual Obligation, Fiscal Year Maturity Schedule	'
	The Company has entered into long-term rental agreements expiring at various dates until 2020. The future rental payments for the next five years and thereafter are estimated as follows:
		$
	2014	4.7
	2015	2.7
	2016	1.4
	2017	0.9
	2018	0.9
	Thereafter	0.5
	Total payments	11.1

Repositioning_Expenses_Tables

Repositioning Expenses (Tables)	12 Months Ended
	Oct. 31, 2013
Restructuring and Related Activities [Abstract]	'
Schedule of Restructuring and Related Costs	'
	2013, 2012 and 2011:
	As of and for the year ended October 31, 2013	Commercial	PDS	Corporate	Total
		$	$	$	$
	Total repositioning liabilities at October 31, 2012				5.5
	Employee-related expenses	9.9	1.8	3.8	15.5
	Consulting, professional and project costs	0.3	—	—	0.3
	Total expenses	10.2	1.8	3.8	15.8
	Repositioning expenses paid				(13.6	)
	Total repositioning liabilities at October 31, 2013				7.7
	As of and for the year ended October 31, 2012	Commercial	PDS	Corporate	Total
		$	$	$	$
	Total repositioning liabilities at October 31, 2011				6.7
	Employee-related expenses	2.8	1.8	—	4.6
	Consulting, professional and project costs	1.4	0.1	—	1.5
	Total expenses	4.2	1.9	—	6.1
	Repositioning expenses paid				(7.3	)
	Total repositioning liabilities at October 31, 2012				5.5
	As of and for the year ended October 31, 2011	Commercial	PDS	Corporate	Total
		$	$	$	$
	Total repositioning liabilities at October 31, 2010				3.2
	Employee-related expenses	3.3	—	1	4.3
	Consulting, professional and project management costs	2.7	—	—	2.7
	Total expenses	6	—	1	7
	Repositioning expenses paid				(3.5	)
	Total repositioning liabilities at October 31, 2011				6.7

Quarterly_Results_of_Operation1

Quarterly Results of Operations - Unuadited (Tables)	12 Months Ended
	Oct. 31, 2013
Quarterly Financial Information Disclosure [Abstract]	'
Schedule of Quarterly Financial Information	'
	The following is a summary of the Company's unaudited quarterly results of operations:
	Year Ended October 31, 2013
		1st Quarter(1)		2nd Quarter(2)		3rd Quarter(3)	4th Quarter(4)
		(Dollar information in millions of USD, except per share
		information)
		$		$		$	$
	Revenues	213.5		253.9		265.7	290
	Gross profit	42.4		57		71.1	78.6
	(Loss) income from continuing operations	(51.4	)	0.1		4.3	11.3
	Loss from discontinued operations	—		—		—	(0.2	)
	Net (loss) income attributable to restricted voting shareholders	(51.4	)	0.1		4.3	11.1
	Basic (loss) income per share:
	From continuing operations	(0.384	)	0.001		0.031	0.08
	From discontinued operations	—		—		—	(0.001	)
		(0.384	)	0.001		0.031	0.079
	Diluted (loss) income per share:
	From continuing operations	(0.384	)	0.001		0.03	0.078
	From discontinued operations	—		—		—	(0.001	)
		(0.384	)	0.001		0.03	0.077
	Year Ended October 31, 2012
		1st Quarter(5)		2nd Quarter(6)		3rd Quarter(7)	4th Quarter(8)
		(Dollar information in millions of USD, except per share
		information)
		$		$		$	$
	Revenues	153.9		181.5		203.7	210
	Gross profit	14.4		34		55.5	55.4
	(Loss) income from continuing operations	(19.3	)	(79.6	)	15.5	(23.0	)
	Loss from discontinued operations	(0.1	)	(0.1	)	—	(0.1	)
	Net (loss) income attributable to restricted voting shareholders	(19.4	)	(79.7	)	15.5	(23.1	)
	Basic and diluted income (loss) per share:
	From continuing operations	(0.149	)	(0.614	)	0.12	(0.177	)
	From discontinued operations	(0.001	)	(0.001	)	—	(0.001	)
		(0.150	)	(0.615	)	0.12	(0.178	)
	-1	Loss from continuing operations included $29.0 million in refinancing expenses, $10.1 million in impairment expenses of the Olds, Alberta, Canada facility, $4.4 million in acquisition costs related to the Banner Acquisition, and $4.0 million in repositioning expenses relating primarily to Banner.
	-2	Income from continuing operations included $2.5 million in repositioning costs relating primarily to Banner, $1.8 million in consulting fees relating to strategic initiatives, and $3.7 million in integration-related costs relating to the Banner Acquisition.
	-3	Income from continuing operations includes $4.6 million in repositioning costs relating primarily to Banner and our operation in Bourgoin, France, $4.0 million relating to acquisition-related litigation costs, $1.2 million in acquisition-related costs relating primarily to Banner, $1.2 million in impairment of IP R&D, and $0.4 million in consulting fees relating to strategic initiatives.
	-4	Income from continuing operations includes $4.8 million in repositioning costs relating primarily to Banner, Puerto Rico, and Swindon, $3.8 million in acquisition-related costs relating primarily to the pending merger that was announced on November 18, 2013, $2.4 million in acquisition-related litigation costs, $1.8 million in impairment primarily relating to the Olds, Alberta, Canada facility, and $1.1 million for inventory write-off's in gross profit associated with the Olds, Alberta, Canada closure.
	-5	Loss from continuing operations included $6.4 million of consulting fees related to strategic initiatives.
	-6	Loss from continuing operations included a $57.9 million impairment charge, $4.4 million of repositioning expenses related to the Plan of Termination and $6.0 million in consulting fees related to strategic initiatives.
	-7	Income from continuing operations included $1.0 million of consulting fees related to strategic initiatives.
	-8	Loss from continuing operations included $36.6 million from recording of a valuation allowance against the Company's Canadian deferred tax assets and $3.2 million of acquisition-related costs.

Summary_of_Significant_Account3

Summary of Significant Accounting Policies (Details)	12 Months Ended
	Oct. 31, 2013
Buildings [Member] | Minimum [Member]	'
Property, Plant and Equipment [Line Items]	'
Estimated useful lives (in years)	'30 years
Buildings [Member] | Maximum [Member]	'
Property, Plant and Equipment [Line Items]	'
Estimated useful lives (in years)	'50 years
Building equipment [Member]	'
Property, Plant and Equipment [Line Items]	'
Estimated useful lives (in years)	'15 years
Machinery and equipment [Member] | Minimum [Member]	'
Property, Plant and Equipment [Line Items]	'
Estimated useful lives (in years)	'5 years
Machinery and equipment [Member] | Maximum [Member]	'
Property, Plant and Equipment [Line Items]	'
Estimated useful lives (in years)	'15 years
Office equipment [Member] | Minimum [Member]	'
Property, Plant and Equipment [Line Items]	'
Estimated useful lives (in years)	'3 years
Office equipment [Member] | Maximum [Member]	'
Property, Plant and Equipment [Line Items]	'
Estimated useful lives (in years)	'10 years
Computer software [Member] | Minimum [Member]	'
Property, Plant and Equipment [Line Items]	'
Estimated useful lives (in years)	'2 years
Computer software [Member] | Maximum [Member]	'
Property, Plant and Equipment [Line Items]	'
Estimated useful lives (in years)	'10 years
Furniture and fixtures [Member] | Minimum [Member]	'
Property, Plant and Equipment [Line Items]	'
Estimated useful lives (in years)	'7 years
Furniture and fixtures [Member] | Maximum [Member]	'
Property, Plant and Equipment [Line Items]	'
Estimated useful lives (in years)	'10 years

Summary_of_Significant_Account4

Summary of Significant Accounting Policies - Narratives (Details) (USD $)	12 Months Ended
In Millions, except Share data, unless otherwise specified	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011	Oct. 31, 2010
	segment
Segment Information [Abstract]	'	'	'	'
Number of operating segments	2	'	'	'
Number of reportable segments	2	'	'	'
Distribution expenses [Abstract]	'	'	'	'
Shipping, Handling and Transportation Costs	$2.60	$0	'	'
Employee benefit plans	'	'	'	'
Active employees covered by pension and other postretirement benefit plans, average remaining service period (in years)	'19 years	'18 years	'	'
Loss per share	'	'	'	'
Options Outstanding, Number Outstanding (in shares)	11,017,225	12,479,678	12,628,458	8,327,357

Banner_Acquisition_Estimated_P

Banner Acquisition - Estimated Purchae Price Allocation (Details) (USD $)	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011	Dec. 14, 2012
In Millions, unless otherwise specified				Banner Acquisition [Member]
Business Acquisition [Line Items]	'	'	'	'
Cash and cash equivalents	'	'	'	$12.70
Accounts receivable	'	'	'	53.4
Inventories	'	'	'	53.7
Income taxes receivable	'	'	'	4.3
Prepaid expenses and other	'	'	'	3.6
Deferred tax assets-short-term	'	'	'	1.8
Capital assets	'	'	'	91
Intangible assets	'	'	'	75.1
Goodwill	48.5	3.5	3.5	45.1
Deferred tax assets - long-term	'	'	'	0.1
Other long-term assets	'	'	'	0.3
Accounts payable and accrued liabilities	'	'	'	-35.7
Deferred tax liabilities - short-term	'	'	'	-0.4
Other long-term liabilities	'	'	'	-1.4
Deferred tax liabilities-long-term	'	'	'	-34.6
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net	'	'	'	$269

Banner_Acquisition_Estimated_F

Banner Acquisition - Estimated Fair Value of Finite-lived Intangible Assets Acquired (Details) (Banner Acquisition [Member], USD $)	12 Months Ended
In Millions, unless otherwise specified	Oct. 31, 2013
Acquired Finite-Lived Intangible Assets [Line Items]	'
Estimated fair value - Finite-lived and indefinite-lived intangible assets acquired	$75.10
Weighted average life of acquired intangible assets	'11 years
Trade Names [Member]	'
Acquired Finite-Lived Intangible Assets [Line Items]	'
Estimated fair value - Finite-lived intangible assets acquired	0.8
Technology [Member]	'
Acquired Finite-Lived Intangible Assets [Line Items]	'
Estimated fair value - Finite-lived intangible assets acquired	46.4
Customer Relationships [Member]	'
Acquired Finite-Lived Intangible Assets [Line Items]	'
Estimated fair value - Finite-lived intangible assets acquired	11.1
In Process Research and Development [Member]	'
Acquired Finite-Lived Intangible Assets [Line Items]	'
Estimated fair value - Indefinite-lived intangible assets acquired	$16.80	[1]
Minimum [Member] | Trade Names [Member]	'
Acquired Finite-Lived Intangible Assets [Line Items]	'
Weighted average life of acquired intangible assets	'5 years
Minimum [Member] | Technology [Member]	'
Acquired Finite-Lived Intangible Assets [Line Items]	'
Weighted average life of acquired intangible assets	'10 years
Minimum [Member] | Customer Relationships [Member]	'
Acquired Finite-Lived Intangible Assets [Line Items]	'
Weighted average life of acquired intangible assets	'7 years
Maximum [Member] | Trade Names [Member]	'
Acquired Finite-Lived Intangible Assets [Line Items]	'
Weighted average life of acquired intangible assets	'6 years
Maximum [Member] | Technology [Member]	'
Acquired Finite-Lived Intangible Assets [Line Items]	'
Weighted average life of acquired intangible assets	'12 years
Maximum [Member] | Customer Relationships [Member]	'
Acquired Finite-Lived Intangible Assets [Line Items]	'
Weighted average life of acquired intangible assets	'12 years
[1]	In process research and development was classified as indefinite-lived intangible assets at the time of the acquisition and will either begin to be amortized upon product approvals or written-off if not approved.

Banner_Acquisition_Financial_R

Banner Acquisition - Financial Results of Acquired Business (Details) (Banner Acquisition [Member], USD $)	12 Months Ended
In Millions, unless otherwise specified	Oct. 31, 2013
Banner Acquisition [Member]	'
Business Acquisition [Line Items]	'
Revenues	$217.30
Loss from continuing operations	($55.90)

Banner_Acquisition_Proforma_Fi

Banner Acquisition - Proforma Financial Information of Acquired Entity (Details) (Banner Acquisition [Member], USD $)	12 Months Ended
In Millions, except Per Share data, unless otherwise specified	Oct. 31, 2013	Oct. 31, 2012
Banner Acquisition [Member]	'	'
Business Acquisition [Line Items]	'	'
Revenues	$1,056.70	$1,016.40
Loss from continuing operations	($9.10)	($117.80)
Loss per share from continuing operations, basic (in dollars per share)	($0.07)	($0.91)

Discontinued_Operations_Plant_2

Discontinued Operations, Plant Consolidations, Sales and Asset Impairments (Details) (USD $)

3 Months Ended

12 Months Ended

0 Months Ended

3 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

In Millions, unless otherwise specified

Oct. 31, 2013

Jul. 31, 2013

Apr. 30, 2013

Jan. 31, 2013

Oct. 31, 2012

Jul. 31, 2012

Apr. 30, 2012

Jan. 31, 2012

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2011

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2011

Feb. 28, 2013

Apr. 30, 2013

Apr. 30, 2012

Apr. 30, 2013

Oct. 31, 2013

Apr. 30, 2012

Apr. 30, 2013

Apr. 30, 2013

Oct. 31, 2013

Jan. 31, 2013

Oct. 31, 2013

Aug. 31, 2012

Oct. 31, 2013

Oct. 31, 2012

Apr. 30, 2013

Oct. 31, 2013

Oct. 31, 2012

Apr. 30, 2013

Canada [Member]

Canada [Member]

Patheon Caguas Puerto Rico Facility [Member]

Patheon Caguas Puerto Rico Facility [Member]

Patheon Caguas Puerto Rico Facility [Member]

Patheon Caguas Facility [Member]

Patheon Caguas Facility [Member]

Patheon Caguas Facility [Member]

Patheon Swindon United Kingdom Facility [Member]

Patheon Swindon United Kingdom Facility [Member]

Patheon Swindon United Kingdom Facility [Member]

Patheon Swindon United Kingdom Facility [Member]

Patheon Swindon United Kingdom Facility [Member]

Olds, Canada Facility [Member]

Olds, Canada Facility [Member]

Olds, Canada Facility [Member]

BCS [Member]

CMO Segment [Member]

CMO Segment [Member]

CMO Segment [Member]

PDS [Member]

PDS [Member]

PDS [Member]

Minimum [Member]

Maximum [Member]

Canada [Member]

Canada [Member]

Canada [Member]

Canada [Member]

Patheon Swindon United Kingdom Facility [Member]

Patheon Swindon United Kingdom Facility [Member]

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Estimated repositioning expense

'

'

'

'

'

'

'

'

'

'

'

'

'

$14.20

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Repositioning expenses incurred in period

'

'

'

'

'

'

'

'

'

'

'

'

'

1.3

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Sales-leaseback agreement

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

7

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Prepaid rent asset recorded due to sale leaseback

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.5

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Gain recorded upon sale

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.1

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Discontinued Operation, Income (Loss) from Discontinued Operation Disclosures [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Revenues

'

'

'

'

'

'

'

'

'

'

'

'

'

0

0

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Costs of goods sold

'

'

'

'

'

'

'

'

'

'

'

'

'

0

0

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Gross loss

'

'

'

'

'

'

'

'

'

'

'

'

'

0

0

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Selling, general and administrative expenses

'

'

'

'

'

'

'

'

'

'

'

'

'

0.2

0.4

0.6

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Gain on sale of capital assets

'

'

'

'

'

'

'

'

'

'

'

'

'

0

-0.1

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Operating loss

'

'

'

'

'

'

'

'

'

'

'

'

'

-0.2

-0.3

-0.6

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Loss before income taxes

'

'

'

'

'

'

'

'

'

'

'

'

'

-0.2

-0.3

-0.6

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net loss for the period

-0.2

[1]

0

[2]

0

[3]

0

[4]

-0.1

[5]

0

[6]

-0.1

[7]

-0.1

[8]

-0.2

-0.3

-0.6

'

'

-0.2

-0.3

-0.6

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Scale and scope of business adjustments, period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'24 months

'36 months

'

'

'

'

'

'

'

'

'

'

Impairment of long-lived assets

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

57.9

'

'

'

'

'

'

'

'

'

'

55.1

'

'

2.8

Long-lived asset, fair value

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

9.5

'

'

'

'

'

'

'

'

'

'

'

'

Impairment of Long-Lived Assets to be Disposed of

1.8

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.7

'

11.8

'

'

'

'

'

'

'

Impairments

'

'

'

'

'

'

'

'

0.1

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.1

'

0.1

'

'

0

'

'

Impairment charge

'

'

'

'

'

'

57.9

'

13.1

57.9

0

11.8

0

'

'

'

'

'

'

'

57.9

'

'

'

'

10.1

11.8

'

13.1

55.1

'

0

2.8

'

Unrecorded Unconditional Purchase Obligation

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3.8

'

'

'

'

'

'

'

'

'

Number of years of experience by Bellwyck Packaging Solutions providing clinical trial and contract services for secondary packaging

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'20 years

'

'

'

'

'

'

Total consideration to be paid to the Company for the sale of BCS

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2.7

'

'

'

'

'

'

Consideration paid in cash

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.35

'

'

'

'

'

'

Consideration to be paid in 24 months, contingent upon revenue targets

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.35

'

'

'

'

'

'

Contingency consideration terms, period of time from date of close

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'24 months

'

'

'

'

'

'

Loss on sale of capital assets

'

'

'

'

'

'

'

'

$1.30

($0.40)

($0.20)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.40

'

'

'

'

'

'

[1]

Income from continuing operations includes $4.8 million in repositioning costs relating primarily to Banner, Puerto Rico, and Swindon, $3.8 million in acquisition-related costs relating primarily to the pending merger that was announced on November 18, 2013, $2.4 million in acquisition-related litigation costs, $1.8 million in impairment primarily relating to the Olds, Alberta, Canada facility, and $1.1 million for inventory write-off's in gross profit associated with the Olds, Alberta, Canada closure.

[2]

Income from continuing operations includes $4.6 million in repositioning costs relating primarily to Banner and our operation in Bourgoin, France, $4.0 million relating to acquisition-related litigation costs, $1.2 million in acquisition-related costs relating primarily to Banner, $1.2 million in impairment of IP R&D, and $0.4 million in consulting fees relating to strategic initiatives.

[3]

operations included $2.5 million in repositioning costs relating primarily to Banner, $1.8 million in consulting fees relating to strategic initiatives, and $3.7 million in integration-related costs relating to the Banner Acquisition

[4]

Loss from continuing operations included $29.0 million in refinancing expenses, $10.1 million in impairment expenses of the Olds, Alberta, Canada facility, $4.4 million in acquisition costs related to the Banner Acquisition, and $4.0 million in repositioning expenses relating primarily to Banner.

[5]

Loss from continuing operations included $36.6 million from recording of a valuation allowance against the Company's Canadian deferred tax assets and $3.2 million of acquisition-related costs.

[6]

Income from continuing operations included $1.0 million of consulting fees related to strategic initiatives.

[7]

Loss from continuing operations included a $57.9 million impairment charge, $4.4 million of repositioning expenses related to the Plan of Termination and $6.0 million in consulting fees related to strategic initiatives.

[8]

Loss from continuing operations included $6.4 million of consulting fees related to strategic initiatives.

Supplemental_Balance_Sheet_Inf2

Supplemental Balance Sheet Information - Inventories (Details) (USD $)	Oct. 31, 2013	Oct. 31, 2012
In Millions, unless otherwise specified
Supplemental balance sheet information [Abstract]	'	'
Raw materials, packaging components and spare parts	$78.70	$47.90
Work-in-process	42.3	34.4
Finished goods	16.8	0
Balance, end of the year	$137.80	$82.30

Supplemental_Balance_Sheet_Inf3

Supplemental Balance Sheet Information - Inventory Provision (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Oct. 31, 2013	Oct. 31, 2012
Inventory Valuation Reserve [Roll Forward]	'	'
Balance, beginning of the year	($14)	($12.60)
Additions	-14.2	-6.5
Write-offs	4.4	5.1
Balance, end of the year	($23.80)	($14)

Supplemental_Balance_Sheet_Inf4

Supplemental Balance Sheet Information - Accounts Payable and Accrued Liabilities (Details) (USD $)	Oct. 31, 2013	Oct. 31, 2012
In Millions, unless otherwise specified
Supplemental balance sheet information [Abstract]	'	'
Trade payables	$133	$101.20
Interest payable	1.7	1
Accrued salaries and related expenses	52.9	51.4
Customer deposits	16.7	16.4
Other accruals	17.6	16.2
Balance, end of the year	$221.90	$186.20

Supplemental_Balance_Sheet_Inf5

Supplemental Balance Sheet Information - Intangible Assets (Details) (USD $)	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2013	Oct. 31, 2013	Oct. 31, 2013	Oct. 31, 2013	Oct. 31, 2013	Jul. 31, 2013	Oct. 31, 2013
In Millions, unless otherwise specified			Banner Acquisition [Member]	Trade Names [Member]	Technology [Member]	Customer Relationships [Member]	In Process Research and Development [Member]	In Process Research and Development [Member]	In Process Research and Development [Member]
				Banner Acquisition [Member]	Banner Acquisition [Member]	Banner Acquisition [Member]		Banner Acquisition [Member]	Banner Acquisition [Member]
Acquired Finite and Indefinite-Lived Intangible Assets [Line Items]	'	'	'	'	'	'	'	'	'
Finite-Lived Intangible Assets, Gross	'	'	'	$0.80	$46.40	$11.10	'	'	'
Finite-Lived Intangible Assets, Accumulated Amortization	'	'	-4.7	-0.1	-3.6	-1	'	'	'
Indefinite-lived Intangible Assets, Accumulated Impairment	'	'	-1.3	'	'	'	'	'	-1.3
Finite-Lived Intangible Assets, Net	'	'	'	0.7	42.8	10.1	'	'	'
Indefinite-Lived Intangible Assets (Excluding Goodwill), Gross of Accumulated Impairment	'	'	'	'	'	'	'	'	16.8
Indefinite-Lived Intangible Assets (Excluding Goodwill), Net of Accumulated Impairment	'	'	'	'	'	'	'	'	15.5
Finite and Indefinite-lived Intangible Assets, Translation Adjustments	'	'	0.1	'	'	'	'	'	'
Intangible Assets, Gross (Excluding Goodwill)	'	'	75.2	'	'	'	'	'	'
Intangible assets	69.2	0	69.2	'	'	'	'	'	'
Impairment charge incurred	'	'	'	'	'	'	$0.10	$1.20	$1.20

Supplemental_Balance_Sheet_Inf6

Supplemental Balance Sheet Information Supplemental Balance Sheet Information - Goodwill (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011
Goodwill [Roll Forward]	'	'	'
Balance at October 31, 2012	$48.50	$3.50	$3.50
Additions	45.1	'	'
Impairments	-0.1	'	'
Balance at October 31, 2013	48.5	3.5	3.5
CMO Segment [Member]	'	'	'
Goodwill [Roll Forward]	'	'	'
Balance at October 31, 2012	48.5	3.5	3.5
Additions	45.1	'	'
Impairments	-0.1	'	'
Balance at October 31, 2013	48.5	3.5	3.5
PDS [Member]	'	'	'
Goodwill [Roll Forward]	'	'	'
Balance at October 31, 2012	0	0	0
Additions	0	'	'
Impairments	0	'	'
Balance at October 31, 2013	0	0	0
Corp. & Other [Member]	'	'	'
Goodwill [Roll Forward]	'	'	'
Balance at October 31, 2012	0	0	0
Additions	0	'	'
Impairments	0	'	'
Balance at October 31, 2013	$0	$0	$0

Supplemental_Balance_Sheet_Inf7

Supplemental Balance Sheet Information - Deferred Revenue (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Oct. 31, 2013		Oct. 31, 2012	Oct. 31, 2011
Movement in Deferred Revenue [Roll Forward]	'		'	'
Balance	$42.80		$36.50	$45.90
Cash received from customers	17.3		25.2	30.4
Cash repaid to customers	0		-5.7	-3.1
Amortization of deferred revenues	-18.3		-13.1	-45
Foreign exchange	1		-0.1	0.2
Other	-7.7	[1]	'	8.1	[1]
Balance	$35.10		$42.80	$36.50
[1]	Other changes to deferred revenues primarily consist of movement between deferred revenue and other long-term liabilities and in fiscal 2011 the amendments and eventual cancellation of a manufacturing agreement.

Capital_Assets_Details

Capital Assets (Details) (USD $)	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011
In Millions, unless otherwise specified
Property, Plant and Equipment [Line Items]	'	'	'
Cost	$878.80	$843.60	'
Accumulated Depreciation	382.1	427.2	'
Net Book Value	496.7	416.4	474.2
Land [Member]	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'
Cost	37.9	30.7	'
Net Book Value	37.9	30.7	'
Buildings [Member]	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'
Cost	309.6	298	'
Accumulated Depreciation	78.8	94.3	'
Net Book Value	230.8	203.7	'
Machinery and equipment [Member]	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'
Cost	417.9	420.5	'
Accumulated Depreciation	256.4	283.6	'
Net Book Value	161.5	136.9	'
Office equipment (including software) [Member]	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'
Cost	53.8	45.4	'
Accumulated Depreciation	37.1	36	'
Net Book Value	16.7	9.4	'
Furniture and fixtures [Member]	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'
Cost	13.5	15.5	'
Accumulated Depreciation	9.8	13.3	'
Net Book Value	3.7	2.2	'
Construction in progress [Member]	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'
Cost	46.1	33.5	'
Net Book Value	$46.10	$33.50	'

Capital_Assets_Narrative_Detai

Capital Assets - Narrative (Details) (Capital Addition Purchase Commitments [Member], USD $)	Oct. 31, 2013	Oct. 31, 2012
In Millions, unless otherwise specified
Capital Addition Purchase Commitments [Member]	'	'
Unrecorded Unconditional Purchase Obligation [Line Items]	'	'
Open purchase commitments	$9.90	$16.90

ShortTerm_Borrowings_Details

Short-Term Borrowings (Details) (USD $)	Oct. 31, 2013	Oct. 31, 2012
In Millions, unless otherwise specified
Short-term Debt [Line Items]	'	'
Short-term borrowings	$3	$2.40
Loans Payable [Member] | Short-term Premium Financing [Member]	'	'
Short-term Debt [Line Items]	'	'
Short-term borrowings	$3	$2.40

LongTerm_Debt_Narratives_Detai

Long-Term Debt - Narratives (Details)

12 Months Ended

12 Months Ended

12 Months Ended

3 Months Ended

3 Months Ended

12 Months Ended

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2011

Oct. 31, 2013

Dec. 14, 2012

Oct. 31, 2012

Oct. 31, 2013

Oct. 31, 2012

Dec. 13, 2013

Oct. 31, 2013

Dec. 14, 2012

Nov. 26, 2012

Oct. 31, 2012

Oct. 31, 2013

Oct. 31, 2013

Dec. 14, 2012

Oct. 31, 2012

Oct. 31, 2013

Oct. 31, 2013

Dec. 14, 2012

Jul. 31, 2013

Oct. 31, 2013

Oct. 31, 2012

Jul. 31, 2013

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2013

USD ($)

EUR (€)

USD ($)

USD ($)

Term Loan [Member]

Term Loan [Member]

Term Loan [Member]

Term Loan [Member]

Term Loan [Member]

Senior Notes [Member]

Senior Notes [Member]

Senior Notes [Member]

Senior Notes [Member]

Senior Notes [Member]

Senior Notes [Member]

Line of Credit [Member]

Line of Credit [Member]

Line of Credit [Member]

Line of Credit [Member]

Line of Credit [Member]

Letter of Credit [Member]

Loans Payable [Member]

Loans Payable [Member]

Loans Payable [Member]

Loans Payable [Member]

Loans Payable [Member]

Loans Payable [Member]

London Interbank Offered Rate (LIBOR) [Member]

London Interbank Offered Rate (LIBOR) [Member]

Base Rate [Member]

Base Rate [Member]

Euribor 6-month [Member]

Prepayment Terms, Requirement One [Member]

Prepayment Terms, Requirement Two [Member]

Prepayment Prior to December 14, 2013 [Member]

Step Down One [Member]

Step Down One [Member]

Scenario, Forecast [Member]

Scenario, Forecast [Member]

Secured Term Loan, December 14, 2018 [Member]

Secured Term Loan, December 14, 2018 [Member]

Secured Term Loan, December 14, 2018 [Member]

ABL [Member]

ABL [Member]

Senior Secured Notes, April 15, 2017 [Member]

Senior Secured Notes, April 15, 2017 [Member]

Senior Secured Notes, April 15, 2017 [Member]

Senior Secured Notes, April 15, 2017 [Member]

Senior Secured Notes, April 15, 2017 [Member]

Senior Secured Notes, April 15, 2017 [Member]

Secured Revolving Credit Facility, December 14, 2017 [Member]

Secured Revolving Credit Facility, December 14, 2017 [Member]

Secured Revolving Credit Facility, December 14, 2017 [Member]

Secured Revolving Credit Facility, December 14, 2017 [Member]

Secured Revolving Credit Facility, December 14, 2017 [Member]

Secured Revolving Credit Facility, December 14, 2017 [Member]

Italian Subsidized Loan, June 30, 2020 [Member]

Italian Subsidized Loan, June 30, 2020 [Member]

Italian Subsidized Loan, June 30, 2020 [Member]

Italian Bank Loan, June 30, 2020 [Member]

Italian Bank Loan, June 30, 2020 [Member]

Italian Bank Loan, June 30, 2020 [Member]

Term Loan [Member]

Line of Credit [Member]

Term Loan [Member]

Line of Credit [Member]

Loans Payable [Member]

Term Loan [Member]

Term Loan [Member]

Term Loan [Member]

Prepayment Terms, Requirement One, Part A [Member]

Prepayment Terms, Requirement One, Part B [Member]

Loans Payable [Member]

Loans Payable [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

EUR (€)

USD ($)

USD ($)

EUR (€)

USD ($)

USD ($)

Secured Term Loan, December 14, 2018 [Member]

Secured Revolving Credit Facility, December 14, 2017 [Member]

Secured Term Loan, December 14, 2018 [Member]

Secured Revolving Credit Facility, December 14, 2017 [Member]

Italian Bank Loan, June 30, 2020 [Member]

Secured Term Loan, December 14, 2018 [Member]

Secured Term Loan, December 14, 2018 [Member]

Secured Term Loan, December 14, 2018 [Member]

Term Loan [Member]

Term Loan [Member]

Italian Subsidized Loan, June 30, 2020 [Member]

Italian Bank Loan, June 30, 2020 [Member]

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Minimum [Member]

USD ($)

USD ($)

USD ($)

Maximum [Member]

First Lien Leverage Ratio, Step-down Trigger Ratio [Member]

USD ($)

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Secured Term Loan, December 14, 2018 [Member]

Secured Term Loan, December 14, 2018 [Member]

EUR (€)

EUR (€)

USD ($)

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Debt Instrument [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Face value

'

'

'

'

'

$575,000,000

'

$75,000,000

'

'

'

'

'

'

'

'

'

'

$85,000,000

'

'

€ 6,000,000

'

'

€ 700,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Credit facility, maximum borrowing capacity

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

85,000,000

'

'

'

30,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Interest rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

8.63%

'

'

'

'

'

'

'

0.50%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Basis spread on variable rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

6.00%

5.50%

5.00%

4.50%

7.10%

'

'

'

'

'

'

'

Debt instrument, floor interest rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.25%

'

2.25%

'

'

'

'

'

'

'

'

'

Commitment fee percentage on unused portion of facility

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.50%

'

'

'

0.38%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Leverage ratio, maxiumum

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3.5

3

'

'

Debt Instrument, Prepayment Amount, Percentage of Excess Cash Flow During Period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

50.00%

100.00%

'

'

'

'

'

Debt Instrument, Prepayment Fee Percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.00%

'

'

'

'

Debt Instrument, Covenant, Leverage Ratio, Minimum

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3.5

'

'

3

'

'

'

Debt Instrument, Prepayment Amount, Percentage of Excess Cash Flow During Period, Step Down Upon First Lien Leverage Ratio

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

25.00%

0.00%

'

'

Debt Instrument, Covenant, Limitation of Dividends, including Subordinated Debt Payments, Base Amount

'

'

'

'

15,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Covenant, Limitation of Dividends, including Subordinated Debt Payments, Incremental Amount

'

'

'

'

7,500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Long-term Debt, Gross

621,200,000

'

310,700,000

'

569,300,000

'

0

0

30,700,000

'

0

'

280,000,000

280,000,000

'

43,700,000

'

0

'

'

'

'

7,400,000

0

'

800,000

0

'

'

'

'

'

'

'

'

'

'

'

'

Principal amount of Notes tendered and not validly withdrawn

'

'

'

'

'

'

'

'

'

279,400,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Principal amount of Notes tendered and not validly withdrawn, percentage

'

'

'

'

'

'

'

'

'

99.80%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Amount paid for Notes tendered and not validly withdrawn

'

'

'

'

'

'

'

'

'

'

'

307,200,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from long-term borrowings

647,000,000

'

40,900,000

13,500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

5,400,000

'

'

600,000

'

'

'

'

'

'

'

'

'

'

'

'

600,000

100,000

Derivative, Basis Spread on Variable Rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

7.10%

'

'

'

'

'

'

'

Revenue from Grants

'

€ 700,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

LongTerm_Debt_Schedule_of_Long

Long-Term Debt - Schedule of Long-Term Debt (Details)

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

Dec. 14, 2012

Oct. 31, 2012

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

Nov. 26, 2012

Oct. 31, 2012

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

Oct. 31, 2013

Jul. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

Jul. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2013

USD ($)

USD ($)

Term Loan [Member]

Term Loan [Member]

Term Loan [Member]

Term Loan [Member]

Term Loan [Member]

Senior Notes [Member]

Senior Notes [Member]

Senior Notes [Member]

Senior Notes [Member]

Line of Credit [Member]

Line of Credit [Member]

Line of Credit [Member]

Loans Payable [Member]

Loans Payable [Member]

Loans Payable [Member]

Loans Payable [Member]

Loans Payable [Member]

Loans Payable [Member]

London Interbank Offered Rate (LIBOR) [Member]

London Interbank Offered Rate (LIBOR) [Member]

Euribor 6-month [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Senior Secured Notes, April 15, 2017 [Member]

Senior Secured Notes, April 15, 2017 [Member]

Senior Secured Notes, April 15, 2017 [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Italian Subsidized Loan, June 30, 2020 [Member]

Italian Subsidized Loan, June 30, 2020 [Member]

Italian Subsidized Loan, June 30, 2020 [Member]

Italian Bank Loan, June 30, 2020 [Member]

Italian Bank Loan, June 30, 2020 [Member]

Italian Bank Loan, June 30, 2020 [Member]

Term Loan [Member]

Line of Credit [Member]

Loans Payable [Member]

Secured Term Loan, December 14, 2018 [Member]

Secured Term Loan, December 14, 2018 [Member]

Secured Term Loan, December 14, 2018 [Member]

ABL [Member]

ABL [Member]

USD ($)

USD ($)

USD ($)

Senior Secured Notes, April 15, 2017 [Member]

Secured Revolving Credit Facility, December 14, 2017 [Member]

Secured Revolving Credit Facility, December 14, 2017 [Member]

Secured Revolving Credit Facility, December 14, 2017 [Member]

USD ($)

EUR (€)

USD ($)

USD ($)

EUR (€)

USD ($)

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Italian Bank Loan, June 30, 2020 [Member]

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Minimum [Member]

USD ($)

USD ($)

Maximum [Member]

Secured Term Loan, December 14, 2018 [Member]

Secured Revolving Credit Facility, December 14, 2017 [Member]

USD ($)

Debt Instrument [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Basis spread on variable rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

6.00%

5.50%

7.10%

Debt instrument, floor interest rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.25%

'

'

Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

7.25%

'

'

Interest rate

'

'

'

'

'

'

'

'

'

'

8.63%

'

'

'

0.50%

'

'

'

'

'

'

'

'

Face value

'

'

'

$575,000,000

'

$75,000,000

'

'

'

'

'

'

'

$85,000,000

'

€ 6,000,000

'

'

€ 700,000

'

'

'

'

Debt Instrument, Interest Rate, Stated Percentage Rate Range, Minimum

'

'

'

'

'

4.03%

'

'

'

'

'

5.80%

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Interest Rate, Stated Percentage Rate Range, Maximum

'

'

'

'

'

5.75%

'

'

'

'

'

7.75%

'

'

'

'

'

'

'

'

'

'

'

Total long-term debt outstanding

621,200,000

310,700,000

569,300,000

'

0

0

30,700,000

0

280,000,000

280,000,000

'

43,700,000

0

'

7,400,000

'

0

800,000

'

0

'

'

'

Less original issue discount, net of accumulated amortization of $2.1 million

-15,200,000

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Less current portion

-6,800,000

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Balance, end of the period

599,200,000

310,700,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Accumulated amortization on original issue discount

$2,100,000

$2,100,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Long_Term_Debt_Schedule_of_Max

Long Term Debt - Schedule of Maximum First Lien Leverage Ratios (Details) (Revolving Credit Facility [Member])	Oct. 31, 2013
April 30, 2013 through July 31, 2014	'
Debt Instrument [Line Items]	'
Leverage ratio, maxiumum	5.5
October 31, 2014 through July 31, 2015	'
Debt Instrument [Line Items]	'
Leverage ratio, maxiumum	5
October 31, 2015 through April 30, 2016	'
Debt Instrument [Line Items]	'
Leverage ratio, maxiumum	4.75
July 31, 2016 through October 31, 2016	'
Debt Instrument [Line Items]	'
Leverage ratio, maxiumum	4.5
January 31, 2017 and thereafter	'
Debt Instrument [Line Items]	'
Leverage ratio, maxiumum	4.25

LongTerm_Debt_Annual_Repayment

Long-Term Debt - Annual Repayments of Long-Term Debt (Details) (USD $)	Oct. 31, 2013	Oct. 31, 2012
In Millions, unless otherwise specified
Debt Disclosure [Abstract]	'	'
2014	$6.80	'
2015	6.8	'
2016	6.8	'
2017	6.8	'
2018	50.8	'
Thereafter	543.2	'
Total long-term debt outstanding	$621.20	$310.70

Other_LongTerm_Liabilities_Nar

Other Long-Term Liabilities - Narrative (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011
Other Long-Term Liabilities [Line Items]	'	'	'
Termination indemnity liability - expected expense for remainder of 2013	$0.40	'	'
Other long-term liabilities, customer funded capital liabilities	3	5.2	'
Other long-term liabilities, deferred compensation plan	2.5	2.2	'
Other long-term liabilities, deferred rent liability	0.7	0.8	'
Other long-term liabilities, post employment benefits	0.8	0.8	'
Italian Government Mandated Retirement Plan [Member]	'	'	'
Other Long-Term Liabilities [Line Items]	'	'	'
Deferred compensation arrangement with individual, employer contribution	3.1	3	'
Deferred compensation arrangement with individual, compensation expense	$3.10	$3	$3.10

Other_LongTerm_Liabilities_Sch

Other Long-Term Liabilities - Schedule of Long-Term Liabilities (Details)	Oct. 31, 2013	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2012
In Millions, unless otherwise specified	USD ($)	EUR (€)	USD ($)	EUR (€)
Other Liabilities Disclosure [Abstract]	'	'	'	'
Defined benefit pension plans	$17.60	'	$22.30	'
Other post-employment benefits	7.8	'	8	'
Unfunded termination indemnities (2012 - 4.4 million (in euros); 2011 - 4.5 million (in euros)	6.4	4.4	5.7	4.5
Other long-term liabilities	10	'	11.8	'
Other long-term liabilities, Total	$41.80	'	$47.80	'

Employee_Future_Benefits_Narra

Employee Future Benefits - Narrative (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]	'	'	'
Other long-term liabilities, accrued benefit for defined benefit pension and other benefit plans	($25.40)	($30.30)	'
Accrued benefit assets included in other long-term assets	0.7	0	'
Net actuarial losses included in other comprehensive income, not yet recognized as a component of net periodic pension costs	27	29.4	'
Health care cost trend rate, period over which rates will decrease	'5 years	'	'
Health care cost trend rate assumed, decrease over next five years	6.00%	'	'
Estimated contributions in next fiscal year	7	'	'
Total cash payments for employee future benefits	11.4	10.3	14.6
Contributions by employer	6.6	5.8	'
Expected amortization from actuarial losses as part of pension costs during fiscal 2013	0.9	'	'
Maximum [Member]	'	'	'
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]	'	'	'
Health care cost trend rate assumed for current fiscal year	8.00%	'	'
Defined Benefit Pension Plans [Member]	'	'	'
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]	'	'	'
Discount rate	4.40%	4.70%	'
Expected long-term return on plan assets	5.30%	5.90%	6.90%
Defined contribution plan, cost recognized	4.8	4.5	2.8
Effect of curtailments on projected benefit obligation	1.6	7.9	'
Contributions by employer	6.4	5.6	10.8
Cash payments directly to beneficiaries	4.2	3.3	'
Other Benefit Plans [Member]	'	'	'
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]	'	'	'
Discount rate	4.30%	5.20%	'
Expected long-term return on plan assets	0.00%	0.00%	0.00%
Effect of curtailments on projected benefit obligation	0	0	'
Contributions by employer	0.2	0.2	'
Cash payments directly to beneficiaries	0.2	0.2	0.2
Defined Contribution Plans [Member]	'	'	'
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]	'	'	'
Cash contributions by employer, defined contribution plans	4.8	4.5	2.8
United Kingdom Benefit Plans [Member]	'	'	'
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]	'	'	'
Effect of curtailments on projected benefit obligation	$7.90	'	'

Employee_Future_Benefits_Chang

Employee Future Benefits - Change in Benefit Obligation (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011
Change in Plan Assets [Roll Forward]	'	'	'
Employer contributions	$6.60	$5.80	'
Defined Benefit Pension Plans [Member]	'	'	'
Change in Benefit Obligation [Roll Forward]	'	'	'
Benefit obligation, beginning of the year	112.4	111	'
Opening benefit obligation from Banner Acquisition	16	0	'
Current service cost	2.1	2	'
Prior year service costs	0	1.2	'
Interest cost	5.4	5.1	5.3
Member contributions during the year	0.4	0.3	'
Effect of curtailments	-1.6	-7.9	'
Benefits paid	-4.2	-3.3	'
Actuarial loss (gain)	3.5	4.3	'
Currency translation	-1	-0.3	'
Benefit obligation, end of the year	133	112.4	111
Change in Plan Assets [Roll Forward]	'	'	'
Market value of plan assets, beginning of the year	90.1	80.3	'
Opening market value of plan assets from Banner Acquisition	15.6	0	'
Actual return on plan assets	8.9	6.9	'
Member contributions during the year	0.4	0.3	'
Employer contributions	6.4	5.6	10.8
Benefits paid	-4.2	-3.3	'
Currency translation	-1.1	0.3	'
Market value of plan assets, end of the year	116.1	90.1	80.3
Unfunded status of plans	-16.9	-22.3	'
Other Benefit Plans [Member]	'	'	'
Change in Benefit Obligation [Roll Forward]	'	'	'
Benefit obligation, beginning of the year	8	7	'
Opening benefit obligation from Banner Acquisition	0	0	'
Current service cost	0.1	0.1	'
Prior year service costs	0	0	'
Interest cost	0.4	0.4	0.4
Member contributions during the year	0	0	'
Effect of curtailments	0	0	'
Benefits paid	-0.2	-0.2	-0.2
Actuarial loss (gain)	-0.2	0.7	'
Currency translation	-0.3	0	'
Benefit obligation, end of the year	7.8	8	7
Change in Plan Assets [Roll Forward]	'	'	'
Market value of plan assets, beginning of the year	0	0	'
Opening market value of plan assets from Banner Acquisition	0	0	'
Actual return on plan assets	0	0	'
Member contributions during the year	0	0	'
Employer contributions	0.2	0.2	'
Benefits paid	-0.2	-0.2	-0.2
Currency translation	0	0	'
Market value of plan assets, end of the year	0	0	0
Unfunded status of plans	($7.80)	($8)	'

Employee_Future_Benefits_Defin

Employee Future Benefits - Defined Benefit Pension Plan and Other Benefit Plan Assumptions (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011
Effect of One-Percentage Point Change in Assumed Health Care Cost Trend Rates	'	'	'
Assumed health care and dental benefit trend rates, Benefit Obligation, Impact of 1% increase	1.1	'	'
Assumed health care and dental benefit trend rates, Benefit Obligation, Impact of 1% decrease	-1	'	'
Assumed health care and dental benefit trend rates, Benefit Expense, Impact of 1% increase	0.1	'	'
Assumed health care and dental benefit trend rates, Benefit Expense, Impact of 1% decrease	-0.1	'	'
Defined Benefit Pension Plans [Member]	'	'	'
Weighted Average Assumptions Used in Calculating Projected Benefit Obligation	'	'	'
Discount rate	4.40%	4.70%	'
Rate of future compensation increases	3.10%	3.50%	'
Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost	'	'	'
Discount rate	4.60%	4.90%	5.20%
Expected long-term return on plan assets	5.30%	5.90%	6.90%
Rate of future compensation increases	3.10%	3.50%	3.90%
Other Benefit Plans [Member]	'	'	'
Weighted Average Assumptions Used in Calculating Projected Benefit Obligation	'	'	'
Discount rate	4.30%	5.20%	'
Rate of future compensation increases	0.00%	0.00%	'
Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost	'	'	'
Discount rate	4.30%	5.20%	5.20%
Expected long-term return on plan assets	0.00%	0.00%	0.00%
Rate of future compensation increases	0.00%	0.00%	0.00%

Employee_Future_Benefits_Defin1

Employee Future Benefits - Defined Benefit Pension Plans and Other Benefit Plans (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011
Defined Benefit Pension Plans [Member]	'	'	'
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]	'	'	'
Service cost	$2.10	$2	$4
Interest cost	5.4	5.1	5.3
Expected return on plan assets	-5.7	-5.1	-5
Amortization of actuarial loss	1.2	1.1	0.5
Amortization of prior service costs	0.1	0.3	0
Curtailment effect	-0.7	0	0
Net periodic benefit costs	2.4	3.4	4.8
Other Benefit Plans [Member]	'	'	'
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]	'	'	'
Service cost	0.1	0.1	0.1
Interest cost	0.4	0.4	0.4
Expected return on plan assets	0	0	0
Amortization of actuarial loss	0	0	0
Amortization of prior service costs	0	0	0
Curtailment effect	0	0	0
Net periodic benefit costs	$0.50	$0.50	$0.50

Employee_Future_Benefits_Pensi

Employee Future Benefits - Pension Plan Assets (Details) (Defined Benefit Pension Plans [Member], USD $)

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2011

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2013

In Millions, unless otherwise specified

Total [Member]

Total [Member]

Level 1 [Member]

Level 1 [Member]

Level 2 [Member]

Level 2 [Member]

Level 3 [Member]

Level 3 [Member]

Equity Securities [Member]

Equity Securities [Member]

Equity Securities [Member]

Equity Securities [Member]

Equity Securities [Member]

Equity Securities [Member]

Equity Securities [Member]

Equity Securities [Member]

Debt Securities [Member]

Debt Securities [Member]

Debt Securities [Member]

Debt Securities [Member]

Debt Securities [Member]

Debt Securities [Member]

Debt Securities [Member]

Debt Securities [Member]

Cash and Other Investments [Member]

Cash and Other Investments [Member]

Cash and Other Investments [Member]

Cash and Other Investments [Member]

Cash and Other Investments [Member]

Cash and Other Investments [Member]

Cash and Other Investments [Member]

Cash and Other Investments [Member]

Canada [Member]

Canada [Member]

Canada [Member]

Canada [Member]

U.K. [Member]

U.K. [Member]

U.K. [Member]

U.K. [Member]

MEXICO

MEXICO

MEXICO

MEXICO

NETHERLANDS

NETHERLANDS

NETHERLANDS

NETHERLANDS

Total [Member]

Total [Member]

Level 1 [Member]

Level 1 [Member]

Level 2 [Member]

Level 2 [Member]

Level 3 [Member]

Level 3 [Member]

Total [Member]

Total [Member]

Level 1 [Member]

Level 1 [Member]

Level 2 [Member]

Level 2 [Member]

Level 3 [Member]

Level 3 [Member]

Total [Member]

Total [Member]

Level 1 [Member]

Level 1 [Member]

Level 2 [Member]

Level 2 [Member]

Level 3 [Member]

Level 3 [Member]

Equity Securities [Member]

Equity Securities [Member]

Debt Securities [Member]

Other [Member]

Equity Securities [Member]

Equity Securities [Member]

Debt Securities [Member]

Other [Member]

Equity Securities [Member]

Equity Securities [Member]

Debt Securities [Member]

Other [Member]

Equity Securities [Member]

Equity Securities [Member]

Debt Securities [Member]

Other [Member]

Domestic [Member]

Foreign [Member]

Domestic [Member]

Foreign [Member]

Domestic [Member]

Foreign [Member]

Domestic [Member]

Foreign [Member]

Defined Benefit Plan Disclosure [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Fair value of plan assets

$116.10

$90.10

$80.30

$116.10

$90.10

$2.70

$0

$113.40

$90.10

$0

$0

$40.60

$33.50

$0

$0

$40.60

$33.50

$0

$0

$37.20

$24

$2.10

$0

$35.10

$24

$0

$0

$38.30

$32.60

$0.60

$0

$37.70

$32.60

$0

$0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Defined benefit plan, target plan asset allocation, minimum

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

25.00%

5.00%

30.00%

0.00%

'

'

'

'

0.00%

0.00%

95.00%

0.00%

'

'

'

'

Defined benefit plan, target plan asset allocation, maximum

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

55.00%

30.00%

70.00%

20.00%

'

'

'

'

5.00%

0.00%

100.00%

0.00%

'

'

'

'

Defined benefit plan, target plan asset allocation

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

38.00%

37.00%

25.00%

0.00%

'

'

'

'

10.00%

0.00%

79.00%

11.00%

Employee_Future_Benefits_Estim

Employee Future Benefits - Estimated Future Benefit Payments (Details) (USD $)	Oct. 31, 2013
In Millions, unless otherwise specified
Defined Benefit Pension Plans [Member]	'
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]	'
2012	$3
2013	3.3
2014	3.5
2015	3.5
2016	3.9
2017-2021	22.1
Total estimated future benefit payments	39.3
Other Benefit Plans [Member]	'
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]	'
2012	0.2
2013	0.3
2014	0.3
2015	0.3
2016	0.3
2017-2021	2.3
Total estimated future benefit payments	$3.70

Shareholders_Equity_Narrative_

Shareholders' Equity - Narrative (Details)

12 Months Ended

12 Months Ended

In Millions, except Share data, unless otherwise specified

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2011

Mar. 10, 2011

Mar. 09, 2011

Oct. 31, 2010

Apr. 26, 2007

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2011

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

USD ($)

CAD

USD ($)

USD ($)

member

Stock Options [Member]

Stock Options [Member]

Stock Options [Member]

Stock Options [Member]

Stock Options [Member]

Executive Committee Members, Excluding CEO [Member]

Restricted Voting Shares [Member]

Restricted Voting Shares [Member]

Restricted Voting Shares [Member]

USD ($)

USD ($)

USD ($)

Maximum [Member]

Minimum [Member]

JLL Patheon Holdings [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of members of Board of Directors that holders of Series D preferred shares have the right to elect

'

'

'

'

'

'

'

3

'

'

'

'

'

'

'

'

'

Total number of members of Board of Directors

'

'

'

'

'

'

'

9

'

'

'

'

'

'

'

'

'

Restricted voting shares, outstanding (in shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

140,930,525

129,297,892

78,524,986

Percentage of total restricted voting shares held by related party

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

56.00%

Maximum number of shares authorized under plan (in shares)

15,500,151

15,500,151

15,500,151

15,500,151

15,500,151

'

'

'

'

'

'

'

'

'

'

'

'

Shares authorized as percent of total outstanding common stock (as a percent)

11.00%

11.00%

'

'

'

7.50%

'

'

'

'

'

'

'

'

'

'

'

Restricted voting share stock options, outstanding (in shares)

11,017,225

11,017,225

12,479,678

12,628,458

'

'

8,327,357

'

'

'

'

'

'

'

'

'

'

Term of options awards (in years)

'

'

'

'

'

'

'

'

'

'

'

'10 years

'

'

'

'

'

Options vesting period (in years)

'

'

'

'

'

'

'

'

'

'

'

'5 years

'3 years

'

'

'

'

Percentage of award vesting at each anniversary date of grant

'

'

'

'

'

'

'

'

'

'

'

33.30%

20.00%

'

'

'

'

Restricted voting shares, issued in period

-2,229,150

-2,229,150

-129,966

0

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value

$3.10

'

$0.20

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted average grant date fair value, options granted (in dollars per share)

'

2.17

'

'

'

'

'

'

$2.17

$1.08

$1.30

'

'

'

'

'

'

Stock-based compensation expense

3.2

'

3.1

3.5

'

'

'

'

'

'

'

'

'

'

'

'

'

Total fair value of shares vested in period

'

'

'

'

'

'

'

'

2.5

2.6

2

'

'

'

'

'

'

Total unrecognized compensation cost, nonvested stock options

'

'

'

'

'

'

'

'

$4.70

'

'

'

'

'

'

'

'

Weighted average remaining vesting period, options (in years)

'

'

'

'

'

'

'

'

'2 years 2 months 1 day

'

'

'

'

'

'

'

'

Granted (in shares)

1,630,000

1,630,000

2,968,502

5,862,000

'

'

'

'

'

'

'

'

'

1,291,750

'

'

'

Shareholders_Equity_Share_Capi

Shareholders' Equity - Share Capital (Details) (USD $)	Oct. 31, 2013	Oct. 31, 2012
In Millions, except Share data, unless otherwise specified
Class of Stock [Line Items]	'	'
Restricted voting shares of 129,297,892; (2011 - 129,167,926), issued	$610.60	$572.50
Restricted Voting Shares [Member]	'	'
Class of Stock [Line Items]	'	'
Restricted voting shares, issued (in shares)	140,930,525	129,297,892
Restricted voting shares, outstanding (in shares)	140,930,525	129,297,892
Restricted voting shares of 129,297,892; (2011 - 129,167,926), issued	610.6	572.5
Restricted voting shares of 129,297,892; (2011 - 129,167,926), outstanding	$610.60	$572.50

Shareholders_Equity_Stock_Opti

Shareholders' Equity - Stock Options Rollforward (Details) (CAD)	12 Months Ended
	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011
Options, Outstanding [Roll Forward]	'	'	'
Outstanding, beginning of period (in shares)	12,479,678	12,628,458	8,327,357
Granted (in shares)	1,630,000	2,968,502	5,862,000
Exercised (in shares)	-2,229,150	-129,966	0
Forfeited (in shares)	-863,303	-2,987,316	-1,560,899
Outstanding, end of period (in shares)	11,017,225	12,479,678	12,628,458
Exercisable, end of period (in shares)	3,052,975	3,717,875	3,893,124
Options, Outstanding, Weighted-Average Exercise Price [Roll Forward]	'	'	'
Outstanding at beginning of period, Weighted-Average Exercise Price (in dollars per share)	2.54	2.88	3.26
Granted, Weighted-Average Exercise Price (in dollars per share)	4.19	2.08	2.5
Exercised, Weighted-Average Exercise Price (in dollars per share)	2.66	2.59	0
Forfeited, Weighted-Average Exercise Price (in dollars per share)	2.95	3.37	3.34
Outstanding at end of period, Weighted-Average Exercise Price (in dollars per share)	2.72	2.54	2.88
Exercisable at end of period, Weighted-Average Exercise Price (in dollars per share)	2.64	2.91	3.65

Shareholders_Equity_Schedule_o

Shareholders' Equity - Schedule of Non-Vested Stock options (Details) (CAD)	12 Months Ended
	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]	'	'	'
Balance at beginning of year (in shares)	8,761,802	'	'
Granted (in shares)	1,630,000	2,968,502	5,862,000
Vested (in shares)	-1,922,550	'	'
Forfeited (in shares)	-505,002	'	'
Balance at end of year (in shares)	7,964,250	8,761,802	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]	'	'	'
Balance at the beginning of the year, Weighted Average Grant Date Fair Value (in dollars per share)	1.24	'	'
Granted, Weighted Average Grant Date Fair Value (in dollars per share)	2.17	'	'
Vested, Weighted Average Grant Date Fair Value (in dollars per share)	1.29	'	'
Forfeited, Weighted Average Grant Date Fair Value (in dollars per share)	1.18	'	'
Balance at the end of the year, Weighted Average Grant Date Fair Value (in dollars per share)	1.43	1.24	'

Shareholders_Equity_Stock_Opti1

Shareholders' Equity - Stock Options Outstanding (Details) (CAD)	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011	Oct. 31, 2010	Oct. 31, 2013	Oct. 31, 2013	Oct. 31, 2013	Oct. 31, 2013	Oct. 31, 2013
					$1.54 - 2.07 [Member]	$2.08 - 2.61 [Member]	$2.62 - 2.88 [Member]	$2.89 - 13.21 [Member]	$3.78 - 11.21
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'	'	'	'	'	'
Options Outstanding, Number Outstanding (in shares)	11,017,225	12,479,678	12,628,458	8,327,357	2,729,750	2,179,700	4,000,000	815,438	1,292,337
Options Outstanding, Weighted Average Remaining Contractual Life	'	'	'	'	'8 years 6 months	'6 years	'7 years 4 months 24 days	'7 years 3 months 18 days	'8 years 8 months 12 days
Options Outstanding, Weighted Average Exercise Price	'	'	'	'	1.94	2.52	2.62	3.32	4.6
Options Exercisable, Number Exercisable (in shares)	3,052,975	3,717,875	3,893,124	'	429,100	1,286,100	1,000,000	225,438	112,337
Options Exercisable, Weighted-Average Exercise Price (in dollars per share)	2.64	2.91	3.65	'	1.82	2.57	2.62	3.39	5.33
Range of Exercise Prices, lower range limit	'	'	'	'	1.54	2.08	2.62	2.89	'
Range of Exercise Prices, upper range limit	'	'	'	'	2.07	2.61	2.88	13.21	'

Shareholders_Equity_Stock_Opti2

Shareholders' Equity - Stock Options, Valuation Assumptions (Details)	12 Months Ended
	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'	'	'
Risk free interest rate	1.40%	1.30%	2.50%
Expected volatility	60.00%	58.00%	59.00%
Expected weighted-average life of options	'5 years 1 month 6 days	'5 years 6 months	'5 years
Expected dividend yield	0.00%	0.00%	0.00%

Other_Information_Narrative_De

Other Information - Narrative (Details) (USD $)	12 Months Ended
	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011
Other Information [Line Items]	'	'	'
Foreign exchange (loss) gain	($800,000)	($500,000)	$1,600,000
Director [Member]	'	'	'
Other Information [Line Items]	'	'	'
Revenue from related parties	0	300,000	100,000
Equity Method Investee [Member] | BSP Pharmaceuticals [Member]	'	'	'
Other Information [Line Items]	'	'	'
Equity method investments	5,800,000	4,000,000	'
Equity method investment, ownership percentage	18.00%	'	'
Income from equity method Investments	1,500,000	1,000,000	100,000
Service Management Costs	0	'	0
Accounts receivable from related parties	0	0	0
Equity Method Investee [Member] | JLL Patheon Holdings [Member]	'	'	'
Other Information [Line Items]	'	'	'
Accounts receivable from related parties	$3,600,000	'	'

Other_Information_Changes_in_W

Other Information - Changes in Working Capital Balances (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011
Supplemental Cash Flow Elements [Abstract]	'	'	'
Accounts receivable	$24.40	($17.80)	'
Inventories	-0.8	-2.7	'
Income taxes receivable	-1.6	2.2	'
Prepaid expenses and other	-1.3	0.7	'
Accounts payable and accrued liabilities	-11	5.3	'
Income taxes payable	-0.9	5.5	'
Net change in non-cash working capital balances related to continuing operations	$8.80	($6.80)	$1

Financial_Instruments_Fair_Val2

Financial Instruments, Fair Value and Risk Management - Narrative (Details)

12 Months Ended

12 Months Ended

12 Months Ended

0 Months Ended

0 Months Ended

In Millions, unless otherwise specified

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2011

Oct. 31, 2010

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2012

Oct. 08, 2013

Oct. 31, 2012

Oct. 31, 2013

Aug. 31, 2012

Oct. 31, 2012

Aug. 31, 2012

USD ($)

USD ($)

USD ($)

USD ($)

Canada [Member]

Foreign Exchange Forward [Member]

Foreign Exchange Forward [Member]

Foreign Exchange Forward [Member]

Foreign Exchange Forward [Member]

Foreign Exchange Collars [Member]

BCS [Member]

BCS [Member]

Contingent Consideration [Member]

Canada [Member]

Canada [Member]

Canada [Member]

Canada [Member]

Canada [Member]

Canada [Member]

Canada [Member]

Canada [Member]

USD ($)

USD ($)

EUR (€)

USD ($)

USD ($)

USD ($)

USD ($)

Derivative [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

Derivative, Notional Amount

'

'

'

'

'

$106.30

$69.40

'

€ 6

$24.20

'

'

'

Total consideration to be paid to the Company for the sale of BCS

'

'

'

'

'

'

'

'

'

'

2.7

'

'

Consideration paid in cash

'

'

'

'

'

'

'

'

'

'

1.35

'

'

Consideration to be paid in 24 months, contingent upon revenue targets

'

'

'

'

'

'

'

'

'

'

1.35

'

'

Contingency consideration terms, period of time from date of close

'

'

'

'

'

'

'

'

'

'

'24 months

'

'

Contingent consideration, fair value

0

'

'

'

'

'

'

'

'

'

'

'

0

Average exchange rate

'

'

'

'

'

1.0162

1.0373

1.3

'

0.9938

'

'

'

Loss recognized in accumulated other comprehensive income

'

'

'

'

'

'

2.2

'

'

'

'

'

'

Loss recognized in accumulated other comprehensive income

'

'

'

'

'

3.4

0.1

'

'

0.8

'

'

'

Percent of revenue from foreign country

'

'

'

'

90.00%

'

'

'

'

'

'

'

'

Percent of operating expenses, transacted in foreign currency

'

'

'

'

10.00%

'

'

'

'

'

'

'

'

Percentage, potential increase/decrease in exchange rate impacting operating income

10.00%

'

'

'

'

'

'

'

'

'

'

'

'

Amount, potential change in exchange rate impacting operating income

18.5

'

'

'

'

'

'

'

'

'

'

'

'

Derivatives, percent of cash flow exposure covered by hedges

80.00%

'

'

'

'

'

'

'

'

'

'

'

'

Derivative, collateral held directly, cash deposits

16.7

16.4

'

'

'

'

'

'

'

'

'

'

'

Cash and cash equivalents

61.6

[1]

39.4

[1]

33.4

53.5

'

'

'

'

'

'

'

'

'

Line of credit available

66.1

'

'

'

'

'

'

'

'

'

'

'

'

Disposal Group, Including Discontinued Operation, Contingent Consideration, Fair Value

'

'

'

'

'

'

'

'

'

'

'

$0.30

'

[1]

Includes cash and cash equivalents in bank accounts bearing interest rates up to 1%.

Financial_Instruments_Fair_Val3

Financial Instruments, Fair Value and Risk Management - Carrying Values of Financial Instruments (Details) (USD $)	Oct. 31, 2013		Oct. 31, 2012		Oct. 31, 2011	Oct. 31, 2010
In Millions, unless otherwise specified
Derivatives, Fair Value [Line Items]	'		'		'	'
Held-for-trading	$61.60	[1]	$39.40	[1]	$33.40	$53.50
Loans and receivables	191.3	[2]	161.7	[2]	'	'
Other financial liabilities	830.9	[3]	499.3	[3]	'	'
Maximum interest rate on bank accounts	1.00%		'		'	'
Allowance for doubtful accounts receivable	1.8		0.8		'	'
Designated as Hedging Instrument [Member]	'		'		'	'
Derivatives, Fair Value [Line Items]	'		'		'	'
Derivatives designated as effective hedges - gain (loss)	-4.2	[4]	1.4	[4]	'	'
Other derivatives	$0.20	[5]	$0.30	[5]	'	'
[1]	Includes cash and cash equivalents in bank accounts bearing interest rates up to 1%.
[2]	Includes accounts receivable, net of an allowance for doubtful accounts of $1.8 million and $0.8 million at October 31, 2013 and 2012, respectively.
[3]	Includes bank indebtedness, accounts payable, accrued liabilities and long-term debt.
[4]	Includes the Company's forward contracts and collars in 2013 and 2012.
[5]	Includes the contingent consideration receivable related to the Burlington sale.

Financial_Instruments_Fair_Val4

Financial Instruments, Fair Value and Risk Management - Fair Value Hierarchy (Details) (USD $)	Oct. 31, 2013	Oct. 31, 2012
In Millions, unless otherwise specified
Level 1 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative assets measured at fair value	$0	$0
Level 2 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative assets measured at fair value	0	0
Level 3 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative assets measured at fair value	0.2	0.3
Fair Value [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative assets measured at fair value	0.2	0.3
Contingent Consideration Receivable [Member] | Level 1 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative assets measured at fair value	0	0
Contingent Consideration Receivable [Member] | Level 2 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative assets measured at fair value	0	0
Contingent Consideration Receivable [Member] | Level 3 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative assets measured at fair value	0.2	0.3
Contingent Consideration Receivable [Member] | Fair Value [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative assets measured at fair value	0.2	0.3
Designated as Hedging Instrument [Member] | Level 1 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative assets measured at fair value	0	0
Designated as Hedging Instrument [Member] | Level 2 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative assets measured at fair value	0	2.1
Designated as Hedging Instrument [Member] | Level 3 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative assets measured at fair value	0	0
Designated as Hedging Instrument [Member] | Fair Value [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative assets measured at fair value	0	2.1
Designated as Hedging Instrument [Member] | Foreign Exchange Forward [Member] | Level 1 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative assets measured at fair value	0	0
Designated as Hedging Instrument [Member] | Foreign Exchange Forward [Member] | Level 2 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative assets measured at fair value	0	2.1
Designated as Hedging Instrument [Member] | Foreign Exchange Forward [Member] | Level 3 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative assets measured at fair value	0	0
Designated as Hedging Instrument [Member] | Foreign Exchange Forward [Member] | Fair Value [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative assets measured at fair value	0	2.1
Other Current Liabilities [Member] | Designated as Hedging Instrument [Member] | Level 1 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative liabilities measured at fair value	0	0
Other Current Liabilities [Member] | Designated as Hedging Instrument [Member] | Level 2 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative liabilities measured at fair value	3.4	0.7
Other Current Liabilities [Member] | Designated as Hedging Instrument [Member] | Level 3 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative liabilities measured at fair value	0	0
Other Current Liabilities [Member] | Designated as Hedging Instrument [Member] | Fair Value [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative liabilities measured at fair value	3.4	0.7
Other Current Liabilities [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Forward [Member] | Level 2 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative liabilities measured at fair value	2.6	'
Other Current Liabilities [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Forward [Member] | Fair Value [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative liabilities measured at fair value	2.6	'
Other Current Liabilities [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Collars [Member] | Level 1 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative liabilities measured at fair value	0	0
Other Current Liabilities [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Collars [Member] | Level 2 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative liabilities measured at fair value	0.8	0.7
Other Current Liabilities [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Collars [Member] | Level 3 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative liabilities measured at fair value	0	0
Other Current Liabilities [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Collars [Member] | Fair Value [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative liabilities measured at fair value	0.8	0.7
Other Noncurrent Liabilities [Member] | Designated as Hedging Instrument [Member] | Level 1 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative liabilities measured at fair value	0	0
Other Noncurrent Liabilities [Member] | Designated as Hedging Instrument [Member] | Level 2 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative liabilities measured at fair value	0.8	0
Other Noncurrent Liabilities [Member] | Designated as Hedging Instrument [Member] | Level 3 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative liabilities measured at fair value	0	0
Other Noncurrent Liabilities [Member] | Designated as Hedging Instrument [Member] | Fair Value [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative liabilities measured at fair value	0.8	0
Other Noncurrent Liabilities [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Forward [Member] | Level 2 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative liabilities measured at fair value	0.8	'
Other Noncurrent Liabilities [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Forward [Member] | Fair Value [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Derivative liabilities measured at fair value	$0.80	'

Financial_Instruments_Fair_Val5

Financial Instruments, Fair Value and Risk Management - Balance Sheet Location (Details) (USD $)	Oct. 31, 2013	Oct. 31, 2012
In Millions, unless otherwise specified
Designated as Hedging Instrument [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Derivative assets measured at fair value	$0.20	$2.10
Derivative liabilities measured at fair value	4.2	0.7
Designated as Hedging Instrument [Member] | Prepaid Expenses and Other [Member] | Foreign Exchange Forward [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Derivative assets measured at fair value	0	1.8
Designated as Hedging Instrument [Member] | Prepaid Expenses and Other [Member] | Contingent Consideration Receivable [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Derivative assets measured at fair value	0.2	0
Designated as Hedging Instrument [Member] | Other Long-term Assets [Member] | Foreign Exchange Forward [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Derivative assets measured at fair value	0	0.3
Designated as Hedging Instrument [Member] | Accounts Payable and Accrued Liabilities [Member] | Foreign Exchange Collars [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Derivative liabilities measured at fair value	0.8	0.3
Designated as Hedging Instrument [Member] | Accounts Payable and Accrued Liabilities [Member] | Foreign Exchange Forward [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Derivative liabilities measured at fair value	2.6	0
Designated as Hedging Instrument [Member] | Other Long-term Liabilities [Member] | Foreign Exchange Collars [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Derivative liabilities measured at fair value	0	0.4
Designated as Hedging Instrument [Member] | Other Long-term Liabilities [Member] | Foreign Exchange Forward [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Derivative liabilities measured at fair value	0.8	0
Not Designated as Hedging Instrument [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Derivative assets measured at fair value	0	0.3
Not Designated as Hedging Instrument [Member] | Other Long-term Assets [Member] | Contingent Consideration Receivable [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Derivative assets measured at fair value	$0	$0.30

Financial_Instruments_Fair_Val6

Financial Instruments, Fair Value and Risk Management - Assets Measured at Fair Value, Level 3 (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Oct. 31, 2013
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'
Opening balance	$0.30
Purchases	0
Issues	0
Total gains (losses)	'
In net loss	0
In other comprehensive income (foreign exchange)	-0.1
Settlements	0
Transfers out of Level 3	0
Closing balance (October 31, 2013)	0.2
Contingent Consideration [Member]	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'
Opening balance	0.3
Purchases	0
Issues	0
Total gains (losses)	'
In other comprehensive income (foreign exchange)	-0.1
Settlements	0
Transfers out of Level 3	0
Closing balance (October 31, 2013)	$0.20

Income_Taxes_Narrative_Details

Income Taxes - Narrative (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011	Oct. 31, 2010
Operating Loss Carryforwards [Line Items]	'	'	'	'
Net operating loss carryforwards	$31.60	'	'	'
Tax credit carryforwards	39.6	'	'	'
Unrecognized tax benefits	3.8	0.8	0.8	1.4
Unrecognized tax benefits that would impact effective tax rate	2.6	0	'	'
Deferred Income Tax Expense (Benefit)	15.3	-34.2	0.5	'
Indefinite Life [Member]	'	'	'	'
Operating Loss Carryforwards [Line Items]	'	'	'	'
Net operating loss carryforwards	15.7	'	'	'
Finite Life [Member]	'	'	'	'
Operating Loss Carryforwards [Line Items]	'	'	'	'
Net operating loss carryforwards	15.9	'	'	'
Foreign [Member]	'	'	'	'
Operating Loss Carryforwards [Line Items]	'	'	'	'
Deferred Income Tax Expense (Benefit)	$1.10	'	'	'

Income_Taxes_Reconciliation_of

Income Taxes - Reconciliation of Expected Income Tax (Recovery) Expense and Net Deferred Tax Assets (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011
Income Tax Contingency [Line Items]	'	'	'
Statutory tax rate	25.00%	'	'
Income Tax Expense (Recovery) Reconciliation, Continuing Operations	'	'	'
Expected income tax expense (benefit) using statutory tax rates	($10.60)	($15.90)	($3.90)
Change in valuation allowance	19	56.6	4
Permanent differences and other:	'	'	'
Foreign	-4.1	3.4	2.3
Domestic	-5.5	-2.2	-5.6
Foreign rate differentials	-5.4	1.5	2.5
Other	0	0	1.8
(Benefit from) provision for income taxes	-6.6	43.4	1.1
Effective tax rate	15.60%	-68.90%	-7.50%
Deferred Income Tax Assets, Net	'	'	'
Net operating loss carry-forward	33.4	18	'
Accounting provisions not currently deductible for tax purposes	21.8	17.7	'
Unrealized foreign exchange losses (gains) on debt	5.6	-0.4	'
Deferred financing costs	5.1	0.2	'
Deferred revenue	11	12.2	'
Unclaimed R&D expenditures	16.8	14	'
Investment tax credits and other credits	27	20.1	'
Other	0.4	0	'
Tax depreciation in excess of book depreciation	-40.1	-28.5	'
Valuation allowance	-91.8	-72	'
Purchased intangible assets	-26.5	0	'
Deferred tax assets, net of deferred tax liabilities	-37.3	-18.7	'
Short-term and Long-term Deferred Assets and Liabilities, Net of Valuation Allowance	'	'	'
Short-term deferred income tax assets	6.2	4.3	'
Long-term deferred income tax liabilities	-43.5	-23	'
Deferred tax assets, net of deferred tax liabilities	-37.3	-18.7	'
Income tax expense	($6.60)	$43.40	$1.10

Income_Taxes_Unrecognized_Tax_

Income Taxes - Unrecognized Tax Benefits Roll Forward (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011
Reconciliation of Unrecognized Tax Benefits [Roll Forward]	'	'	'
Beginning balance	$0.80	$0.80	$1.40
Decreases related to positions taken in the current year	-0.2	0	-0.8
Increases based on tax positions taken in the current year	3.3	0	0.2
Reductions related to lapse of applicable statute of limitations	-0.1	'	'
Ending balance	$3.80	$0.80	$0.80

Income_Taxes_Loss_from_Continu

Income Taxes - Loss from Continuing Operations (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011
Operating Loss Carryforwards [Line Items]	'	'	'
Loss from continuing operations before income taxes	($42.30)	($63)	($14.70)
Domestic [Member]	'	'	'
Operating Loss Carryforwards [Line Items]	'	'	'
Loss from continuing operations before income taxes	-30.6	-14.3	-12.5
Foreign [Member]	'	'	'
Operating Loss Carryforwards [Line Items]	'	'	'
Loss from continuing operations before income taxes	($11.70)	($48.70)	($2.20)

Income_Taxes_Provision_for_Ben

Income Taxes - Provision for (Benefit from) Income Taxes (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011
Provision for (Benefit from) Income Taxes [Line Items]	'	'	'
Domestic - Current	$0	$0	$0
Domestic - Deferred	0	34.4	0
Foreign - Current	8.7	9.2	1.6
Foreign - Deferred	-15.3	-0.2	-0.5
(Benefit from) provision for income taxes	($6.60)	$43.40	$1.10

Segmented_Information_Narrativ

Segmented Information - Narratives (Details) (USD $)	3 Months Ended	12 Months Ended					3 Months Ended	12 Months Ended
In Millions, unless otherwise specified	Apr. 30, 2012	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011	Oct. 31, 2013	Oct. 31, 2012	Jan. 31, 2013	Oct. 31, 2013	Oct. 31, 2013	Oct. 31, 2013
		segment			Canada [Member]	Canada [Member]	Olds, Canada Facility [Member]	Olds, Canada Facility [Member]	Patheon Swindon United Kingdom Facility [Member]	Banner Acquisition [Member]
							Canada [Member]	Canada [Member]		In Process Research and Development [Member]
Segment Reporting [Abstract]	'	'	'	'	'	'	'	'	'	'
Number of operating segments	'	2	'	'	'	'	'	'	'	'
Number of reportable segments	'	2	'	'	'	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'	'	'	'	'	'
Impairment charge	$57.90	$13.10	$57.90	$0	$11.80	$0	$10.10	$11.80	$57.90	$1.30

Segmented_Information_Reportin

Segmented Information - Reporting by Segment (Details) (USD $)

3 Months Ended

12 Months Ended

In Millions, unless otherwise specified

Oct. 31, 2013

Jul. 31, 2013

Apr. 30, 2013

Jan. 31, 2013

Oct. 31, 2012

Jul. 31, 2012

Apr. 30, 2012

Jan. 31, 2012

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2011

Segment Reporting, Other Significant Reconciling Item [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenues

$290

[1]

$265.70

[2]

$253.90

[3]

$213.50

[4]

$210

[5]

$203.70

[6]

$181.50

[7]

$153.90

[8]

$1,023.10

$749.10

$700

Adjusted EBITDA

'

'

'

'

'

'

'

'

146.2

87.4

78.9

Total assets

1,077.80

'

'

'

742.9

'

'

'

1,077.80

742.9

824.6

Depreciation

'

'

'

'

'

'

'

'

48.4

40.8

53.2

Impairment

'

'

'

'

'

'

57.9

'

13.1

57.9

0

Goodwill

48.5

'

'

'

3.5

'

'

'

48.5

3.5

3.5

Capital expenditures

'

'

'

'

'

'

'

'

49.8

53.4

47.8

Commercial [Member]

'

'

'

'

'

'

'

'

'

'

'

Segment Reporting, Other Significant Reconciling Item [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenues

'

'

'

'

'

'

'

'

876.8

610.7

572.6

Adjusted EBITDA

'

'

'

'

'

'

'

'

146

92.4

85.1

Total assets

905.7

'

'

'

617.4

'

'

'

905.7

617.4

673

Depreciation

'

'

'

'

'

'

'

'

43.8

35

46.4

Impairment

'

'

'

'

'

'

'

'

13.1

55.1

'

Goodwill

48.5

'

'

'

3.5

'

'

'

48.5

3.5

3.5

Capital expenditures

'

'

'

'

'

'

'

'

45.4

47.3

38.4

PDS [Member]

'

'

'

'

'

'

'

'

'

'

'

Segment Reporting, Other Significant Reconciling Item [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenues

'

'

'

'

'

'

'

'

146.3

138.4

127.4

Adjusted EBITDA

'

'

'

'

'

'

'

'

41

30.7

24.1

Total assets

71.8

'

'

'

69.7

'

'

'

71.8

69.7

84.5

Depreciation

'

'

'

'

'

'

'

'

3.8

4.9

5.8

Impairment

'

'

'

'

'

'

'

'

0

2.8

'

Goodwill

0

'

'

'

0

'

'

'

0

0

0

Capital expenditures

'

'

'

'

'

'

'

'

4.3

4.7

8.8

Corp. & Other [Member]

'

'

'

'

'

'

'

'

'

'

'

Segment Reporting, Other Significant Reconciling Item [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenues

'

'

'

'

'

'

'

'

0

0

0

Adjusted EBITDA

'

'

'

'

'

'

'

'

-40.8

-35.7

-30.3

Total assets

100.3

'

'

'

55.8

'

'

'

100.3

55.8

67.1

Depreciation

'

'

'

'

'

'

'

'

0.8

0.9

1

Impairment

'

'

'

'

'

'

'

'

0

0

'

Goodwill

0

'

'

'

0

'

'

'

0

0

0

Capital expenditures

'

'

'

'

'

'

'

'

0.1

1.4

0.6

Swindon Facility [Member]

'

'

'

'

'

'

'

'

'

'

'

Segment Reporting, Other Significant Reconciling Item [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Impairment

'

'

'

'

'

'

'

'

$57.90

'

'

[1]

Income from continuing operations includes $4.8 million in repositioning costs relating primarily to Banner, Puerto Rico, and Swindon, $3.8 million in acquisition-related costs relating primarily to the pending merger that was announced on November 18, 2013, $2.4 million in acquisition-related litigation costs, $1.8 million in impairment primarily relating to the Olds, Alberta, Canada facility, and $1.1 million for inventory write-off's in gross profit associated with the Olds, Alberta, Canada closure.

[2]

Income from continuing operations includes $4.6 million in repositioning costs relating primarily to Banner and our operation in Bourgoin, France, $4.0 million relating to acquisition-related litigation costs, $1.2 million in acquisition-related costs relating primarily to Banner, $1.2 million in impairment of IP R&D, and $0.4 million in consulting fees relating to strategic initiatives.

[3]

operations included $2.5 million in repositioning costs relating primarily to Banner, $1.8 million in consulting fees relating to strategic initiatives, and $3.7 million in integration-related costs relating to the Banner Acquisition

[4]

Loss from continuing operations included $29.0 million in refinancing expenses, $10.1 million in impairment expenses of the Olds, Alberta, Canada facility, $4.4 million in acquisition costs related to the Banner Acquisition, and $4.0 million in repositioning expenses relating primarily to Banner.

[5]

Loss from continuing operations included $36.6 million from recording of a valuation allowance against the Company's Canadian deferred tax assets and $3.2 million of acquisition-related costs.

[6]

Income from continuing operations included $1.0 million of consulting fees related to strategic initiatives.

[7]

Loss from continuing operations included a $57.9 million impairment charge, $4.4 million of repositioning expenses related to the Plan of Termination and $6.0 million in consulting fees related to strategic initiatives.

[8]

Loss from continuing operations included $6.4 million of consulting fees related to strategic initiatives.

Segmented_Information_Adjusted

Segmented Information - Adjusted EBITDA (Details) (USD $)

3 Months Ended

9 Months Ended

12 Months Ended

In Millions, unless otherwise specified

Oct. 31, 2013

Jul. 31, 2013

Apr. 30, 2013

Jan. 31, 2013

Oct. 31, 2012

Jul. 31, 2012

Apr. 30, 2012

Jan. 31, 2012

Jul. 31, 2013

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2011

Segment Reporting [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

Total Adjusted EBITDA per above

'

'

'

'

'

'

'

'

'

$146.20

$87.40

$78.90

Depreciation and amortization

'

'

'

'

'

'

'

'

'

-48.4

-40.8

-53.2

Repositioning expenses

-4.8

-4.6

-2.5

'

'

'

'

'

'

-15.8

-6.1

-7

Acquisition and integration costs

'

'

'

'

'

'

'

'

'

-20.2

-3.2

0

Interest expense, net

'

'

'

'

'

'

'

'

'

-47.8

-26.5

-25.6

Interest expense, net

'

'

'

'

'

'

-57.9

'

'

-13.1

-57.9

0

Gain (loss) on sale of capital assets

'

'

'

'

'

'

'

'

'

1.3

-0.4

-0.2

Refinancing expenses

'

'

'

-29

'

'

'

'

-29.2

-29.2

0

0

Benefit from (provision for) income taxes

'

'

'

'

'

'

'

'

'

6.6

-43.4

-1.1

Consulting

'

'

'

'

'

'

'

'

'

-2.3

-13.3

-9

Acquisition-related litigation expenses

-2.4

'

'

'

'

'

'

'

'

-6.4

0

0

Stock-based compensation expense

'

'

'

'

'

'

'

'

'

-3.2

-3.1

-3.5

Purchase accounting adjustments

'

'

'

'

'

'

'

'

'

-5

0

0

Other

'

'

'

'

'

'

'

'

'

1.6

0.9

4.9

Loss from continuing operations

$11.30

[1]

$4.30

[2]

$0.10

[3]

($51.40)

[4]

($23)

[5]

$15.50

[6]

($79.60)

[7]

($19.30)

[8]

'

($35.70)

($106.40)

($15.80)

[1]

Income from continuing operations includes $4.8 million in repositioning costs relating primarily to Banner, Puerto Rico, and Swindon, $3.8 million in acquisition-related costs relating primarily to the pending merger that was announced on November 18, 2013, $2.4 million in acquisition-related litigation costs, $1.8 million in impairment primarily relating to the Olds, Alberta, Canada facility, and $1.1 million for inventory write-off's in gross profit associated with the Olds, Alberta, Canada closure.

[2]

Income from continuing operations includes $4.6 million in repositioning costs relating primarily to Banner and our operation in Bourgoin, France, $4.0 million relating to acquisition-related litigation costs, $1.2 million in acquisition-related costs relating primarily to Banner, $1.2 million in impairment of IP R&D, and $0.4 million in consulting fees relating to strategic initiatives.

[3]

operations included $2.5 million in repositioning costs relating primarily to Banner, $1.8 million in consulting fees relating to strategic initiatives, and $3.7 million in integration-related costs relating to the Banner Acquisition

[4]

Loss from continuing operations included $29.0 million in refinancing expenses, $10.1 million in impairment expenses of the Olds, Alberta, Canada facility, $4.4 million in acquisition costs related to the Banner Acquisition, and $4.0 million in repositioning expenses relating primarily to Banner.

[5]

Loss from continuing operations included $36.6 million from recording of a valuation allowance against the Company's Canadian deferred tax assets and $3.2 million of acquisition-related costs.

[6]

Income from continuing operations included $1.0 million of consulting fees related to strategic initiatives.

[7]

Loss from continuing operations included a $57.9 million impairment charge, $4.4 million of repositioning expenses related to the Plan of Termination and $6.0 million in consulting fees related to strategic initiatives.

[8]

Loss from continuing operations included $6.4 million of consulting fees related to strategic initiatives.

Segmented_Information_Geograph

Segmented Information - Geographic Segment Reporting (Details) (USD $)

3 Months Ended

12 Months Ended

In Millions, unless otherwise specified

Oct. 31, 2013

Jul. 31, 2013

Apr. 30, 2013

Jan. 31, 2013

Oct. 31, 2012

Jul. 31, 2012

Apr. 30, 2012

Jan. 31, 2012

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2011

customer

Revenues from External Customers and Long-Lived Assets [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenues

$290

[1]

$265.70

[2]

$253.90

[3]

$213.50

[4]

$210

[5]

$203.70

[6]

$181.50

[7]

$153.90

[8]

$1,023.10

$749.10

$700

Capital assets

496.7

'

'

'

416.4

'

'

'

496.7

416.4

474.2

Impairment

'

'

'

'

'

'

57.9

'

13.1

57.9

0

Goodwill

48.5

'

'

'

3.5

'

'

'

48.5

3.5

3.5

Intangible assets

69.2

'

'

'

0

'

'

'

69.2

0

'

Number of major customers

'

'

'

'

'

'

'

'

1

'

'

Revenue by major customer, percentage

'

'

'

'

'

'

'

'

11.00%

'

'

Canada [Member]

'

'

'

'

'

'

'

'

'

'

'

Revenues from External Customers and Long-Lived Assets [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenues

'

'

'

'

'

'

'

'

22

13.7

12

Capital assets

116.5

'

'

'

115.7

'

'

'

116.5

115.7

115.6

Impairment

'

'

'

'

'

'

'

'

11.8

0

'

Goodwill

3.3

'

'

'

3.5

'

'

'

3.3

3.5

3.5

Intangible assets

1

'

'

'

'

'

'

'

1

'

'

U.S. [Member]

'

'

'

'

'

'

'

'

'

'

'

Revenues from External Customers and Long-Lived Assets [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenues

'

'

'

'

'

'

'

'

607.3

[9]

434.2

[9]

348.9

[9]

Capital assets

180.8

[9]

'

'

'

144.8

[9]

'

'

'

180.8

[9]

144.8

[9]

133.6

[9]

Impairment

'

'

'

'

'

'

'

'

1.3

0

'

Goodwill

35.1

[9]

'

'

'

0

[9]

'

'

'

35.1

[9]

0

[9]

0

[9]

Intangible assets

48

'

'

'

'

'

'

'

48

'

'

Europe [Member]

'

'

'

'

'

'

'

'

'

'

'

Revenues from External Customers and Long-Lived Assets [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenues

'

'

'

'

'

'

'

'

333.4

259.4

302.4

Capital assets

191.9

'

'

'

154.4

'

'

'

191.9

154.4

223.3

Impairment

'

'

'

'

'

'

'

'

0

57.9

'

Goodwill

7

'

'

'

0

'

'

'

7

0

0

Intangible assets

12.2

'

'

'

'

'

'

'

12.2

'

'

Other [Member]

'

'

'

'

'

'

'

'

'

'

'

Revenues from External Customers and Long-Lived Assets [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Revenues

'

'

'

'

'

'

'

'

60.4

[10]

41.8

36.7

Capital assets

7.5

[10]

'

'

'

1.5

'

'

'

7.5

[10]

1.5

1.7

Impairment

'

'

'

'

'

'

'

'

0

[10]

0

'

Goodwill

3.1

[10]

'

'

'

0

'

'

'

3.1

[10]

0

0

Intangible assets

$8

'

'

'

'

'

'

'

$8

'

'

[1]

Income from continuing operations includes $4.8 million in repositioning costs relating primarily to Banner, Puerto Rico, and Swindon, $3.8 million in acquisition-related costs relating primarily to the pending merger that was announced on November 18, 2013, $2.4 million in acquisition-related litigation costs, $1.8 million in impairment primarily relating to the Olds, Alberta, Canada facility, and $1.1 million for inventory write-off's in gross profit associated with the Olds, Alberta, Canada closure.

[2]

Income from continuing operations includes $4.6 million in repositioning costs relating primarily to Banner and our operation in Bourgoin, France, $4.0 million relating to acquisition-related litigation costs, $1.2 million in acquisition-related costs relating primarily to Banner, $1.2 million in impairment of IP R&D, and $0.4 million in consulting fees relating to strategic initiatives.

[3]

operations included $2.5 million in repositioning costs relating primarily to Banner, $1.8 million in consulting fees relating to strategic initiatives, and $3.7 million in integration-related costs relating to the Banner Acquisition

[4]

Loss from continuing operations included $29.0 million in refinancing expenses, $10.1 million in impairment expenses of the Olds, Alberta, Canada facility, $4.4 million in acquisition costs related to the Banner Acquisition, and $4.0 million in repositioning expenses relating primarily to Banner.

[5]

Loss from continuing operations included $36.6 million from recording of a valuation allowance against the Company's Canadian deferred tax assets and $3.2 million of acquisition-related costs.

[6]

Income from continuing operations included $1.0 million of consulting fees related to strategic initiatives.

[7]

Loss from continuing operations included a $57.9 million impairment charge, $4.4 million of repositioning expenses related to the Plan of Termination and $6.0 million in consulting fees related to strategic initiatives.

[8]

Loss from continuing operations included $6.4 million of consulting fees related to strategic initiatives.

[9]

Includes Puerto Rico

[10]

Includes Mexico in fiscal 2013

Commitments_and_Contingencies_1

Commitments and Contingencies - Narrative (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011
Commitments and Contingencies Disclosure [Abstract]	'	'	'
2014	$4.70	'	'
2015	2.7	'	'
2016	1.4	'	'
2017	0.9	'	'
2018	0.9	'	'
Thereafter	0.5	'	'
Total payments	11.1	'	'
Operating leases, rental expense	$9.40	$7.50	$7.20
Damages from Product Defects, Class Action [Member] | Pending Litigation [Member]	'	'	'
Loss Contingencies [Line Items]	'	'	'
Numbr of pending actions against Company's customer	1	'	'
Individual Plaintiff [Member] | Pending Litigation [Member]	'	'	'
Loss Contingencies [Line Items]	'	'	'
Numbr of pending actions against Company's customer	4	'	'

Repositioning_Expenses_Narrati

Repositioning Expenses - Narrative (Details) (USD $)

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

In Millions, unless otherwise specified

Oct. 31, 2013

Jul. 31, 2013

Apr. 30, 2013

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2011

Oct. 31, 2013

Oct. 31, 2013

Oct. 31, 2013

Jan. 31, 2013

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2011

Oct. 31, 2011

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2011

Apr. 30, 2012

Oct. 31, 2012

Plan of Termination [Member]

Banner Synergy Initiatives [Member]

Bourgoin, France Facility Restructuring Initiative [Member]

Caguas Facility Closing [Member]

Caguas Facility Closing [Member]

Caguas Facility Closing [Member]

Caguas Facility Closing [Member]

Strategic Initiatives in Zug and Swindon [Member]

Employee Severance [Member]

Employee Severance [Member]

Employee Severance [Member]

Employee Severance [Member]

Employee Severance [Member]

Plan of Termination [Member]

Plan of Termination [Member]

positions

Restructuring Cost and Reserve [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Repositioning expenses

$4.80

$4.60

$2.50

$15.80

$6.10

$7

$2.10

$9.90

$2.30

$4

$1.30

$1.70

$4

$3

$15.50

$4.60

$4.30

$4.40

$4.40

Expected number of positions eliminated (in number of positions)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

91

Repositioning_Expenses_Reposit

Repositioning Expenses - Repositioning Expenses and Charges (Details) (USD $)	3 Months Ended			12 Months Ended
In Millions, unless otherwise specified	Oct. 31, 2013	Jul. 31, 2013	Apr. 30, 2013	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011
Restructuring Reserve [Roll Forward]	'	'	'	'	'	'
Total repositioning liabilities at beginning of period	'	'	'	$5.50	$6.70	$3.20
Repositioning expenses	4.8	4.6	2.5	15.8	6.1	7
Repositioning expenses paid	'	'	'	-13.6	-7.3	-3.5
Total repositioning liabilities at end of period	7.7	'	'	7.7	5.5	6.7
Commercial [Member]	'	'	'	'	'	'
Restructuring Reserve [Roll Forward]	'	'	'	'	'	'
Repositioning expenses	'	'	'	10.2	4.2	6
PDS [Member]	'	'	'	'	'	'
Restructuring Reserve [Roll Forward]	'	'	'	'	'	'
Repositioning expenses	'	'	'	1.8	1.9	0
Corporate [Member]	'	'	'	'	'	'
Restructuring Reserve [Roll Forward]	'	'	'	'	'	'
Repositioning expenses	'	'	'	3.8	0	1
Employee-related expenses [Member]	'	'	'	'	'	'
Restructuring Reserve [Roll Forward]	'	'	'	'	'	'
Repositioning expenses	'	'	'	15.5	4.6	4.3
Employee-related expenses [Member] | Commercial [Member]	'	'	'	'	'	'
Restructuring Reserve [Roll Forward]	'	'	'	'	'	'
Repositioning expenses	'	'	'	9.9	2.8	3.3
Employee-related expenses [Member] | PDS [Member]	'	'	'	'	'	'
Restructuring Reserve [Roll Forward]	'	'	'	'	'	'
Repositioning expenses	'	'	'	1.8	1.8	0
Employee-related expenses [Member] | Corporate [Member]	'	'	'	'	'	'
Restructuring Reserve [Roll Forward]	'	'	'	'	'	'
Repositioning expenses	'	'	'	3.8	0	1
Consulting, professional and project costs [Member]	'	'	'	'	'	'
Restructuring Reserve [Roll Forward]	'	'	'	'	'	'
Repositioning expenses	'	'	1.8	0.3	1.5	2.7
Consulting, professional and project costs [Member] | Commercial [Member]	'	'	'	'	'	'
Restructuring Reserve [Roll Forward]	'	'	'	'	'	'
Repositioning expenses	'	'	'	0.3	1.4	2.7
Consulting, professional and project costs [Member] | PDS [Member]	'	'	'	'	'	'
Restructuring Reserve [Roll Forward]	'	'	'	'	'	'
Repositioning expenses	'	'	'	0	0.1	0
Consulting, professional and project costs [Member] | Corporate [Member]	'	'	'	'	'	'
Restructuring Reserve [Roll Forward]	'	'	'	'	'	'
Repositioning expenses	'	'	'	$0	$0	$0

Refinancing_Expenses_Details

Refinancing Expenses (Details) (USD $)	3 Months Ended	9 Months Ended	12 Months Ended
In Millions, unless otherwise specified	Jan. 31, 2013	Jul. 31, 2013	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011	Dec. 14, 2012
Refinancing Expenses and Deferred Financing Costs [Abstract]	'	'	'	'	'	'
Refinancing expenses	$29	$29.20	$29.20	$0	$0	'
Early redemption penalty	'	23.8	'	'	'	'
Deferred financing costs written off	'	5.3	'	'	'	'
Other refinancing costs incurred	'	'	0.1	'	'	'
Deferred financing costs	'	22.7	'	'	'	'
Less original issue discount, net of accumulated amortization of $2.1 million	'	'	'	'	'	$17.30

Quarterly_Results_of_Operation2

Quarterly Results of Operations - Unuadited (Details) (USD $)

3 Months Ended

9 Months Ended

12 Months Ended

In Millions, except Per Share data, unless otherwise specified

Oct. 31, 2013

Jul. 31, 2013

Apr. 30, 2013

Jan. 31, 2013

Oct. 31, 2012

Jul. 31, 2012

Apr. 30, 2012

Jan. 31, 2012

Jul. 31, 2013

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2011

Schedule of Quarterly Financial Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

Revenues

$290

[1]

$265.70

[2]

$253.90

[3]

$213.50

[4]

$210

[5]

$203.70

[6]

$181.50

[7]

$153.90

[8]

'

$1,023.10

$749.10

$700

Gross profit

78.6

[1]

71.1

[2]

57

[3]

42.4

[4]

55.4

[5]

55.5

[6]

34

[7]

14.4

[8]

'

249.1

159.3

131.8

(Loss) income from continuing operations

11.3

[1]

4.3

[2]

0.1

[3]

-51.4

[4]

-23

[5]

15.5

[6]

-79.6

[7]

-19.3

[8]

'

-35.7

-106.4

-15.8

Loss from discontinued operations

-0.2

[1]

0

[2]

0

[3]

0

[4]

-0.1

[5]

0

[6]

-0.1

[7]

-0.1

[8]

'

-0.2

-0.3

-0.6

Net (loss) income attributable to restricted voting shareholders

11.1

[1]

4.3

[2]

0.1

[3]

-51.4

[4]

-23.1

[5]

15.5

[6]

-79.7

[7]

-19.4

[8]

'

-35.9

-106.7

-16.4

Basic (loss) income per share:

'

'

'

'

'

'

'

'

'

'

'

'

From continuing operations (in dollars per share)

$0.08

[1]

$0.03

[2]

$0.00

[3]

($0.38)

[4]

'

'

'

'

'

'

'

'

From discontinued operations (in dollars per share)

($0.00)

[1]

$0

[2]

$0

[3]

$0

[4]

'

'

'

'

'

'

'

'

Basic (loss) income per share (in dollars per share)

$0.08

[1]

$0.03

[2]

$0.00

[3]

($0.38)

[4]

'

'

'

'

'

'

'

'

Diluted (loss) income per share:

'

'

'

'

'

'

'

'

'

'

'

'

From continuing operations (in dollars per share)

$0.08

[1]

$0.03

[2]

$0.00

[3]

($0.38)

[4]

'

'

'

'

'

'

'

'

From discontinued operations (in dollars per share)

($0.00)

[1]

$0

[2]

$0

[3]

$0

[4]

'

'

'

'

'

'

'

'

Diluted (loss) income per share (in dollars per share)

$0.08

[1]

$0.03

[2]

$0.00

[3]

($0.38)

[4]

'

'

'

'

'

'

'

'

Earnings Per Share, Basic and Diluted [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

From continuing operations (in dollars per share)

'

'

'

'

($0.18)

[5]

$0.12

[6]

($0.61)

[7]

($0.15)

[8]

'

($0.26)

($0.82)

($0.12)

From discontinued operations (in dollars per share)

'

'

'

'

($0.00)

[5]

$0

[6]

($0.00)

[7]

($0.00)

[8]

'

($0.00)

($0.00)

($0.01)

Basic and diluted (loss) income per share (in dollars per share)

'

'

'

'

($0.18)

[5]

$0.12

[6]

($0.62)

[7]

($0.15)

[8]

'

($0.26)

($0.82)

($0.13)

Refinancing expenses

'

'

'

29

'

'

'

'

29.2

29.2

0

0

Impairment charge

'

'

'

'

'

'

57.9

'

'

13.1

57.9

0

Acquisition and integration costs

3.8

4

'

'

3.2

'

'

'

'

13.1

3.2

0

Repositioning expenses

4.8

4.6

2.5

'

'

'

'

'

'

15.8

6.1

7

Consulting fees related to strategic initiatives

'

0.4

'

'

'

1

6

6.4

'

'

'

'

Business Combination, Litigation Expense

2.4

'

'

'

'

'

'

'

'

6.4

0

0

Impairment of Long-Lived Assets to be Disposed of

1.8

'

'

'

'

'

'

'

'

'

'

'

Inventory Write-down

1.1

'

'

'

'

'

'

'

'

'

'

'

Canada [Member]

'

'

'

'

'

'

'

'

'

'

'

'

Schedule of Quarterly Financial Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

Revenues

'

'

'

'

'

'

'

'

'

22

13.7

12

Earnings Per Share, Basic and Diluted [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

Impairment charge

'

'

'

'

'

'

'

'

'

11.8

0

'

Canadian Operations [Member]

'

'

'

'

'

'

'

'

'

'

'

'

Earnings Per Share, Basic and Diluted [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

Release of valuation allowance reserves

'

'

'

'

36.6

'

'

'

'

'

'

'

Caguas Facility Closing [Member]

'

'

'

'

'

'

'

'

'

'

'

'

Earnings Per Share, Basic and Diluted [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

Repositioning expenses

'

'

'

4

'

'

'

'

'

1.3

1.7

4

Plan of Termination [Member]

'

'

'

'

'

'

'

'

'

'

'

'

Earnings Per Share, Basic and Diluted [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

Repositioning expenses

'

'

'

'

'

'

'

'

'

2.1

'

'

Banner Synergy Initiatives [Member]

'

'

'

'

'

'

'

'

'

'

'

'

Earnings Per Share, Basic and Diluted [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

Repositioning expenses

'

'

'

'

'

'

'

'

'

9.9

'

'

Bourgoin, France Facility Restructuring Initiative [Member]

'

'

'

'

'

'

'

'

'

'

'

'

Earnings Per Share, Basic and Diluted [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

Repositioning expenses

'

'

'

'

'

'

'

'

'

2.3

'

'

Consulting, professional and project costs [Member]

'

'

'

'

'

'

'

'

'

'

'

'

Earnings Per Share, Basic and Diluted [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

Repositioning expenses

'

'

1.8

'

'

'

'

'

'

0.3

1.5

2.7

Employee Severance [Member]

'

'

'

'

'

'

'

'

'

'

'

'

Earnings Per Share, Basic and Diluted [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

Repositioning expenses

'

'

'

'

'

'

'

'

'

15.5

4.6

4.3

Employee Severance [Member] | Plan of Termination [Member]

'

'

'

'

'

'

'

'

'

'

'

'

Earnings Per Share, Basic and Diluted [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

Repositioning expenses

'

'

'

'

'

'

4.4

'

'

'

4.4

'

Banner Acquisition [Member]

'

'

'

'

'

'

'

'

'

'

'

'

Earnings Per Share, Basic and Diluted [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

Acquisition and integration costs

'

1.2

'

4.4

'

'

'

'

'

'

'

'

Business Combination, Integration Related Costs

'

'

3.7

'

'

'

'

'

'

'

'

'

Olds, Canada Facility [Member] | Canada [Member]

'

'

'

'

'

'

'

'

'

'

'

'

Earnings Per Share, Basic and Diluted [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

Impairment charge

'

'

'

10.1

'

'

'

'

'

11.8

'

'

Impairment of Long-Lived Assets to be Disposed of

1.7

'

'

'

'

'

'

'

'

11.8

'

'

In Process Research and Development [Member]

'

'

'

'

'

'

'

'

'

'

'

'

Earnings Per Share, Basic and Diluted [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

Impairment charge incurred

'

'

'

'

'

'

'

'

'

0.1

'

'

In Process Research and Development [Member] | Banner Acquisition [Member]

'

'

'

'

'

'

'

'

'

'

'

'

Earnings Per Share, Basic and Diluted [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

Impairment charge

'

'

'

'

'

'

'

'

'

1.3

'

'

Impairment charge incurred

'

$1.20

'

'

'

'

'

'

'

$1.20

'

'

[1]

Income from continuing operations includes $4.8 million in repositioning costs relating primarily to Banner, Puerto Rico, and Swindon, $3.8 million in acquisition-related costs relating primarily to the pending merger that was announced on November 18, 2013, $2.4 million in acquisition-related litigation costs, $1.8 million in impairment primarily relating to the Olds, Alberta, Canada facility, and $1.1 million for inventory write-off's in gross profit associated with the Olds, Alberta, Canada closure.

[2]

Income from continuing operations includes $4.6 million in repositioning costs relating primarily to Banner and our operation in Bourgoin, France, $4.0 million relating to acquisition-related litigation costs, $1.2 million in acquisition-related costs relating primarily to Banner, $1.2 million in impairment of IP R&D, and $0.4 million in consulting fees relating to strategic initiatives.

[3]

operations included $2.5 million in repositioning costs relating primarily to Banner, $1.8 million in consulting fees relating to strategic initiatives, and $3.7 million in integration-related costs relating to the Banner Acquisition

[4]

Loss from continuing operations included $29.0 million in refinancing expenses, $10.1 million in impairment expenses of the Olds, Alberta, Canada facility, $4.4 million in acquisition costs related to the Banner Acquisition, and $4.0 million in repositioning expenses relating primarily to Banner.

[5]

Loss from continuing operations included $36.6 million from recording of a valuation allowance against the Company's Canadian deferred tax assets and $3.2 million of acquisition-related costs.

[6]

Income from continuing operations included $1.0 million of consulting fees related to strategic initiatives.

[7]

Loss from continuing operations included a $57.9 million impairment charge, $4.4 million of repositioning expenses related to the Plan of Termination and $6.0 million in consulting fees related to strategic initiatives.

[8]

Loss from continuing operations included $6.4 million of consulting fees related to strategic initiatives.

Subsequent_Events_Narrative_De

Subsequent Events - Narrative (Details) (Arrangement Agreement With JLL/Delta Patheon Holdings, L.P. [Member], Subsequent Event [Member])	0 Months Ended			0 Months Ended
	Nov. 19, 2013	Nov. 19, 2013	Nov. 19, 2013	Nov. 19, 2013	Nov. 19, 2013	Nov. 19, 2013	Nov. 19, 2013	Nov. 19, 2013
	USD ($)	Restricted Stock [Member]	Preferred Stock [Member]	JLL Partners, Inc. Affiliates [Member]	Parties to The Voting Agreements Eligible to Vote in Majority-of-the-Minority Vote [Member]	Agreement Termination, Scenario One [Member]	Agreement Termination, Scenario Two [Member]	$1.65 Billion Commitment by J.P. Morgan, UBS, Jefferies, Morgan Stanley, and Key Bank [Member]
		USD ($)	CAD	USD ($)		USD ($)	USD ($)	Letter of Credit [Member]
								USD ($)
Subsequent Event [Line Items]	'	'	'	'	'	'	'	'
Percentage of total restricted voting shares held by related party	66.08%	'	'	56.00%	20.45%	'	'	'
Sale of Stock, Price Per Share	'	$9.32	'	'	'	'	'	'
Share Price	'	'	9.72	'	'	'	'	'
General Partners' Capital Account, Expected Investment	'	'	'	$60,000,000	'	'	'	'
Limited Partners' Capital Account, Expected Investment	'	'	'	50,000,000	'	'	'	'
Face value	'	'	'	'	'	'	'	1,650,000,000
Equity Financing, Aggregate Contribution Expected	489,000,000	'	'	'	'	'	'	'
Loss on Contract Termination	23,640,000	'	'	'	'	'	'	'
Arrangement Agreement, Termination Fee, Receivable	'	'	'	'	'	$49,260,000	$24,630,000	'